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Abstract 
Lead (Pb), arsenic (As) and manganese (Mn) are metals with neurotoxic effects that are 
present in mines as metal mixtures, making miners potentially vulnerable to an 
increased risk of neurotoxicity. Biomarkers can be crucial tools to detect these 
disorders in their earlier stages enabling patients to avoid the disease progression. 
Several biomarkers for Pb, As and Mn have been investigated, yet only for single 
exposures despite the different metals can interact within the brain. The aim of this 
work was to identify biomarkers of neurotoxicity which may be used to control and 
prevent the risk of chronic low levels exposure to the mixture of Pb, As and Mn. After 
performing an in vivo assay with Wistar rats repeatedly exposed (for 8 days) to Pb, As, 
Mn or the 3-metal mixture, the co-exposure increased behavioral toxicity and 
augmented Pb’s deposition in brain more than upon single exposures, with blood Pb 
levels failing to reflect this alteration, thus, contributing to underestimate the risk 
associated with Pb-induced damages. Mechanistic insights concerning the 
consequences of in vivo Pb, As and Mn interactions revealed changes in 
neurotransmitters and heme precursors’ levels in the brain. Changes of these BMs in 
peripheral samples suggested their suitability to be used as BMs of exposure and/or 
neurotoxicity upon exposure to this mixture. A multibiomarker approach based on 
multiparameter analysis of independent markers was used; the results suggest that the 
combination of biomarkers is a better tool to predict the type of exposures and the 
magnitude of neurotoxic effects, better than when used alone. A preliminary human 
study in a mining population was performed to apply the results obtained in the in vivo 
model. According to the results, the miners might be exposed to excessive levels of Pb, 
As and Mn, and the integration of experimentally selected BMs, Pb and Mn blood 
levels and urinary Pb, As and delta-aminolevulinic acid levels, revealed to be a good 
tool to identify excessive exposed workers. Exploration of BMs’ integration 
methodologies seems certainly promising to assess “real-life” scenarios of exposure to 
chemical mixtures. 
 
Keywords 
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Resumo 
 
 
Introdução: O aumento crescente da exposição humana a metais é atualmente um 
problema de Saúde Pública. De entre os diversos metais, o chumbo (Pb) e o arsénio 
(As) são dos principais metais detetados em diversos contextos ambientais, e no que 
se refere ao Mn, as suas emissões são também significativas com efeitos nefastos para 
a saúde pública dado a sua vasta utilização na indústria metalúrgica. Os três metais 
têm efeitos neurotóxicos e estão presentes na forma de misturas em diversos locais de 
trabalho, como nas minas, resultando para os mineiros um risco acrescido de 
neurotoxicidade. A exposição a metais com efeitos neurotóxicos leva frequentemente 
a desordens neurológicas crónicas, progressivas, sem sinais de alerta, e quando os 
sintomas são clinicamente percetíveis, os efeitos podem ser muitas vezes irreversíveis. 
É neste contexto que os biomarcadores podem constituir ferramentas cruciais para a 
deteção de exposições excessivas a metais e assinalar atempadamente o aparecimento 
de efeitos adversos na fase inicial, enquanto o efeito tóxico for ainda reversível. 
Diversos biomarcadores têm vindo a ser propostos para avaliação da exposição ao Pb, 
ao As e ao Mn, contudo apenas para exposições a cada um dos metais isoladamente. 
Embora estudos de mecanismos de interação de metais no cérebro sejam conhecidos, 
há ainda muito trabalho a desenvolver no que respeita à pesquisa de biomarcadores 
de neurotoxicidade induzida pela exposição a misturas de metais. Nesta perspetiva, a 
Toxicologia Preditiva é uma área que utiliza ferramentas estatísticas para integrar os 
resultados experimentais de modelos toxicológicos (in vitro e in vivo) e 
epidemiológicos. Esta área tem vindo a revelar-se promissora na deteção precoce de 
diversas doenças, nomeadamente as neurodegenerativas integrando resultados de 
painéis de biomarcadores de exposição e efeito. Pretendeu-se com este trabalho 
identificar biomarcadores de neurotoxicidade para o controlo e prevenção do risco de 
exposição crónica à mistura de Pb, As e Mn. Os objetivos específicos consistiram em: i- 
avaliar efeitos neurotóxicos induzidos por esta mistura num modelo in vivo; ii- estudar 
o mecanismo das interações entre o Pb, o As e o Mn na sua disposição em órgãos alvo; 
iii- identificar a co-exposição e estimar a severidade dos efeitos neurotóxicos através 
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de procedimentos preditivos, mediante a integração de biomarcadores recorrendo a 
ferramentas estatísticas; e iv- fazer a translação dos resultados experimentais obtidos 
no estudo in vivo para um estudo preliminar realizado numa população de mineiros 
co-expostos aos mesmos metais. Metodologia: foi realizado um ensaio de exposição 
repetida com cinco grupos de ratos Wistar a que foram administradas 8 doses de, Pb 
(5 mg/Kg/dia), As (60 mg/L) e Mn (10 mg/Kg/dia), sendo nos Grupos I, II e III 
administrado cada metal isoladamente, no Grupo IV, administrada a mistura dos 
metais, e tendo constituído o Grupo V, o grupo controlo. A atividade motora foi 
avaliada no início da experiência e 24 horas após a administração da última dose, 
assim como a recolha de urina de 24h. No final do ensaio e após o sacrifício dos ratos 
procedeu-se à recolha do sangue, cérebro, rim e fígado para determinação dos 
seguintes biomarcadores: níveis dos 3 metais em todas as amostras biológicas, 
atividade da acetilcolinesterase no cérebro e no sangue, níveis de ácido delta-
aminolevulínico e o perfil de porfirinas no cérebro e urina, prolactina no soro e 
porfirinas totais na urina. Os resultados obtidos foram utilizados para selecionar 
biomarcadores periféricos de exposição e efeito considerando que: 1) os melhores 
biomarcadores de exposição permitiam distinguir de entre os ratos expostos a cada 
metal, ratos expostos à mistura dos 3 metais, e ratos controlo; 2) e os melhores 
biomarcadores de efeito apresentavam uma boa correlação com os resultados obtidos 
nos ensaios de atividade motora. Os biomarcadores selecionados em 1) e 2) foram 
posteriormente integrados, em procedimentos preditivos recorrendo a ferramentas 
estatísticas. Aplicaram-se 2 procedimentos preditivos: o primeiro combinando os 
níveis dos 3 metais no sangue e/ou urina, as concentrações urinárias de ácido delta-
aminolevulínico e das porfirinas totais, a atividade da acetilcolinesterase no sangue e a 
prolactina no soro; e o segundo, integrando o perfil urinário das porfirinas, uma 
alternativa mais prática e menos dispendiosa. Cada um dos procedimentos consistiu 
numa 1ª fase que recorrendo a análise discriminante, visou identificar o tipo de 
exposição de cada rato, e numa 2ª fase, que através de análise de regressão 
multivariada se destinou a estimar a magnitude dos efeitos neurotóxicos. Através de 
um estudo preliminar, os 2 procedimentos preditivos foram testados posteriormente 
numa população de mineiros de uma mina no Alentejo em que os trabalhadores 
estavam co-expostos ao Pb, As e Mn. Neste estudo preliminar foram utilizadas 2 
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populações controlo: um grupo de indivíduos de uma área urbana (Lisboa) e um grupo 
constituído pelos trabalhadores administrativos da empresa mineira que vivem numa 
zona rural. Resultados: os ratos tratados com a mistura de Pb, As e Mn diminuíram 
significativamente (p<0,05) a atividade motora relativamente aos restantes grupos, 
exceto relativamente à atividade vertical quando comparada com o grupo exposto ao 
Pb. Foram detetadas interações significativas (p<0,05) entre os três metais ao nível do 
cérebro. Neste órgão, os níveis de Pb e ácido delta-aminolevulínico revelaram-se mais 
elevados (p<0,05) quando comparados com os ratos tratados com apenas um dos 
metais, e a atividade da acetilcolinesterase diminuiu significativamente (p<0,05), 
quando comparada com os controlos e com os ratos tratados unicamente com As. 
Apesar de não relevantes, detetaram-se também alterações no perfil de porfirinas no 
cérebro. No que diz respeito aos níveis de metais no sangue, não foram observadas 
diferenças significativas entre o grupo tratado com a mistura e os grupos tratados com 
apenas um dos metais, e não foram igualmente detetadas diferenças na atividade da 
acetilcolinesterase entre os 5 grupos. As concentrações de prolactina no soro de ratos 
co-expostos revelaram-se significativamente (p<0,05) mais elevadas que nos controlos, 
assim como a excreção urinária de Pb, Mn, ácido delta-aminolevulínico e porfirinas 
totais quando comparadas com todos os restantes grupos (p<0,05). Além disso, as 
alterações destes biomarcadores observadas em amostras periféricas foram sugestivas 
da sua aplicabilidade como indicadores da co-exposição e de efeitos neurotóxicos. 
Contudo nenhum biomarcador isoladamente se revelou ser suficiente para identificar 
o tipo de exposição e/ou prever a intensidade dos efeitos neurotóxicos. Desta forma 
optou-se por combinar os biomarcadores recorrendo a ferramentas estatísticas. A 
integração de biomarcadores no primeiro procedimento permitiu identificar 
corretamente o tipo de tratamento administrado a cada rato em 96,7% dos casos. Por 
sua vez, a atividade motora dos ratos co-expostos foi estimada pelo modelo com um 
erro de 11% na atividade horizontal (relativo ao número médio de movimentos dos 
ratos controlo) e de 13% na atividade vertical. A integração do perfil urinário das 
porfirinas levou à classificação correta do tipo de exposição em 90% dos ratos e teve a 
capacidade de estimar a severidade das desordens motoras com erros de 11 e 16%, 
para as atividades horizontal e vertical, respetivamente. Quanto aos resultados obtidos 
no estudo preliminar realizado nos trabalhadores das minas, estes trabalhadores 
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apresentaram os níveis dos 3 metais aumentados no sangue, embora tratando-se de 
uma alteração ligeira e sem significado estatístico relativamente aos trabalhadores 
administrativos (controlo). A excreção urinária de Pb, As e Mn revelou-se mais elevada 
que em ambos os grupos controlo, embora as diferenças observadas nos níveis de Pb 
não tivessem significado estatístico. A atividade da acetilcolinesterase no sangue e a 
excreção de porfirinas totais revelou-se significativamente mais elevada, ao comparar 
estes valores com os dos trabalhadores administrativos. A aplicação de procedimentos 
preditivos obtidos experimentalmente conduziu à identificação correta de 97,1% de 
todos os indivíduos quanto ao seu tipo de exposição. Por sua vez a integração do perfil 
urinário de porfirinas classificou corretamente 61,7% dos casos. Conclusões: Este 
trabalho evidenciou que a co-exposição ao Pb, As e Mn através de um modelo 
experimental aumentou significativamente a toxicidade a nível da atividade motora, 
quando comparada com a exposição a cada um dos metais separadamente. O 
tratamento com a mistura levou também ao aumento da acumulação de Pb no 
cérebro e no rim, relativamente à exposição ao Pb isoladamente. Além disso, verificou-
se que os níveis de Pb no sangue de ratos co-expostos não refletiram a acumulação 
acrescida de Pb no cérebro, o que pode implicar que o risco de neurotoxicidade 
induzido pela exposição à mistura de Pb, As e Mn seja subestimado através da 
monitorização da exposição através do doseamento de Pb no sangue. A co-exposição a 
estes metais revelou pela primeira vez consequências da interação destes elementos 
ao nível de neurotransmissores e à acumulação de precursores da síntese do heme no 
cérebro, que quando em excesso podem atuar como toxinas. As alterações destes 
biomarcadores observadas em amostras periféricas foram sugestivas da sua 
aplicabilidade como indicadores da co-exposição e de efeitos neurotóxicos, mas 
nenhum revelou ser específico do tipo de exposição quando aplicado isoladamente. 
Desta forma a integração dos biomarcadores selecionados revelou-se a melhor 
ferramenta preditiva, tanto em ratos como no estudo em humanos no que concerne à 
identificação da exposição. No que se refere á seleção de biomarcadores preditivos de 
neurotoxicidade e estimativa da magnitude dos efeitos neurotóxicos, esta só foi obtida 
no estudo em ratos, mas mais estudos em humanos estão previstos a curto termo. A 
combinação de biomarcadores de exposição e efeito no controlo da exposição a 
 x 
 
misturas de metais é uma nova abordagem que poderá contribuir para a prevenção do 
risco de neurotoxicidade nos contextos ocupacionais abordados.  
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1.1. Metals in the environment 
 
Pollution is a world problem with immeasurable consequences and toxic metals are 
compounds frequently found as their components (Rodrigues et al, 1996) because their 
intensive use by modern society has, over the years, leaded to an increase of their levels 
in the biosphere (Al-Attar, 2011; Kakkar and Jaffery, 2005). Elevated concentrations of 
metals in the environment as a result of human activities have been recorded since 
ancient times (Wong et al, 2006), particularly since the middle of the 19th century, when 
the production of heavy metals increased steeply for more than 100 years. At the end of 
the 20th century, the emissions of heavy metals started to decrease in developed 
countries, however in less developed regions is even increasing (Järup, 2003). As generally 
considered, there are no frontiers for pollution and therefore, globally the contamination 
of the environment with heavy metals continues to grow. Furthermore, industrial metallic 
emissions into the atmosphere can have a short life-time (few days), but they travel long 
distances from their point of emission, accumulate on land and form sediments in lakes 
and rivers, where their lifetime can reach from a few hundred years to several thousand 
years (Rodríguez et al, 1998). Unlike organic chemicals, metals are neither created nor 
destroyed by biological or chemical processes (Wong et al, 2006) and consequently they 
can accrue in  the environment,  passing  up  to the food  chain and accumulate in the 
tissues of living organisms (Al-Attar, 2011). For these reasons, metals exposures to 
general population, through air, food or drinking water has become an increasing and a 
global phenomenon (Martinez- Finley et al, 2012; Wong et al, 2006).  
 
 
1.1.1. Environmental exposure to metal mixtures 
 
Along with actual apprehensions pertaining to human exposures to metals, it is becoming 
recognized that environmental exposures are not to single chemicals. The truth is that 
exposure to mixtures is the environmental reality in a nowadays chemically sophisticated 
world (Simmons, 1995). All environmental media have naturally occurring mixtures of 
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metals and metals are often introduced into the environment as mixtures (Fairbrother et 
al, 2007). These mixtures are ubiquitous in air, water and soil (Simmons, 1995) and thus, 
people  are  exposed  either concurrently  or  sequentially, by  various  routes  of exposure 
and from  a variety  of  sources,  to  a large  numbers  of  toxicants at low doses that may 
result in similar or dissimilar effects over exposure periods that can range from short-
term to a lifetime (ASTDR, 2000,  Pohl et al, 1997). In this perspective, and according with 
the public concern, the U.S. Environmental Protection Agency (EPA) recommends greater 
efforts on the understanding of the combined toxic effects of metals (ASTDR, 2000; 
Fairbrother et al, 2007), although the undergone studies have been largely concerned 
with single exposures (Kortenkamp and Faust, 2009; Pohl et al, 1997). To  illustrate, in 
1994, 94.3%  of  122  technical  reports  from  the  National  Toxicology  Program  
described  the  chronic  toxicity  of  single  chemicals (Simmons, 1995) and still in 2006,  
most  of  the  performed studies  focused  on  the  adverse health  effects  of  toxic  metals  
were  conducted  on populations  with  relatively  high  exposure  and  the majority 
considered  individual  metals (Kossowska et al, 2013). Until when mixtures are viewed as 
a simple collection of a few component chemicals, the poor understanding of the nature 
and the magnitude of toxicological interactions will lead to great uncertainties (ASTDR, 
2000) and the practical consequence of the strategy of studying single metal exposures 
may be the fail, underestimating the health risks of affected populations (Kordas et al, 
2010; Kortenkamp and Faust, 2009). Further,  we  are  defied  to  assess  the potential  
health  risk  of  multiple  exposures, and gradually  substitute  (unrealistic)  single  
compound-oriented  standard  setting  for mixture-oriented  (real life-oriented)  standard  
setting   (Feron et al, 1995).  
 
Fortunately studies of chemical mixtures are starting to progress by incorporating more 
knowledge of specific modes of toxicological action and greater use of statistical methods 
and mathematical models (ASTDR, 2000).  Even so, predicting the health consequences of 
multiple chemical exposures is still a challenge (Pohl et al, 1997) because their study 
incorporates the understanding of interactions at several levels occurring: i) in the 
environmental media that may modulate the external exposure (external dose), ii) during 
processes of speciation, binding and transport; iii) at  site(s) of uptake and/or elimination 
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from the organisms, resulting in modifications of the total accumulated internal dose; iv)  
and at the target site may affecting the binding of one of more chemicals to a receptor 
through which toxicity may be mediated. These interactions may change toxicokinetics 
and toxicodynamics (Spurgeon et al, 2010). That way mixtures can inﬂuence the expected 
adverse health effects and this is particularly worrying when the components of the 
mixture individually attack the same organs or, together, overwhelm a particular 
mechanism essential for the organism to defend itself against toxic substances (Calderon 
et al, 2003), eventually resulting in greater (synergistic) toxicity (Lister et al, 2011). Low 
doses that might not individually cause health effects, in concert may become a public 
health issue (Calderon et al 2003).  It is reported that exposure to metal mixtures at 
concentrations below environmental quality guideline levels for individual components 
resulted in adverse effects, that were attributed to interactions among the components 
(Yen Le et al, 2013). This matter was recently recognized by the U.S. EPA as a key gap in 
metal risk assessments (Abboud and Wilkinson, 2013); thus, a demand exists for the 
research into the toxicity of metals, very specially as regards to metal mixtures in trace 
levels (Kim et al, 2009). 
 
  
1.1.2. Criteria to select metal mixtures 
 
Given the almost infinite number of chemical mixtures, regulators are faced with the 
problem of the choice of chemicals to joint assessment and regulation (ASTDR, 2004; 
Kortenkamp and Faust, 2009). Components produced and emitted together from an 
industrial process or that occur together in the same environment or human body 
compartment are certainly to be considered (despite there are still considerable 
knowledge gaps concerning to mixture of chemicals present in human tissues). Chemicals 
thought to exhibit their effects through common mechanisms have been often grouped 
together based on similarities in chemical structure or derived from mechanistic 
considerations. Recently it has been argued that grouping criteria should focus on 
common adverse outcomes, with less emphasis on similarity of mechanisms (Kortenkamp 
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and Faust, 2009) and that attention should be  focused  on  those  having  the  greatest  
potential  impact  on  human health (ASTDR, 2004). Also, for practical purposes, criteria 
are needed to define the relevant components of a mixture. Such criteria cannot rely 
simply on the concentrations of the compounds in the mixture, but must also take note of 
the expected contribution to relevant endpoints of toxicity (Kortenkamp and Faust, 2009). 
Reproductive, carcinogenic and neurotoxic effects are considered potentially important 
health end points in epidemiological studies of complex mixtures, most particularly when 
such mixtures contain trace metals (Shy, 1993). Exposure to neurotoxic agents represents 
indeed a concern of high priority in modern society, given the constantly increasing 
reported frequency of neurological diseases (Lucchini and Zimmerman, 2009), where 
apprehension has been also growing with respect to the induced long-term effects 
(Emerit et al, 2004).  
 
Metals have several particularities that should be taken in account when accessing the 
risks of their exposure: metals can be transformed by biological or chemical processes 
into species with different valence states and be converted between inorganic and 
organic forms. All these forms may present different behaviors, such as absorption, 
distribution, transformation, and excretion and/or different toxicities; metals do not 
require metabolic activation to become toxic or, conversely, to be detoxiﬁed and 
excreted. Some metals are nutritionally essential elements at low levels, but are toxic at 
higher levels (e.g. manganese [Mn]), while others have no known biological functions 
[e.g., lead (Pb) and arsenic (As)]; because metals naturally occur in the environment, 
many organisms developed speciﬁc mechanisms for its uptake and deposition, specially 
the accumulation of essential metals. All these particularities can impact the use and 
interpretation of bioaccumulation data and toxicity of metals (Fairbrother et al, 2007).  
 
1.1.3. Sources of Pb, As and Mn 
 
Pb and As are among the leading toxic agents detected in the environment (Järup, 2003). 
A recent assessment on the global health impacts of contaminants identiﬁed As and Pb 
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among the six most toxic pollutants threatening human health (Csavina et al, 2012); these 
elements have been extensively studied, with their effects on human health regularly 
reviewed by international bodies such as the World Health Organization (WHO) (Järup, 
2003). Mn is also of great environmental and public health signiﬁcance due to its broadly 
use in many areas of the metal industry (ASTDR, 2007b); in addition Mn (along with Pb 
and As) is included in a list of metals of primary interest for environmental agencies like 
EPA (Fairbrother et al, 2007). 
 
Pb is naturally present in the earth’s crust where it may exist in three oxidation states, Pb 
(0), Pb (II) and Pb (IV). In the environment, Pb primarily occurs as Pb (II), while the 
occurrence of Pb (0) is less common and Pb (IV) only forms under extremely oxidizing 
conditions. Organic Pb compounds can also be found as organolead (II) but organolead 
chemistry is dominated by the tetravalent (IV) oxidation state.  Due to its low melting 
point, easy molding and excellent corrosion resistance Pb is extensively used by men 
(ASTDR, 2007c). Pb usage may have begun prior to 2000 B.C., when abundant supplies 
were obtained from ores as a by-product of smelting silver (Casarett and Doull's, 2007). 
Excessive releases of toxic trace metals into the environment associated with health 
implications only became apparent in the 1960s and merely when anthropogenic Pb 
contamination of the urban environment was denoted. In that decade Patterson (1965) 
wrote that ‘‘the industrial use of Pb is so massive today that the amount of Pb mined and 
introduced into our relatively small urban environments each year is more than 100 times 
greater than the amount of natural Pb leached each year from soils by streams and added 
to the oceans over the entire earth ’’ (Wong et al, 2006). During the last century the 
majority of Pb emissions to ambient air resulted from burning gas, coal, oil and waste 
with over 50% of these emissions originated from petrol. It is estimated that body 
burdens of Pb in humans in the modern era are 1000-fold higher than during the 
preindustrial era (Finkelstein et al, 1998). Fortunately over the last few decades, Pb 
emissions in developed countries have markedly decreased and happened mainly due to 
the abolishment of leaded gasoline, with a subsequent decrease of blood Pb levels in the 
general population (Järup, 2003). However, since Pb is a persistent element (Patrick, 
2006) past emissions are still a matter of concern. It is estimated that the combustion of 
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leaded gasoline has accounted for 90% of the Pb that until today is still deposited in the 
atmosphere. Moreover a number of developing countries continue to use leaded 
gasoline, still contributing to Pb elevated levels in the atmosphere and other human 
activities, such as metal smelting, also contribute to significantly release Pb in 
atmosphere, (ASTDR, 2007b). Airborne Pb can be deposited on soil and water, reaching 
humans via the food chain. Nowadays, drinking water is a great source of Pb exposure, 
estimated to be responsible for approximately 20% of the total daily exposure 
experienced by the majority of the U.S. population (Patrick, 2006).  
 
The metalloid As is particularly difficult to characterize as a single element because it has 
a complex chemistry and there are many different As compounds, with different 
oxidation states, each one inducing different toxicities. This element may naturally occur 
in rocks, soil, water and air (Järup, 2003; Rodríguez et al, 2003) being present as trivalent 
or pentavalent forms; concerning toxicity, the trivalent form is the most toxic. The most 
common inorganic trivalent As compounds are As trioxide, sodium arsenite, and As 
trichloride. Pentavalent inorganic compounds may occur as As pentoxide, As acid, and as 
arsenates, such as Pb arsenate and Ca arsenate. Organic As compounds may also be 
trivalent or pentavalent and occur in methylated forms resulting from biomethylation in 
living organisms, such as mammals, and also in others which are present in soil, fresh 
water and seawater. When compared with inorganic As, the methylated metabolites are 
less reactive with the tissue constituents, less acutely toxic, less cytotoxic, and more 
readily excreted in urine (Casarett and Doull’s, 2007; Jomova and Valko, 2011). Due to its 
wide distribution in Nature arsenical compounds have been known since primordial times 
and were used in ancient Greece and Rome as cosmetics, therapeutic agents but also as 
poisons. During the Middle Age and Renaissance, As continued to be used as a poison 
namely in France and Italy, until the discovery by Marsh in 1836 of a sensitive method to 
detect As in the tissues of the victims (Rodríguez et al, 2003). Nowadays, the public health 
concerns pertaining to As are different, and regards to chronic exposures (Hughes et al, 
2011; Moinuddin, 2004). Indeed due to the presence of As in the environment, 
attributable to natural (e.g. geothermal discharges) and anthropogenic sources (e.g. 
fungicides, industrial products and wastes), exposure of millions of persons to As-
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contaminated water is a major concern in many Asiatic countries, where the largest 
population at risk by groundwater As contamination is in Bangladesh. Several other 
countries deal with similar harms, namely India, Cambodia, Myanmar, Nepal and Vietnam 
(ASTDR, 2007a; Kakkar and Jaffery, 2005; Jarup, 2003). Smelting of non-ferrous metals 
and the production of energy from fossil fuel are the two major industrial processes that 
lead to As contamination of air, water and soil. Smelting activities are the largest 
anthropogenic source of atmospheric pollution (Jarup, 2003), being estimated that 40% of 
the total atmospheric emissions of As arise from these operations (Csavina et al, 2012). 
Other sources of contamination are industrial products and wastes such as, agricultural 
pesticides (insecticides and fungicides), wood preservatives and antifouling paints (Jarup, 
2003; Kakkar and Jaffery, 2005; Martinez-Finley et al, 2012).  
 
Mn is the 12th most abundant element in Nature and represents approximately 0.1% of 
the earth’s crust. In its natural form, Mn usually exists as oxides, carbonates, and silicates, 
with Mn dioxide the most commonly found (Martinez-Finley et al, 2012). This transitional 
metal can exist in 11 different oxidation states, from III to VII, being the most common 
valence in biological systems is II (Casarett and Doull's, 2007).  Mn is an essential element 
and despite only few cases of Mn deficiency have been reported in humans, its deficiency 
can lead to serious health disorders (Santamaria, 2008). However, when in excess Mn 
may also cause a wide range of deleterious effects (ASTDR, 2007c) being the diet, drinking 
contaminated water and inhalation the main sources to the general population (Wright et 
al, 2006). In recent years this metal has received increasing attention, since there have 
been indications that it could become a successor to Pb in urban settings in terms of 
pervasiveness and long-term adverse health effects (Wong et al, 2006). Indeed, organic 
Mn is becoming highly present in the environment through the substitution in several 
countries of leaded-gasoline for the antiknock gasoline additive methylcyclopentadienyl 
manganese tricarbonyl (MMT). The European Union and Japan have thus far opted 
against MMT but the compound was approved for use in Argentina, Australia, Bulgaria, 
Canada, Russia, and conditionally in New Zealand. Also in the U.S., it was decided that the 
use of MMT is compatible with catalytic converters and has granted a waiver for its use in 
unleaded gasoline (Gulson et al, 2006; Menkes and Fawcett, 1997). MMT usage has 
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already been associated with increased Mn atmospheric concentrations (Gulson et al, 
2006) and elevated levels of Mn in children's blood have been detected in regions where 
the additive is allowed (Batterman et al, 2011; Gulson et al 2006). Nowadays, 
environmental exposure to Mn, through MMT, is an emerging issue still with little 
information (Batterman et al, 2011).  
 
 
 
1.2. Occupational exposure to chemical mixtures  
 
Occupational illnesses are adverse health conditions, occurring with different types of 
severity and related to chemical or physical factors during work.  An occupational illness 
may develop over time following repeated exposure to a hazard, such as a chemical, and 
the consequent clinical manifestations may vary with the dose and time of exposure. In 
this perspective, Occupational Toxicology applies the principles and methodology of 
toxicology toward chemical hazards encountered at work.  Sometimes, health problems 
become clinically apparent long after the exposure, even after employment has ended, 
turning difficult the treatments and the establishment of the causal link between the past 
exposures and the chronic diseases and/or diseases with long latencies, such as are the 
neurotoxic outcomes. Therefore anticipation is crucial in these contexts, being the main 
objective of Occupational Toxicology to prevent adverse health effects in workers that 
arise from their work environment (Casarett and Doull’s, 2007).   
 
Millions of workers are employed in manufacturing, mining, construction and other 
industries, where signiﬁcant amounts of airborne metals and metal compounds are 
generated and may cause occupational illness (Ashley, 2009; Félix et al, 2013). Many 
workers are exposed to high levels of Pb during activities like the manufacture of 
batteries, sheet lead, bronze plumbing, ceramic glazes, caulking, radiation shields, circuit 
boards and military equipment (Patrick, 2006) and low or moderate exposure may also 
take place in the glass industry (Järup, 2003). Occupational exposures to As occurs as well 
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in several industries, particularly in nonferrous smelting, electronics, wood preservatives, 
glass manufacturing and application of arsenical pesticides (Kakkar and Jaffery, 2005). The 
most prominent occupations involving exposure to Mn are mining, namely during ore-
crushing, ferromanganese production, smelting and welding (Weiss, 2005). Mn is also 
found in high concentrations in various other industrial settings, as it is used in the 
manufacturing of dry-cell batteries, production of Mn-containing organic pesticides, 
ﬁreworks, ceramics, glass, leather, textiles, paint and cosmetics (Martinez-Finley et al, 
2012; Nelson et al, 2012). Descriptions exist in these settings where excessive Mn 
exposure is associated with several negative health outcomes (Wright et al, 2006). 
 
 
1.2.1. Occupational exposure in mines 
 
Mining is one of the most hazardous activities for workers (Coelho, 2013) being this 
occupation  long recognized as arduous and liable to injury and disease; the reason is that 
miners are subject to physical, chemical, biological, ergonomic and psychosocial 
occupational health hazards, during the mining and also during the associated 
metallurgical processes (Donoghue, 2004). In the perspective of mining tasks, mineral 
production can be divided into two general phases: the extraction phase, which consists 
on removing material from the earth, and the processing phase which separates the 
mineral component from the ore. Commonly but not quite correctly, the word “mining” is 
used to describe the phase of extraction, whereas processing describes the phase of 
preparing the product for human use, but usually the people involved in both processes 
are called miners or mineworkers (Dahtrak and Nandi, 2009). During both tasks workers 
are exposed to large amounts of mine dust with various potentially toxicants for eight 
hours/day and six days/week over a lifetime (Donoghue, 2004). Low-dose chronic 
exposure to toxic substances results in the accumulation of toxicants in the body (Dahtrak 
and Nandi, 2009); since some degree of minerals processing is usually undertaken at mine 
sites, it happens during the processing of ore but also during the associated metallurgical 
processing, which may involve great risks because air concentrations of pollutants exceed 
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even those experienced during the mining of the ore. Furthermore, heat and humidity are 
in deep underground mines, where the virgin rock and air temperatures increase with 
depth, due to the geothermal gradient and auto-compression of the air column 
(Donoghue, 2004). Thus, in mining environment, where dermal and inhalational 
exposures predominate (Dahtrak and Nandi, 2009), inhalation is the primary route of 
metals exposure (Fairbrother et al, 2007), and the intensity of exposure is often higher 
due to increased respiration rates (Dahtrak and Nandi, 2009). Bearing in mind that 
mixtures of neurotoxic metals are present in these settings, this is a quite relevant matter 
because in the olfactory epithelium the dendrites of the primary olfactory neurons are in 
contact with the nasal lumen, and these neurons are connected to the olfactory bulbs in 
the brain. Consequently, materials which come into contact with the olfactory epithelium 
can be transported to the olfactory bulbs and even further into other areas of the brain 
(Tjälve and Henriksson, 1999).  The most commonly studied occupational health problems 
of miners all over the world are silicosis, coal workers' pneumoconiosis, asbestosis, etc., 
but there is a need to study other effects of toxic materials in the mining environment. 
Whereas acute toxicity is rare in the mining industry, low-dose chronic exposure may 
result in insidious poisoning that may manifest clinically at a very late stage, and cases of 
miners with elevated blood levels/body burden of toxicants with vague/no symptoms are 
not rare. In these cases traditional early warning symptoms of toxicity are often 
nonclassical because of subclinical toxicity and the possibility of multi-toxicant effects 
(Dahtrak and Nandi, 2009). It is hence considered vital to monitor mine workers for low 
toxic levels of mixtures so that subclinical poisoning may be identified at an early stage 
(Dahtrak and Nandi, 2009; Kakkar and Jaffery, 2009).   
 
 
1.2.2. Mining activity as a relevant source of exposure to Pb, As and Mn 
 
Mining is one of the oldest activities in human civilization and still a vital economic sector 
for many countries (Coelho et al, 2013). However, mining operations pose a great 
potential risk to the environment and to human health (Ericson et al., 2008) since 
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constitute a signiﬁcant contributor to  pollution of the air, soil and water with a complex 
mixture of metals (Moreno et al, 2010). In a recent comprehensive assessment of the 
worst environmental pollution problems, activities associated with mining operations 
were identiﬁed as fourth of the world's top ten pollution problems (Erikson et al, 2004). 
Mining is a process that begins with the search of mineral deposits and continues with its 
exploration through ore extraction and processing, which consist of excavating, crushing, 
grinding, separation, smelting, reﬁning and management of tailings. It also includes the 
closure and the remediation of worked-out sites (Ericson et al., 2008; Csavina et al, 2012). 
The environmental and the health impact occur at all of these stages (Ericson et al., 2008) 
because the vast majority of mining operations produce coarse dusts at high 
temperatures, potentially laden with the metals and metalloids that are present in the 
ore. The release of coarse dusts does not occur only in the mine area, but also happens 
during the transportation of ore with haul trucks and trains (Csavina et al, 2012). Pb, As 
and Mn are among the major toxicants present in mining environments (Basu et al, 2011; 
Choudhury and Mudipalli, 2008; Dahtrak and Nandi, 2009; Yim, 2006) with workers and 
populations living near mining sites exposed to soil and dust containing higher levels of 
this toxic mixture (Rodríguez et al, 1998). Accordingly, Pb and As contamination have 
been reported in smelter and mining areas located in different countries, such as Poland, 
Russia, United States, Mexico, Bolivia, Chile, Peru, Brazil, Philippines, Zimbabwe and 
Tanzania ( Calderon et al, 2003). Water contamination with these elements was reported 
in Zambia (Ndilila et al, 2013) as well as in soil, air and household dust in Mexico 
(Calderon et al, 2003). Also the analysis of the components of a mining waste in Villa La 
Paz (México), revealed the presence of the three elements, Pb, As and Mn (Espinosa-
Reyes et al, 2014). In Europe about 2.75 billion tons of mining wastes have been produced 
between 1998 and 2001. Mining and quarrying waste account for 15% of the total waste 
in Western Europe and for 31% in the former Eastern European countries (Grangeia et al, 
2011).  
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1.2.3. Mining activity in Portugal 
 
In Portugal, mining and quarrying activities generated 17 Mt in 2001 representing 58% of 
the total industrial waste (Grangeia et al, 2011) and nowadays, mining still plays an 
important role in both local and Portuguese economies. However, in some locations the 
activity is still performed in an uncontrolled way, giving rise to serious environmental 
contamination. More than a few environmental studies performed in mines and mining 
surrounding areas in Portugal report anomalous concentrations of metals and metalloids 
in stream sediments, superﬁcial and groundwater from local courses, road dust, soils and 
plants for human consumption from nearby villages (Coelho et al, 2013). Soils from the 
abandoned Pb mine in Braçal had concentrations of Pb higher than the values allowed for 
agricultural practice (Anjos et al, 2012) and the analysis of heavy metals in wild ﬂora soils 
suggested that metal contamination,  especially with Pb, is a matter of great concern in 
the Barbadalhos area (Pratas et al, 2013). Also in the abandoned Ribeira mine in the 
northeast of Portugal, the highest degree of pollution was for As (Ferreira da Silva et al, 
2009a) and another area near a closed mine in northern Portugal as well as in abandoned 
uranium mines in Cunha Baixa were highly contaminated with Mn (Carvalho et al, 2013; 
Neves et al, 2012). Contaminations with binary mixtures of these elements are also 
reported in several regions of Portugal. In Coval da Mó mine a huge contamination with 
Pb (with mean values exceeding 376 times background values) was found in water and 
Mn was also present in high concentrations (Ferreira da Silva et al, 2009b). The levels of 
Pb and As in surface water near Panasqueira mine exceeded the reference limits for 
water quality proposed by the Portuguese Law (Grangeia et al, 2011) and surface waters 
near the Lousal mine were also contaminated with these elements (Silva, 2009). High 
concentrations of Pb and As were recorded in the soil near the mine of S.Domingos 
(Pereira et al, 2004) and water contamination with As and  Mn  was reported in  northern  
Portugal  mining  areas, near  old  Sb-Au mines  (Carvalho et al, 2013). The co-occurrence 
of the three metals, Pb, As and Mn, in higher levels was described in stream sediments 
that received direct drainage from an abandoned uranium mine in Pinhal do Souto, in 
Central Portugal (Neiva et al, 2013). Some authors mention that Portuguese mining 
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activities may adversely affect the health of communities living near mine sites and also 
the health of miners (Coelho et al, 2013), who are exposed to higher levels of these toxic 
elements. These informations justify undoubtedly the need to assess the health 
consequences for workers from Portuguese mines. In Portugal higher levels of Pb, As and 
Mn were already determined in biological matrices of workers and populations living near 
the Panasqueira mine (Coelho et al, 2013). In Southeast Alentejo higher concentrations of 
As and Mn were recorded in peripheral samples of individuals living near a mine and also 
in subjects that frequently consumed milk and cheese obtained from cattle breeding in 
the area (Pereira et al, 2004). 
 
 
 
1.3. Toxicity of metals 
 
Metals can bioaccumulate being stored in both soft and hard tissues of living organisms 
(Martinez- Finley et al, 2012) and thus, even the exposure to low levels can lead to long 
term toxic effects (Dahtrak and Nandi, 2009). Metals disrupt metabolic processes by 
altering a number of homeostatic processes, which may include antioxidant balance, 
binding to free sulfhydryl groups (-SH) and compete for binding sites on enzymes, 
receptors and transport proteins (Martinez-Finley et al, 2012). Pb is considered a 
dangerous toxicant (Sansar et al, 2011) that may cause neurotoxicity, hypertension, 
anemia, renal impairment and interfere with sperm production (ASTDR, 2007b; 
Reckziegel et al, 2011; Patrick, 2006).  Pb compounds are reasonably anticipated to be 
human carcinogens based on limited evidence from studies in humans and sufficient 
evidence from animal studies (ASTDR, 2007b).  The metalloid As can induce cancer, 
genotoxicity and affect the hematopoietic system, liver, kidneys, skin and brain (Halatek 
et al, 2009). Exposure to As through drinking water may cause stomach and intestine 
irritation as well as decreased production of red and white blood cells.  The exposure to 
As has also been reported to increase the risk of cancer in skin liver, bladder and lungs. 
Long-term Mn exposure is usually associated with central and peripheral nervous system 
  
16 
 
disorders. Reproductive outcomes might be affected, with decreased libido, impotence 
and sexual dysfunction. There is no evidence that Mn causes cancer in humans as well as 
no firm conclusions can be drawn from studies with animals suggesting carcinogenic 
effects (ASTDR, 2007c). 
 
 
1.3.1. Neurotoxicity 
 
Neurotoxicity may be defined as any adverse effect, permanent or reversible, on the 
structure or function of the central and/or peripheral nervous system induced by a 
biological, chemical or physical agent that diminishes the ability of an organism to survive, 
reproduce or adapt to its environment (Costa, 1996; Costa and Manzo, 1995). The 
nervous system can in truth compensate for the toxic effects caused by low doses of 
neurotoxicants, but a prolonged or lifetime exposure even to its very low levels, can lead 
to delayed neurodegenerative effects (Lucchini and Zimmerman, 2009), with a 
progressive loss of neural tissues (Rachakonda et al, 2004). That way neurotoxic effects 
can be seen as abiding legacies of processes whose roots lie buried in events or conditions 
occurring even decades earlier and frequently emerging after long latencies. The 
properties that clinically identify them may bear no more than a superﬁcial resemblance 
to those manifestations marking their prior stages, explaining why the earliest stages of 
such diseases may be confused with some other sources, like aging (Weiss, 2006). 
Neurotoxicity is a sensitive endpoint due to the unique and critical role of the nervous 
system in the control of body function, including the endocrine and the immune systems. 
Besides the limited ability of neurons to regenerate after injury, explains 
neurodegenerative disease related loss of function, as neurons die (Emerit et al, 2004; 
Mutii, 1999). These disorders may not be healed (Rachakonda et al, 2004) and hence the 
consequences of neurotoxic effects do not sweep through populations like inﬂuenza and 
then retreat. Rather, they are gradually progressive and the ability of their victims to 
effectively and efﬁciently function will be impaired at stages of the disease far earlier than 
its eventual detection (Weiss, 2006). Thus, an apprehension exists that in a near future 
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low-dose long-term exposure to metals may give rise to a society where lifelong loss of 
intelligence and motor capacities, permanent psychological disturbances and disruption 
of behavior shall be frequently prevalent, giving rise to an unhealthy stressful generation 
(Kakkar and Jaffery, 2005). These effects can produce reduction of economic productivity 
and the resulting economic impact may be even greater than the costs of metal pollution 
control itself (Landrigan et al, 2006). 
 
Chronic exposure to low levels of metals significantly contribute to neurological diseases 
in multiple populations around the world (Christensen, 1995; Wright and Baccarelli, 
2007). Many literature data demonstrate increased levels of metals in critical brain areas 
of neurodegenerative disease patients (Migliore and Coppedè, 2009). The brain may 
sometimes compensate for the effects of an individual chemical itself acting on a 
particular target system; inversely, when multiple targets or functional sites within one 
system are affected by different mechanisms (such as in multi-metal exposures) 
homeostatic capabilities may be impaired, thereby leading to cumulative damage 
(Lucchini and Zimmerman, 2009). The actual public health concern on the potential for 
exacerbated cognitive and behavioral deﬁcits resulting from children's exposure to 
multiple toxic metals is an example, with investigations on the effects on cognition of at 
least two metals together suggesting that combinations of metals may result in increased 
toxicity at this level (Kordas et al, 2010). Even so, the effect of mixture interactions on 
neurotoxicity remains largely unknown (Tiffany-Castiglioni et al, 2006). 
 
1.3.1.1. Neurotoxic effects induced by Pb, As and Mn 
 
There is conclusive evidence from experimental and epidemiological investigations that 
Pb, As and Mn can induce neurotoxicity. The three metals accumulate in the brain 
(ASTDR, 2007a,b,and c)  and the central nervous system (CNS) is a primary target for Pb 
and Mn (Santos, 2008; Yadav et al, 2011) being neurotoxic effects considered as their 
critical endpoints (Dukhande et al, 2006; Landrigan et al, 2007; Reckziegel et al, 2011; 
Reddy et al, 2003;  Rodríguez et al, 2010). Pb and Mn induced neurotoxicity is mainly 
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associated with a CNS dysfunction, whereas As toxicity has been often associated with 
peripheral nervous system (PNS) alterations. However As CNS effects have been reported 
in experimental models and humans (Calderon et al, 2003). Additionally, the three 
neurotoxic elements share common mechanisms of toxicity such as the induction of 
oxidative stress (OS) (García-Chávez et al, 2006; Patrick, 2006; Zhang et al, 2004) a 
condition to which the CNS is highly sensitive (Migliore and Coppedè, 2009). Therefore, 
Pb, As and Mn are relevant elements in the perspective of neurotoxicity induced by 
mixtures of metals and studies on the interaction of the mixture of these elements are 
certainly necessary. 
 
Lead 
 
The CNS is a primary target for Pb toxicity (Finkelstein et al, 1998), with the analysis of 
deceased Pb smelter workers leading to find that Pb accumulation in brain was higher 
than not occupationally exposed persons (Gerhardson et al, 1995). In cases of exposure to 
high levels of Pb acute encephalopathy may occur with failure of the blood brain barrier 
(BBB) function (Lockitch, 1993). This structure is highly vulnerable to the toxic action of Pb 
and once damaged, Pb itself and other toxicants can easily enter in the brain (Zheng et al, 
2003), which in the perspective of exposure to mixtures in occupational contexts is a 
relevant event. In vivo experiments also showed that the cerebral cortex and the basal 
ganglia are intensely affected by Pb poisoning. Pb exposure may lead to basal ganglia 
degeneration, resulting in impairment of neuromuscular coordination and motor control, 
being actually motor activity in open-ﬁeld a behavioral parameter experimentally used to 
assess Pb-induced behavioral toxicity (Moreira et al, 2001). Indeed, performed 
experiments already leaded to observe smaller number of crossing and rearing 
movements in rats (Reckziegel et al, 2011) but also sensory function impairment was 
observed even at low concentrations (Mameli et al, 2001). In addition, because Pb 
exposure can affect virtually  all the neurotransmitters  in  the brain, such as  
dopaminergic, cholinergic and glutaminergic systems, most frequently early symptoms of 
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Pb  neurotoxicity include varied signs such as irritability,  fatigue, depression, head-ache,  
decreased  attention,  memory  loss  and low-level cognitive impairment (Patrick, 2006).  
 
Despite there is no direct animal test parallel to human IQ tests, a wide variety of assays 
performed in animals to assess attention, learning and memory suggest that Pb exposure 
of animals leads to a global deficit, in the same way as it is indicated by decrements in IQ 
scores in exposed children (ASTDR, 2007b; Finkelstein et al, 1998; Patrick, 2006). Children 
exposed to Pb may also exhibit symptomatic manifestations of the clinical Attention 
Deficit Disorder (Finkelstein et al, 1998; Menkes and Fawcett, 1997) along with 
delinquent behavior, sensory effects (such as hearing and vision) and deficits in 
neuromotor function (ASTDR, 2007b; Finkelstein et al, 1998). These manifestations were 
accessed with high Pb body burden conditions, but also with lower blood Pb values such 
as near or below 10 µg/dL (ASTDR, 2007b; Finkelstein et al, 1998; Patrick, 2006). Pb can 
also affect the PNS with children having blood Pb levels as low as 0.96 µmol/L exhibiting 
subclinically impaired peripheral nerve function, shown by slowing the motor nerve  
conduction (Lockitch, 1993). In adults a most common neurological symptom of Pb 
exposure is peripheral neuropathy involving extensor muscle groups (Lockitch, 1993;  
Patrick, 2006) and weakness or paralysis  of the  wrist, with histopathology analysis 
showing segmental axonal demyelination and degeneration (Lockitch, 1993). This 
situation is more common in chronically exposed workers, where blood Pb concentration 
exceeds 14 μg/dL (a possible threshold). Postural sway abnormalities and essential 
tremor, particularly for those with genetic susceptibility to Pb exposure, is also 
documented. It is recognized that past occupational exposure to Pb increases the risk of 
developing amyotrophic lateral sclerosis and motor neuron disease (ASTDR, 2007b).  
 
Another matter of concern related with chronic exposures to Pb is the fact that the metal 
can accumulate in bones for 20 years or more (Casarett and Doull's, 2007) and may be 
released long after the exposure has ceased, due to age-related increases in the rate of 
bone breakdown (van Wijngaarden et al, 2011). Animal studies showed that mobilization 
of Pb from bone co-occurs with increased levels in the brain (Finkelstein et al, 1998). That 
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way, past exposure to Pb continues to be a concern later in life even in the absence of 
concurrent external exposure sources, with increasing evidences that Pb exposure may 
contribute to age-related cognitive deﬁcits (ASTDR, 2007b). While chelation is the 
conventional recommendation for acute Pb toxicity with encephalopathic damage, 
treatment for chronic low-level exposure is still under investigation and issues 
surrounding the consequences of low-level environmental exposure are still required 
(Patrick, 2006). 
 
Arsenic 
 
The effects of As in nervous system have received considerably less attention than other 
systems (Rodríguez et al, 2003) and thus to date, limited information exists about the 
effects of As exposure as well as about cellular and molecular mechanisms of the induced 
neurological effects (García-Chávez et al, 2004). The most consistent behavioral change in 
rats after As administration—as arsenic trioxide, sodium arsenate or sodium arsenite — is 
decreased in motor activity (horizontal and vertical parameters) (Yadav et al, 2009), 
although some neurobehavioral studies also showed that mice exposed to arsenic 
trioxide can have a biphasic response on motor activity. Indeed, a low dose of arsenic 
trioxide (3 mg/kg) was able to increase motor activity, while a high dose (10 mg/kg) 
leaded to it decrease (Rodríguez et al, 2001). Changes within the basal ganglia may be 
involved in these effects, but today there is not enough data to attribute the observed 
behavioral changes to a speciﬁc action of As on any particular region of the brain. Other 
CNS functions also seem to be impaired by As, such as learning and memory, with rats 
exposed to sodium arsenate showing a delay in the acquisition of an operant task 
(Rodrigues et al, 2003; Flora et al, 2009). In humans As neurotoxic effects are described in 
children chronically exposed via drinking water (Batterman et al, 2011) and also in 
exposed workers (Flora, 2011).  
 
Since the ﬁrst descriptions of neurological injury caused by As in humans were mostly 
case reports of peripheral neuropathies following its inhalation or ingestion (Rodrigues et 
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al, 2003), the effects of As in the PNS are better documented than in the CNS (Yadav et al, 
2009). Indeed several works described symmetrical peripheral neuropathy, with sensory 
nerves more sensitive than motor nerves, along with neurons with large axons being 
more affected than the ones with short axons. Histological examinations showed that 
axonopathy and demyelination are the main changes in nerves induced by As and a 
detailed inspection of the distal portion of the nerves showed fragmentation and 
resorption of myelin. In some nerves there was a reduction, fragmentation or complete 
degeneration of the axons (Rodrigues et al, 2003). Other cases refer impaired conduction 
velocity in peripheral motor or sensory nerves (Halatek et al, 2009) and clinical symptoms, 
such as numbness and paresthesia of the distal extremities (Halatek et al, 2009; Rodrigues 
et al, 2003; Yadav et al, 2009). Peripheral neuropathy was also present in 15% of residents 
from a community immediately surrounding a pesticide packaging plant that released As-
containing compounds in the form of windblown dust for several years (from 1925 to 
1985). These individuals showed signiﬁcant differences in grip strength, ﬁnger tapping, 
hand–eye coordination and tremor. This study was conducted in 1996 thus showing that 
neurological deﬁcits in the PNS after chronic exposure to As can be long lasting. In 
occupational contexts smelter workers showed a signiﬁcant correlation between 
decrement of nerve conduction velocity in peripheral nerves and exposure to 50 g of 
As/m3 in air in the working area (Rodrigues et al, 2003).  
 
With respect to the CNS, As easily crosses the BBB and although not much information 
exists about the precise targets of As in brain, basal ganglia has been shown to be quite 
vulnerable and As can also have marked effects on corpus striatum, hippocampus and 
cortex (Yadav et al, 2009). Gharibzadeh and Hoseini (2008) suggested that As exposure 
may be a risk factor for Alzheimer's disease (AD) by inducing apoptosis in cortical neurons 
(Rodrigues et al, 2003), having been the exposure to this element also associated with 
Parkinson disease (PD) (de Vizcaya-Ruiza et al, 2009). Children exposed to As and other 
metals in San Luis Potosí also showed symptoms of CNS alterations, such as impaired 
learning and memory, sleep disturbances, abnormal performances and altered latency of 
auditive evoked potentials (Mejía et al, 1995; Yadav, 2009). In patients with occupational 
exposure to As, encephalopathy in cases of acute exposure was already observed and 
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description exist about impairments of superior neurological functions such as learning, 
recent memory and concentration (Mejía et al, 1995; Rodrigues et al, 2003). Exposure to 
As can also lead to behavioral alterations and  namely, a patient who repaired a smelting 
furnace without respiratory protection exhibited disorientation, severe agitation, 
paranoid ideation and emotional liability (Rodrigues et al, 2003). Also, Morton and Caron 
(1989) described the case of two workers occupationally exposed to As fumes that 
displayed increased irritability; in one worker the symptoms improved 3 months after 
cessation of the exposure while in the other, four weeks after the exposure the urinary As 
level was within normal limits. In some cases the severity of the symptoms can be 
described as related to the duration of the exposure and the symptoms tend to disappear 
after the end of the exposure  (Rodrigues et al, 2003), while in other cases the effects are 
irreversible (Flora, 2011). 
 
Manganese 
 
Mn presents a special conundrum for risk assessment because is a potent neurotoxicant 
but it is also an essential nutrient (Weiss, 2005). Mn is required for many essential 
enzymatic reactions (Wright and Baccarelli, 2006) having a role in a variety of metabolic 
functions including those involved in skeletal development, energy metabolism, 
activation of certain enzymes, immunological system, reproduction hormone and also in 
nervous system function. In the brain, Mn is a cofactor of several enzymes, including the 
antioxidant enzyme superoxide dismutase (SOD) and also enzymes involved in 
neurotransmitter synthesis and metabolism (Santamaria, 2008). Thus, a deﬁciency in Mn 
can lead to serious adverse effects involving the CNS, such as the impairment of 
neurological functions, seizures and mental retardation (Wong et al, 2006).  
 
On the other hand Mn can be toxic to several organs, where the critical target organ is 
precisely the CNS, with induced adverse effects documented at lower levels of exposure 
comparing with other systems (Health Canada, 2008). In vivo studies reveal that following 
manganese chloride (MnCl2) administration striatal Mn concentrations could increase by 
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205%; in another experiment, after exposure to Mn phosphate and Mn phosphate/sulfate 
mixture, the Mn concentrations in the striatum reached higher levels than the controls 
(116 and 147%, respectively) (Normandin et al, 2004). Other experiments with mice 
demonstrated that repeated injections with Mn resulted in its  increase  in  brain  and  
blood,  with levels  in  brain  appearing  to  persist  at  consistently higher  levels for  
longer  periods. These  results  suggest  that  the  slowly  developing neurotoxicity  in  
response  to  Mn  exposure  may  be due  to  a  persistent  retention  of  this element  by  
the  brain  (Gianutsos et al, 1985), being Mn pointed as a possible long-term cumulative 
neurotoxicant (Jiang et al, 2007). The major behavioral effect induced in exposed rodents 
upon exposure to Mn is the modification of spontaneous motor activity. Some studies 
describe an increased motor activity that occurs in the initial phase of toxicity, while 
others report Mn-induced reduction in motor activity with no initial increase (Health 
Canada, 2008; Normandin et al, 2004). Mn also induces learning impairments in rodents 
(Health Canada, 2008).   
 
Epidemiological data suggest that high concentrations of Mn in drinking water may be 
associated with neurological impairment (Weiss, 2005). Nevertheless neurotoxic effects 
induced by Mn in humans emerge almost exclusively from inhalation exposure, although 
this exposure route has not been well studied in rats (Health Canada, 2008). Even so, it is 
achieved that inhaled Mn bypasses the gut and can enter the brain in two ways: 1) 
through the olfactory pathways providing a direct path into the brain tissue (Weiss, 
2005); 2) and through the lungs (Weiss, 2005). In 1) Mn has been found to be taken up 
and pass transneuronally to other parts of the brain, with these events previously 
associated to occupational neurotoxicity induced by the inhalation of Mn (Tjälve and 
Henriksson, 1999. In 2) Mn is not sent directly to the liver, eliminating the first-pass effect 
and placing Mn available for direct delivery to the brain. Moreover, absorption within the 
respiratory tract is not thought to be under homeostatic regulation (Health Canada, 
2008). 
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The recognition of the neurotoxic properties of inhaled Mn came since the 19th century 
and concerns to the context of mines. As described by Couper (1837) four Mn ore 
crushers developed lower extremity predominant ‘‘muscular weakness’’, festination, 
postural instability, facial masking, hypophonia and sialorrhea. The  syndrome was  more 
clearly delineated by Rodier (1955) when he described a group of Moroccan Mn miners 
with a neurologic illness characterized by parkinsonism, gait disorder, dystonia, psychosis 
and emotional labiality (Nelson et al, 2012). Nowadays this syndrome is broadly 
documented and is known as “manganism”, a clinical and severely debilitating 
neurological disease that most frequently occurs in workers exposed through inhalation 
to very high levels of this metal (generally over 1 mg/m3), but that may also be induced by 
prolonged and subclinical exposure (Wong, 2006). Manganism is indeed identified in 
miners (Ramteke et al, 2009; Weiss, 2005) namely in workers involved in activities such as 
ore processing and welding (Antonini et al, 2006; Bowler et al, 2006; Weiss, 2005). This 
progressive syndrome typically begins with relatively mild nonspecific symptoms, which 
can gradually evolve to a severely debilitating disease (Ostiguy et al, 2005). Two or three 
clinical phases distinguish the development of chronic manganism. During the prodromal 
period, the disorders start gradually with symptoms that include asthenia, anorexia, 
apathy, headaches, hypersomnia, spasms, legs, arthralgia and irritability. This is followed 
by the intermediate phase in which signs such as speech disorders, clumsiness in 
movements and masked facial appearance show up. Finally, the late (or established) 
phase is characterized by muscular rigidity and tremor of the upper limbs (Ellingsen et al, 
2008; Normandin et al, 2004), among several other effects described in diverse 
occupational studies such as memory loss, impulsive-compulsive behaviors, abnormal 
laughter, psychotic experiences, impaired coordination and bradykinesia  (Weiss, 2005; 
Wong et al, 2006; Wright and Baccarelli, 2006). There are characteristics of manganism 
that resembles the neurodegenerative movement disorder PD in symptomatology and 
cellular mechanisms. This includes motor and postural signs consistent with those of PD 
as well as Mn-induced oxidative stress and also a selective toxicity towards dopaminergic 
neurons, which are involved in the regulation and control of movement (Normandin et al, 
2004). This overlap has led to debates about whether Mn neurotoxicity is truly a form of 
PD (Wasserman et al, 2011), while some authors defend that enough differences are 
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apparent to support the distinction (Weiss, 2005). Neurodegeneration in PD occurs 
primarily in the substantia nigra pars compacta, while in manganism the main evidence of 
degeneration is seen in the globus pallidus, with the nigrostriatal pathway usually 
preserved and exhibiting less severe damage in nearby structures including the striatum 
(putamen and caudate nucleus) and in the substantia nigra pars reticulate (Ellingsen et al, 
2008; Weiss, 2005). Additionally, despite in both PD and manganism there is a generalized 
bradykinesia and widespread rigidity, manganism differs from PD by a notably less-
frequent resting tremor, more frequent dystonia, a particular propensity to fall 
backwards, and a failure to achieve a prolonged therapeutic response to levodopa 
(Normandin et al, 2004). In any case the subclinical deficits observed in Mn-exposed 
subjects are consistent with damage of the basal ganglia in the brain (Health Canada, 
2008) where its accumulation has been seen in welders (Ellingsen et al, 2008).  Risk 
factors for manganism include liver diseases, that increase the body load of Mn and also  
alcoholism, whose effects add to the neurotoxic action of Mn (Ostiguy et al, 2005), being 
important to contemplate that this risk factor is relevant in mining environment ever 
since high prevalence of alcohol and drugs abuse may occur in these occupations (VWA, 
2014). Manganism is considered an irreversible condition, although some evidence exists 
that in the early stages of intoxication the symptoms may be reversible (Bowler et al, 
2006). It is also known that Mn neurotoxicity may manifest even years after the exposure 
has ceased, being neurological alterations reported for ex-miners in South Africa (Myers 
et al, 2003a). Nonetheless even considering the available information about manganism 
and Mn induced neurotoxicity, there is much to be learned and evaluated concerning 
prolonged exposure to low levels of this metal (Landrigan et al, 2007).  
 
 Binary mixtures  
 
Practically no reports are found respecting specifically to the neurotoxic effects induced 
by the mixture of Pb, As and Mn, except a few experimental works on their binary 
mixtures demonstrating interactions between the metals. The co-administration of Pb 
and Mn to rats leaded to observe that the gestational exposure to both elements reduced 
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brain’s weight in a greater extent than either metal alone (Kim et al, 2009a). Pb levels also 
increased in several brain regions like the cerebellum, cerebral cortex, corpus striatum, 
hippocampus and midbrain, as compared with the administration of Pb alone (Shukla and 
Chandra 1987). ln addition Pb increased the concentration of Mn in corpus striatum and 
midbrain as compared with Mn alone at the same dose (ASTDR 2007c; Shukla and 
Chandra 1987). Even very low doses of Pb plus Mn raised the striatal Mn and Pb 
concentrations (Shukla and Chandra, 1987).  Behavioral changes were also denoted such 
as a significant hypoactivity an aggravation of the aggressive behavior induced by Pb 
(Chandra et al, 1981). Tests of learning ability, that measured conditioned avoidance 
responses, showed that the mixture of Pb and Mn impaired learning in a greater extent 
than the single administration of Pb. These results suggest the  possibility  of  serious  
brain  dysfunctions in humans  after  co-exposure  to  even  subclinical levels  of the two  
metals through  a  polluted  environment (Shukla and  Chandra, 1987).  Accordingly EPA 
recommended further assessing of the potential hazard to public health of the joint toxic 
action of the Mn/Pb mixture, with relevance for the estimation of endpoints for 
neurological effects (ASTDR, 2004). In humans a positive correlation between Mn and Pb 
in blood was detected while the co-exposure to environmental Pb and Mn revealed to 
affect the intelligence of school-aged children (Kim et al, 2009b). A few studies were 
performed with other binary mixtures, such as the co-administration of Pb and As in rats 
resulting in increased Pb brain levels, along with decreased As concentrations (Mejía et al, 
1997). Neurotransmitter changes were also found over control values, alterations that 
were not elicited by either metal alone (Carrizales et al, 2006). The mixture of As and Pb 
showed to induce neuropsychological effects in children living in Morales (Mexico) 
despite in this study no conclusive results were obtained regarding to interactions 
between these elements (Carrizales et al, 2006). Some work exists as well with the 
mixture of As and Mn, where Rodriguez et al (1998) observed that As and Mn had a 
greater accumulation in rats’ brains comparing to animals with single metal exposures. In 
addition, higher hair As and Mn levels in humans were associated with signiﬁcantly lower 
scores on IQs test and also on verbal learning and memory tests. In some cases, a 
signiﬁcant Mn and As interaction was determined (Wright et al, 2006). With respect to 
the mixture of the three elements one study reported that when combined, Pb, As and 
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Mn were associated with changes in neurotransmitters. The authors concluded that the 
ﬁndings were complex, but the data clearly supported the concept that co-exposure to 
multiple metals could cause neurotoxic effects not seen with exposure to a single metal 
at the same dose (Wright and Baccarelli, 2009). 
 
 
 
1.4. Mechanisms of neurotoxicity induced by Pb, As and Mn 
 
 
1.4.1. Oxidative stress 
 
Oxidative stress (OS) is an important convergent point on the mechanisms of metal 
toxicity (Whittaker et al, 2010) representing a pathway that leads to the destruction of 
cells, including neurons and vascular cells in the CNS (Chong et al, 2005). This condition 
seems to be a leading mechanism of Pb (Adonaylo and Oteiza, 1999), As (Jomova and 
Valko, 2011; Rodríguez et al, 2003) and Mn (Erikson et al, 2004) neurotoxicity and either 
as a cause or as consequence, and directly or indirectly, OS is related with the biomarkers 
(BMs) of effect for these metals that will be focused along this work. By these reasons, a 
particular emphasis will be given to this deleterious condition.  
 
Oxidative stress can be deﬁned as an imbalance between biochemical processes leading 
to the production of reactive oxygen species (ROS) and those responsible for its removal 
(Sayre et al, 2008; Wang and Michaelis, 2010; Whittaker et al, 2003). In healthy conditions 
a wide variety of ROS are produced in cells during the course of the normal metabolism 
(Migliore and Coppedè, 2009). ROS formation occurs mostly as a byproduct of oxidative 
phosphorylation (Perry et al, 2002) since under physiological O2 levels 1–2% of the O2 
consumed is converted to ROS (Emerit et al, 2004; Migliore and Coppedè, 2009). The 
most common cellular free radicals are superoxide radical (O2
-•) and the hydroxyl radical 
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(•OH). Other molecules, such as hydrogen peroxide (H2O2) are not free radicals, but can 
lead to their generation through various chemical reactions (Gilgun-Sherki et al, 2001). 
Despite not much referred, ROS have several important functions in cells such as the 
modulation of critical cellular functions, notably for neurons, astrocytes and microglia, 
such as mitogene-activated protein (MAP) kinase cascade activation, ion transport, Ca 
mobilization and apoptosis program activation (Emerit et al, 2004). When excessive ROS 
accumulation occurs, cells possess an intricate network of defense mechanisms to 
neutralize them, including antioxidant compounds such as glutathione (GSH), arginine, 
taurine, creatine, Se, Zn, vitamin E, vitamin C, vitamin A and antioxidant enzymes like 
superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR) and glutathione 
peroxidase (GPx). Therefore, under physiological conditions, cells are able to cope with 
the ﬂux of ROS (Lawrence et al, 2005; Maes et al, 2011; Migliore and Coppedè, 2009) and 
its presence is inclusively a benefit. Oxidative stress rises when an excessive amount of 
these molecules accumulate and/or when cellular antioxidant defenses are insufﬁcient to 
keep the levels of ROS below a toxic threshold (Migliore and Coppedè, 2009; Wang and 
Michaelis, 2010). Since these reactive species contain one or more unpaired electrons 
they are more reactive and essentially capture electrons from other molecules present in 
the living tissues (Gilgun-Sherki et al, 2001). Not rarely these reactions result in the 
creation of a new radical (Qureshi et al, 2004) that can be just as damaging as the initial 
ROS (Migliore and Coppedè, 2009; Sayre et al, 2008). By this mean, reactive species are 
detrimental to cells (Emerit et al, 2004) damaging lipids, sugars, proteins, polynucleotides 
and inactivating enzymes and other proteins or inducing DNA strand breaks (Whittaker et 
al, 2011). The net result is cell damage and decreased viability of the cell system, leading 
to critical failure of biological functions and ultimately cell imbalance and death (Perry et 
al, 2002).  
 
Like other tissues, the brain is exposed throughout life to OS and certain nervous system 
diseases are thought to involve oxidative damage, either as a primary cause and/or as a 
consequence of disease progression (Gilgun-Sherki et al, 2001). The CNS is particularly 
vulnerable to oxidative insult, on account of the high rate of O2 utilization (Migliore and 
Coppedè, 2009) which is actually about one-ﬁfth of the oxygen consumed by the body 
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(Emerit et al, 2004; Lawrence et al, 2005; Migliore and Coppedè, 2009); In the brain there 
are also relatively poor concentrations of antioxidants and related enzymes like GPx and 
CAT, along with a high content of polyunsaturated lipids, biomolecules highly susceptible 
to oxidation (Migliore and Coppedè, 2009); Regionally high concentrations of redox-active 
transition metals exist, such as Fe, which is capable of the catalytic generation of ROS 
(Chong et al, 2005); the metabolism of neurotransmitters also produces ROS (Migliore 
and Coppedè, 2009). For all these reasons it is not surprising that OS is a common 
discussion point for neurodegeneration (Chong et al, 2005; Gilgun-Sherki et al, 2001; 
Sayre et al, 2008).  
 
The exposure to environmental chemicals can induce alterations in the cellular redox 
balance, being exposure to metals an important contribution for the development of 
oxidative events. Both oxidant-mediated damage and/or depletion of antioxidant 
molecules has been widely reported as the main mechanisms of metal-induced 
cytotoxicity (Campbell et al, 2001; Franco et al, 2009; Migliore and Coppedè, 2009), 
where abnormal tissue accumulation of redox-active transition metals (such as Mn) and 
also redox inert-metals (such as Pb and As) (Jomova and Valko, 2011; Sayre et al, 2008) 
induce perturbations of metal homeostasis, resulting an array of cellular disturbances 
(Campbell et al, 2001;  Jomova and Valko, 2011). Pb-induced OS has been identified as the 
primary contributory agent in the pathogenesis of Pb poisoning (Flora et al 2005; Gurer 
and Ercal, 2000; Reckziegel et al, 2011), with evidences of oxidative damage in several 
organs including the brain (Patrick, 2006). Free radical Pb-induced damage is 
accomplished by two independent although related mechanisms. The ﬁrst involves the 
direct formation of ROS including singlet oxygen (1O2), H2O2 and also the formation of 
peroxynitrite (ONOO−). The second one relies on Pb capacity to bind to enzymes with 
functional -SH groups, directly depleting antioxidant molecules containing these groups 
(Franco et al, 2009). Pb can deplete SOD, CAT and GPx (Franco et al, 2009; Jomova and 
Valko, 2011; Patrick, 2006; Reckziegel et al, 2011) leading to decreased reduced 
glutathione: oxidized glutathione (GSH: GSSG) ratios that will render cells more 
susceptible to oxidative damage (Gurer and Ercal, 2000). Depressed levels of GR and GPx 
were found in Pb occupationally-exposed workers (Casarett and Doull's, 2007). Moreover, 
  
30 
 
Pb conjugates directly with GSH (Franco et al, 2009; Jomova and Valko, 2011), which 
represents more than 90% of the non-tissue sulphur pool of human body. Reduced GSH 
levels were already observed in Pb-treated animals as well as in exposed workers (Gurer 
and Ercal, 2000). Pb is also known to have toxic effects on membrane structures 
enhancing lipid peroxidation (Ahamed and Siddiqui, 2007). 
 
Oxidative stress is currently the most widely accepted mechanism of As toxicity and is 
possibly the leading path for their induced neurological defects (Flora, 2011).  It is 
assumed that As can directly attack the mitochondria leading to the generation of ROS, 
namely via the uncoupling of the oxidative phosphorylation by As (V) (Franco et al, 2009). 
Concomitantly As species can either induce ROS, which target the mitochondria (Flora, 
2001; Franco et al, 2009) through several proposed paths: the generation of intermediary 
arsine species may produce signiﬁcant amounts of free radicals, where namely molecular 
oxygen can react with dimethylarsine to form dimethylarsinic radical [(CH3)2As•] and O2
-• 
and further, the addition of another molecule of O2 results in a dimethylarsinic peroxyl 
radical [(CH3)2AsOO•]; As species may also displace Fe and Cu from metalothionein (MT) 
and other metal-containing proteins (Jomova and Valko, 2011). In turn, these redox-
active metals play a central role in the generation of ROS by promoting the conversion of 
H2O2 into the highly reactive •OH radical through Fenton reactions; under physiological 
conditions the oxidation of arsenite [As (III)] to arsenate [As (V)] results in the formation 
of H2O2 (Flora, 2001); also As can mediate the formation of singlet oxygen (1O2) and nitric 
oxide (NO•) (Flora, 2001; Jomova and Valko, 2011). Accordingly, As-induced •OH 
generation was reported in the striatum of rats (Flora, 2001), with the presence of this 
reactive species associated with As-induced disturbances in the CNS (Jomova and Valko, 
2011). This metalloid can also intensively affects ROS-metabolizing enzymes including 
SOD, CAT, thioredoxin reductase as well as GPx, glutathione S-transferase (GST) and GR 
thus, interfering with GSH. Generally short-term exposure to low As concentrations 
results in increased activity of these enzymes, whereas chronic exposure usually results in 
their reduction (Flora, 2011; Franco et al, 2009; Jain et al, 2011; Jomova and Valko, 2011). 
Additional mechanisms exist for As-induced cellular GSH pools depletion, which are: via 
GSH-mediated reduction of pentavalent to trivalent arsenicals where GSH acts as an 
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electron donor; direct interaction of GSH with As; and GSH oxidation through As-induced 
generation of free radicals (Flora et al, 2005; Franco et al, 2009; Jomova and Valko, 2011). 
It must be emphasized that concerning the exposure to mixtures the depletion of GSH is a 
quite sensitive event, since may contribute to raise the toxicity of other metals (Jomova 
and Valko, 2011). 
 
Mn is a very interesting element concerning its OS mechanism of toxicity. At normal levels 
Mn plays a role against oxidative damage since is a constituent of mitochondrial Mn-SOD, 
contributing to keep O2
-• at nontoxic levels. On the other hand, when in higher 
concentrations Mn may induce OS (Milatovic et al, 2009) since may contribute precisely 
to the formation of the same species, the O2
-•. In cells the metal preferentially 
accumulates in mitochondria, where it disrupts oxidative phosphorylation by interfering 
with the mitochondrial electron transfer and increasing this way, the generation of ROS 
(Milatovic et al, 2009; Zhang et al, 2004). More explicitly proteins or quinones that 
participate in the transfer of electrons such as the complex I can be damaged by Mn and 
consequently the chain begins to donate electrons directly to O2 leading to the creation of 
the O2
-• (Erikson et al, 2004). Additionally the physiological cycling between Mn(II) and 
Mn(III) can also involve the induction of OS (Casarett and Doull's, 2007), through the 
following reactions:  
 
Mn (II) + O2 →  Mn (III) + O2 
-•  
Mn (II) + H2O2  → Mn (III) + OH
- + •OH 
 
 
In the brain, the pro-oxidant effects of both Mn (II) and Mn (III) have been conﬁrmed in 
vitro and in vivo studies, with the suggestion that Mn exposure enhances the rate of ROS 
generation in a dose-dependent manner (Erikson et al, 2004). It is also documented that 
rats exposed to Mn exhibited a signiﬁcant decrease of GSH levels in striatum and a 
signiﬁcant decreases in GPx activity in the cerebral cortex (Huang et al, 2011).  
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1.4.2. Interference with the dopaminergic system 
  
Dopamine (DA) is a neurotransmitter involved in a variety of CNS processes, like 
cognition, mood, attention and learning and most particularly, in motor activity (Clavier et 
al, 2009).  Thus, it is not surprising that alterations in DA transmission can adversely affect 
a variety of neurological processes leading to various debilitating behavioral disorders. 
Dopaminergic transmission is a complex process that occurs through several linked 
processes, including synthesis, release, uptake, storage and catabolism of DA. Tyrosine 
hydroxylase (TH) converts L-tyrosine to L-DOPA which in turn, is decarboxylated to DA by 
aromatic L-amino acid decarboxylase. Once synthesized, DA is packaged into synaptic 
vesicles and in response to a presynaptic action potential is released from the cell. Once 
released, DA activates a variety of postsynaptic receptors which are coupled to various 
cell signaling mechanisms. DA transmission is inactivated by reuptake of DA via the DA 
transporter (DAT) into the presynaptic neuron (Jones and Miller, 2008). During this 
process a relation exists between DA metabolism and OS since DA is easily metabolized 
via monoamine oxidase (MAO) or by autoxidation to produce cytotoxic ROS (Chong et al, 
2005). In the oxidation of DA by MAO, dihydroxyphenylacetic acid and H2O2 are 
generated and because in DAergic neurons transition metals are abundant, H2O2 can 
react with metals, specially Fe, to form the most cytotoxic radical  •OH. When non-
enzymatical and spontaneous autoxidation of DA occurs, O2
-• and reactive quinones are 
produced. To worsen when DA neurons are damaged, an excess amount of cytosolic DA 
exists outside the synaptic vesicule and is spontaneously oxidized. An interesting note is 
that DA quinones are also generated in the enzymatic oxidation of DA by cyclooxigenase 
(COX) (Miyazaki and Asanuma, 2009) and neuroinflammation (a potential source of ROS 
by itself) is caused by Pb, As and Mn (Kasten-Jolly et al, 2011; Shavali and Sens, 2008; 
Streifel, 2011). 
 
Neuronal damages induced by Pb may result in changes of DA transmission (Reckziegel et 
al, 2011), which is demonstrated by several animal studies (Rodríguez et al, 1998; Roses 
et al, 1989).  While neonatal exposure to low doses of Pb may result in increased DA 
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levels, a large dose leads to decreased levels, which suggests that the dose has a major 
impact on the effects of Pb on DA neurotransmission (Jones and Miller, 2008). The 
mechanisms through which inorganic Pb affects neurochemistry and behavior are still 
unknown (Struiyriska and Rafafalowska, 1994), but most of the available evidence 
suggests that Pb may impair regulation of DA synthesis and release, indicating a 
presynaptic site of action (ASTDR, 2007b, Reckziegel et al, 2011). Post-weaning exposure 
of rats to Pb resulted in hypersensitivity of D1 and D2 dopamine receptors, which can be 
interpreted as a compensatory response to decreased synthesis and/or release of DA 
(ASTDR, 2007b). Oxidative damages to the postsynaptic membranes has also been 
demonstrated (Reckziegel et al, 2011) and additionally Pb(II)/Ca(II) interactions might play 
an important role in the neurotoxicity of Pb, since Pb can mimic or displace Ca during 
neurotransmission processes, interacting at sites involved in the release of 
neurotransmitters. By blocking the influx of Ca ions into the presynaptic terminals during 
their depolarization by the nerve action potential, Ca-dependent DA release may be 
inhibited (Struiyriska and Rafafalowska, 1994). 
 
It is acknowledged that As can affect dopaminergic functions (Rodríguez et al, 2010) 
decreasing DA levels in exposed rats (ASTDR, 2007a), namely striatal DA (Rodríguez et al, 
1998); decreased striatal DA was also exhibited in animals treated with mining waste 
containing a high concentration of As (Bardullas et al, 2009).  As-induced changes in brain 
DA levels were also found to be linked with enhanced OS, being demonstrated that a 
mixture of As (III) and DA was synergistic concerning its ability to elicit the death of SH-
SY5Y cells, a human neuroblastoma cell line that retains dopaminergic differentiation. 
Raised DA-quinone leaded the authors to propose that As (III) together with DA could 
produce highly toxic free radicals (Shavali and Sens, 2007). Additionally, when antioxidant 
defenses are surpassed (the effect of As on antioxidant systems was previously referred) 
inorganic As may cause alterations at the transcriptional level in neurotransmission 
systems or in the afﬁnity of DA receptors. Again the formation of ROS may be involved, 
where H2O2 as a by-product of the reaction of inorganic As with oxygen could play a role 
as a disruptor of DA receptors gene expression, although further studies are necessary to 
conﬁrm this hypothesis (Rodríguez et al, 2010).  
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Mn is a potent dopaminergic neurotoxicant which ultimately leads to impairments in DA-
associated behaviors, explaining the specific effects on motor, memory and mood 
functions, usually associated with Mn overexposure (Finkelstein et al, 2007; Takser et al, 
2004). Actually, this metal seems to have a selectivity for dopaminergic neurons (Ellingson 
et al, 2003) where exerts cytotoxic effects that can lead to its degeneration and death 
(Jones and Miller, 2008; Prabhakaran et al, 2008). Experiments with mice feeded with 
Mn-enriched pellets showed striatal DA decrease, while other studies with rodents 
demonstrated decreased motor activity after Mn paralleled striatal DA loss dose–
dependent. More than 70% loss of striatal DA was recently reported after experimental 
exposure to Mn, through inhalation of an ultranebulized mixture of divalent and trivalent 
forms (Madison et al, 2012; Peneder et al, 2011; Takser et al, 2004). Oxidative stress 
seems to be involved in these events, more specifically via Mn-induced oxidation of DA 
(Erikson, 2004; Jones and Miller, 2008). It is believed that free radicals generated by Mn 
(II) ions increase the oxidation of this catecholamine, a process that is accompanied by an 
increase of quinones (Jones and Miller, 2008; Prabhakaran et al, 2008) with resulting OS 
and neurotoxicity, may causing dopaminergic cell death (Zhang et al, 2004). It is also 
postulated that DA auto-oxidation following Mn exposure activates intracellular signaling 
cascades, particularly nitric oxide synthase (NOS) potentiating dopaminergic toxicity 
(Prabhakaran et al, 2008). DAT may also mediate Mn accumulation in dopaminergic 
terminals or serve as a target for Mn-induced ROS which in turn, can lead to a disruption 
of DA metabolism (Jones and Miller, 2008; Ramteke et al, 2009). Some authors suggest 
that increased DAT levels observed in in vivo experiments upon exposure to Mn may be a 
compensatory response to Mn-induced DAT inhibition and that the transient increase in 
DAT levels may reﬂect an early event in Mn neurotoxicity, predisposing the DA cell to 
oxidative damage (Jones and Miller, 2008).  Mn may also interfere with Ca homeostasis 
aﬀecting in this way Ca – dependent DA release (Ramteke et al, 2009).  
 
Prolactin (PRL) is a polypeptide neurohormone synthesized and secreted from the 
lactotroph cells in the anterior pituitary gland. Aside from its action on reproduction and 
lactation, PRL plays important roles in the regulation of the immune system, osmotic 
balance and angiogenesis (Ellingson et al, 2003; Meeker et al, 2009; Rattanakul and 
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Lenbury, 2009). PRL is becoming increasingly used as a measure of 
neuroendocrine/dopaminergic function in environmental and occupational epidemiology 
studies (Meeker et al, 2009; Takser et al, 2004). In fact DA, along with other compounds, 
regulate the release of PRL (Meeker et al, 2009) since DA input from the hypothalamic 
tuberoinfundibular dopaminergic system (TIDA neurons), released into the hypothalamic 
hypophyseal portal system and bound to D2-receptors of lactotropes, are responsible for 
the secretion of PRL in the pars distalis (Clavier et al, 2009;  Ellingson et al, 2003;  
Marreiha dos Santos et al, 2011; Rattanakul and Lenbury, 2009) The activation of D2 
receptors result in increased K conductance that provokes hyperpolarization and 
inactivation of voltage-dependent Ca channels (Montes et al, 2011; Takser et al, 2005). A 
variety of other modulators of PRL secretion (e.g., serotonin and GABA) act at the 
hypothalamic level inhibiting or reinforcing the dopaminergic tone and by its turn the 
hypothalamic dopaminergic neurons (Marreiha dos Santos et al, 2011). Down regulation 
of the expression of PRL gene is an additional mechanism for the control of PRL release by 
DA (Montes et al, 2011; Takser et al, 2005). Decreased DA turnover in hypothalamus leads 
indeed to a corresponding increase in PRL levels in rats (Santos et al, 2008) and this 
evidence in humans has been corroborated by observations that drugs which interfere 
with DA release affect circulating PRL levels (Marreilha dos Santos et al, 2011).  
 
Pb ingestion may interfere with PRL secretion in pregnant mice leading to aggressive 
social behavior and again, increased serum PRL was associated to depression of inhibitory 
dopaminergic influence on pituitary PRL release. Additional mechanisms have been 
proposed from studies with pregnant women, where a relationship between serum PRL 
and blood Pb levels could be due to the PRL effect on bone metabolism which increases 
bone Ca mobilization during pregnancy. Given Pb’s capability to substitute Ca (Casarett 
and Doull's, 2007), Pb mobilization from maternal skeleton could be associated with 
elevated serum PRL levels (Takser et al, 2005). Also, Pb exposure in ﬁsh Catla catla caused 
a decrease in Ca content of bones, which was ascribed to the increased activity of PRL 
cells and consequent PRL release to restore decreased blood Ca (Srivastav et al, 2013). 
Biochemical mechanisms underlying Mn toxicity include free radical generation and DA 
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oxidation (Smargiassi and Mutti, 1999) where elevated serum PRL suggest DA disturbance 
(Montes et al, 2011).  
 
 
1.4.3. Interference with the cholinergic system 
 
The  cholinergic  system  is  involved  in  many  functions  of  the  nervous  system,  
ranging  from  vegetative  functions  (heart  rate, blood  pressure), to locomotion,  
muscular  contraction and  cognition. Thus, the consequences of disturbing this system 
are complicated and diverse (Finkelstein et al, 2007; Moser, 1995; Shen, 2004). 
Acetylcholine (ACh) is a neurotransmitter (Richetti et al, 2011) of this system and 
acetylcholinesterase (AChE) is an enzyme involved in the metabolism of ACh (Yadav et al, 
2011). The enzyme plays a role in the cessation of the impulse transmission at cholinergic 
synapses in the extracellular space, by rapid hydrolysis of ACh (Dvira et al, 2010) into 
choline and acetic acid. This reaction is necessary to allow a cholinergic neuron to return 
to its resting state after activation (Ali et al, 2010). Besides currently available evidence 
obtained from in vivo and in vitro experiments shows that AChE possess many other 
functions that do not seem to be solely related to their hydrolytic properties and include 
neurogenesis and its development, synaptogenesis and its development, neurotrophic 
activity, cell proliferation, cell differentiation, cell adhesion, cell plasticity, signal 
transduction, regulation of the BBB and glucose energy metabolisms (Shen, 2004). Several 
chemicals inhibit AChE causing neurotoxicity (Ali et al, 2010) namely through ACh 
accumulation  in  the  synaptic  cleft  with  overstimulation  of muscarinic  and  nicotinic  
ACh  receptors (Santos et al, 2011). AChE is anchored to the plasma membrane and there 
is evidence that lipid peroxidation aroused from OS can alter its activity (Ademuyiwa et al, 
2007; Santos et al, 2011; Rosenberg et al, 2010).  Also AChE  inhibition  in  rats’  brain may  
lead  to  oxidative  events  and  eventually  disrupt  the delicate balance between  ACh  
and  DA (Finkelstein et al, 2007) in  the  cholinergic-dopaminergic  system, where  ACh  is  
thought  to  act  directly  on  DAergic  terminals. Cholinergically induced release of DA that 
occurs in the presence of tetrodotoxin supports this supposition (Santos et al, 2012). 
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AChE is found in nervous tissues but also in the erythrocytes (Ali et al, 2010) and thus, 
measurements of AChE activity in blood are well accepted BMs of exposure to neurotoxic 
chemicals (Ali et al, 2010; Solé et al, 2008). Erythrocyte-AChE determinations are used in 
occupational medicine for periodical screening of agricultural workers exposed to 
organophosphorous pesticides (Finkelstein et al, 2007). Although much less studied than 
dopaminergic systems, cholinergic functions are also disturbed by Pb (Ademuyiwa et al, 
2007), As (Rodríguez et al, 2003) and Mn (ASTDR, 2007c). 
 
Pb exposure affects the cholinergic system mainly by reducing ACh release, uptake and 
turnover rates (Amal and Mona, 2009). In vitro and in vivo studies have also shown the 
inhibitory effects of Pb on AChE activity (Ademuyiwa et al, 2007; Finkelstein et al, 1998; 
Reddy et al, 2003), with whole brain AChE activity showing marked depletions (Tripathi et 
al, 1997). Some authors attribute arsenite effects to its interaction with the disulﬁde 
group of AChE (Flora, 2011; Rodríguez, 2003). In addition As enhances free radical 
generation and impairs anti-oxidant defenses leading to increased OS in the brain. These 
events are accompanied by a decrease in cholinergic receptors in the hippocampus and 
frontal cortex of exposed rats. The described damages were associated with memory   
deﬁcits  observed in the animals (Yadav et al, 2011). Mn seems to exert various effects in 
multiple sites within the cholinergic neurons in peripheral, motor nerves and 
neuromuscular junctions (Finkelstein et al, 2007) and also in the CNS. In the brain Mn 
perturbs cholinergic mechanisms not only in the basal ganglia but also in cortical brain 
regions such as the hippocampus, the frontal cortex and the parietal cortex. The blocking 
of the release of ACh by Mn at presynaptic levels is among the proposed mechanisms 
(Finkelstein et al, 2007), being also suggested that Mn-induced AChE targeting may trigger 
or contribute to the development of OS. In vivo experiments already showed decreased 
brain AChE activity accompanied by higher levels of indicators of peroxidation in 
membranes (neuro and isoprostanes) upon Mn exposure (Santos et al, 2012). 
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1.4.4. Interference with the hematopoietic system 
 
Pb, As and Mn can exert several effects in the hematopoietic system (Case et al, 2013; 
Cory-Slechta, 1990, Pereira et al, 2010), which includes interferences with heme 
synthesis, may leading to neurotoxicity (Demasi, 1996, Flora et al, 2005; Reckziegel  et al, 
2011). Heme is an indispensable cofactor in oxygen transport and storage (hemoglobin, 
myoglobin), mitochondrial electron transport (complexes II–IV), drug and steroid 
metabolism (cytochromes), signal transduction (nitric oxide synthases, soluble guanylate 
cyclases), transcription and even regulation of antioxidant-defense enzymes (CAT and 
GPx) (Krishnamurthy et al, 2007; Ryter and Tyrrell, 2000). The synthesis of heme occurs in 
every human cell, although about 85% occurs in the bone marrow, where the majority is 
used for hemoglobin formation (Hift et al, 2011; Kauppinen, 2005; Quintanilla-Vega et al, 
1996).  In this pathway succinyl-coA and glycine are combined under the enzymatic 
control of delta-aminolevulinic acid synthase (ALAS) to form delta-aminolevulinic acid 
(ALA). Subsequently, two molecules of delta-ALA are condensed to form the pyrrole ring 
structure of porphobilinogen (PBG), catalyzed by ALA dehydratase (ALAD). Collectively 
ALA and PBG are known as porphyrin precursors (Hift et al, 2011). Four PBG molecules 
are then joined by hydroxymethylbillane synthase (HMBS) to form hydroxymethylbillane 
(HMB), a tetrapyrrole ring structure. The majority of HMB is converted to 
uroporphyrinogen III by uroporphyrin synthase although there is a lesser amount of non-
enzymatic conversion of HMB to uroporphyrinogen I and then to coproporphyrinogen I. 
Uroporphyrinogen III is decarboxylated by uroporphyrinogen decarboxylase to 
coproporphyrinogen III, which then enters in the mitochondria for the ﬁnal steps of heme 
synthesis. Protoporphyrinogen IX is formed after oxidative decarboxylation of 
coproporphyrinogen III by coproporphyrinogen oxidase and subsequently Fe is added to 
the molecule by ferrochelatase (FECH) to form heme (Simon and Herkes, 2011) (Fig.1.1).  
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Fig. 1.1: Heme biosynthetic pathway.  Steps are  catalyzed  by  (1)  d-aminolevulinic  acid  synthetase 
(ALAS), (2)  ALA  dehydratase (ALAD),  (3)  uroporphyrinogen  I  synthetase, (4)  uroporphyrinogen  III  
cosynthetase, (5)  uroporphyrinogen  decarboxylase,  (6)  corporpophyrinogen  oxidase,  (7)  
protoporphyrinogen  oxidase,  and  (8) ferrochelatase.  Adapted from Woods et al,  1991. 
 
 
Eight enzymes catalyze these reactions (Hift et al, 2011; Kauppinen, 2005) and most 
importantly, those enzymes have been shown to be specifically susceptible to impairment 
by a variety of toxic agents (Bleiberg et al, 1967; Quintanilla-Vega et al, 1995). These 
agents includes metals such as Pb and As (Ng et al, 2005), due to its strong afﬁnity for 
their functional -SH groups (Flora, 2011; Woods et al, 2009); concerning Mn little 
information exists related with the impairment of these enzymes (Maines, 1980). When 
interferences occur in the heme biosynthetic pathway, there is characteristically an 
excessive accumulation and excretion of ALA and/or porphyrins (Adhikari et al, 2006; 
Guolo et al, 1996). Because individual porphyrins differ by the side chain substituents, 
different metals may induce speciﬁc and different changes in porphyrin excretion 
patterns (Woods et al, 2009).  Thus, the urinary porphyrins profile became a key tool for 
the diagnosis of heme biosynthetic pathway disturbances (Bozek et al, 2005) and may 
serve as a BM of exposure to toxic metals in humans (Li et al, 2011; Ng et al, 2005). The 
circumstance that different metals can exert their effects at different points of this 
metabolic pathway is a curious particularity that justifies the opinion of some authors, 
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who mention porphyrins as promising BMs of toxicity induced by metal mixtures (Wang 
and Fowler, 2008). 
 
1.4.4.1. Delta-aminolevulinic acid 
 
ALAD is a metalloenzyme containing -SH groups and Zn, which are essential for its activity, 
but on the other hand turns this enzyme highly sensitive to heavy metals, molecular 
oxygen and other pro-oxidant conditions. The impairment of its activity may result in 
heme synthesis depression stimulating ALAS, by virtue of negative feedback control 
(Quintanilla-Vega et al, 1996), leading to increased production of delta-aminolevulinic 
acid (delta-ALA). The consequent increased in delta-ALA body burden can be detected by 
the presence of a considerable amount of the precursor in circulating blood and excreted 
urine (Gurer and Ercal, 2000; Makino et al, 2000; Schmatz et al, 2012). Delta-ALA 
accumulates especially in the liver and in the CNS (Onuki et al, 2004). The mechanism 
whereby delta-ALA is transported to the brain is uncertain, but it was suggested that 
delta-ALA enters through passive diffusion via the BBB. Delta-ALA is also produced in the 
brain (Adhikari et al, 2006) and the presence of ALAS and other enzymes of heme 
biosynthesis was already detected in this organ (Maines 1980). It was proposed that 
excessive delta-ALA brain levels play a central role in the development of neuromuscular 
and neuropsychiatric manifestations of inherited and acquired porphyric disarrays, such 
as mood disorders, aggressiveness, hallucinations, convulsions and seizures (Adhikari et 
al, 2006; Demasi, 1996). Indeed delta-ALA causes CNS damage and peripheral neuropathy 
(Ryter and Tyrrel, 2000) being demonstrated that excess of delta-ALA is involved in 
neuronal cell death mainly due to its pro-oxidant effects  (Adhikari et al, 2006; Onuki et al, 
2004; Rocha et al, 1995; Schmatz et al, 2012). At physiological pH, metal catalyzed 
autoxidation of delta-ALA generates a carbon centered radical (ALA•) as well as O2
-•. The 
ALA• further oxidizes to the imino form of delta-ALA, producing O2
-•, which dismutates to 
H2O2 (Ahamed and Siddiqui, 2007; Demasi, 1996; Gurer and Ercal, 2000; Reckziegel et al, 
2011; Ryter and Tyrrel, 2000). Delta-ALA-generated O2
-• also promotes Fe release from 
the endoplasmic reticulum which may contribute to the generation of •OH through the 
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Haber-Weiss reaction (Onuki et al, 2004). Also the coupled autoxidation of delta-ALA with 
oxyhemoglobin [Hb-Fe (II)] produces methemoglobin and H2O2 (Ryter and Tyrrel, 2000). 
Oxidative damage to brain lipids and proteins, concomitant with cerebral Fe accumulation 
due to delta-ALA administration to rats, are in vivo confirmations of these evidences 
(Demasi, 1996). Disruption of mitochondrial membrane potential and promotion of Ca (II) 
release from the intramitochondrial matrix, with subsequent mitochondrial damage may 
also occur (Adhikari et al, 2006; Onuki et al, 2004). The inhibition  of  Na+,  K+  -ATPase and  
alterations  on  gamma-aminobutyric  acid  (GABA) and glutamate uptake or release, are 
additional proposed mechanisms (Demasi et al., 1996; Emanuelli, 2003; Juknat et al., 
1995). 
 
Blood ALAD is sensitive to the inhibitory action of Pb because this metal replaces the Zn 
cations in the active site of the enzyme. A study where the addition of Zn plus thermic 
treatment resulted in the recovery of diminished activity of ALAD upon Pb exposure 
supports this belief (Rocha et al, 1995). Another mechanism whereby Pb interferes with 
the ALAD catalytic activity is through the binding to it - SH groups. Also OS induced by 
accumulated delta-ALA is accepted as being associated with the pathophysiology of Pb 
poisoning (Gurer and Ercal, 2000). However, the association between low level Pb 
exposure and OS has not been yet systematically explored (Ahamed and Siddiqui, 2007). 
Even so, direct correlations between Pb blood levels and ALAD decreased activity, with 
subsequent increase of malondialdehyde (MDA) erythrocytic levels, an indicator of lipid 
peroxidation (Franco et al, 2009), has been observed among workers exposed to Pb 
(Jomova and Valko, 2011). ALAD is highly sensitive to the presence of As by virtue of its 
sulfhydryl moiety (Flora, 2011) and indeed the exposure of rats to As already leaded to 
observe a significantly decrease in the brain ALAD activity (42%) (Reckziegel et al, 2011).  
Despite statistical correlations of decreased ALAD upon As exposure were not scrutinized 
in an in vivo work, brain GSH levels decreased (Flora et al, 2005). No mechanistic 
information is available concerning Mn interference with heme synthesis. 
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1.4.4.2. Porphyrins 
 
Porphyrins are formed as intermediates of heme biosynthesis (Quintanilla-Vega et al, 
1996) (Fig. 1.1) and the synthesis and intracellular concentrations of porphyrins and heme 
are tightly regulated trough delta-ALA, PGB and also porphyrins  (considered as oxidized 
forms of PGB) levels (Lelli et al, 2005). Such tight regulation is due to the fact that heme 
synthesis is a quite sensitive process. Reduced heme concentrations in nonerythroid cells 
causes among several adverse effects OS, impaired function of the mitochondrial 
respiratory chain, Fe accumulation and cell death (Krishnamurthy et al, 2007). On the 
other hand enzymatic disarrays affecting this metabolic pathway (porphyrias) lead to the 
accumulation of heme precursors that when in excess can act as toxins (Hift et al, 2011; 
Krishnamurthy et al, 2007).   
 
Excessive accumulation of porphyrins is deemed to be responsible for pathological 
pictures affecting the CNS and the PNS (Simon and Herkes, 2011). Porphyria has been 
linked to the madness that affected King George III of Great Britain and the illness of 
Vincent van Gogh (Lin et al, 2008).  The mechanism by which altered heme synthesis 
results in nervous dysfunction is unknown. Even so, evidence today suggests that direct 
toxic effects of porphyrin precursors in the nervous system as well as intracellular 
metabolic derangement resulting from heme deficits contribute to the observed 
neurologic disorders (Simon and Herkes, 2011). Presynaptic inhibition of  
neurotransmitters  release is a proposed mechanism; the deficiency of heme in neural 
tissues also produces diminished energy capacity with consequent dysfunction of the 
energy dependent Na+/K+ ATPase; there is also depletion of essential substrates or 
cofactors arising from the heme biosynthetic pathway defect, such as pyridoxal 
phosphate, Zn or glycine; abnormal products derived from the porphyrin precursors, such 
as hemopyrrole may also have an important role (Juknat et al, 1995; Kuo et al, 2007; Lin 
et al, 2011; Moore, 1998). Oxidative damages can also occur since due to its lipophilic 
nature, excess protoporphyrins and other porphyrins may accumulate in membranes and 
generate ROS upon exposure to light (430-635 nm). The formation of 1O2 and O2
-• 
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through photochemical reactions has been reported (Krishnamurthy et al, 2007; Ryter 
and Tyrrell, 2000). Porphyrins may also form a porphyrin anion radical, that may 
substitute for O2
-• in Fenton-type reactions or produce O2
-• by reducing O2 (Ryter and 
Tyrrell, 2000). Under these conditions, excess porphyrins can cause oxidative damage to 
membrane components, with proteins and lipids as the main targets of photodamage, 
leading eventually to cell death (Krishnamurthy et al, 2007; Ricchelli, 1995). 
 
In  Pb-treated  cell cultures,  porphyrin  production was found to be decreased  as  shown  
by  the reduced  levels  of  inter- and intracellular  porphyrins. This  effect  could  be  
primarily explained  by  ALAD  inhibition, resulting  in  a decreased  of monopyrrole  
supply  for  porphyrin  biosynthesis. An interesting outcome from this study is that Pb 
concentrations could produce a biphasic effect on porphyrin production (Quintanilla-Vega 
et al, 1996). It has been reported that As can interfere with porphyrin metabolism, with 
uroporphyrinogen synthase, coproporphyrinogen oxidase and FECH being affected by this 
metal (Shaw et al, 2012). Little information exists on the effect of Mn in heme 
biosynthesis, expect a few studies demonstrating that Mn can alter heme metabolism in 
an in vitro assay using rat brain cells (Qato and Maines, 1985).   
 
 
   
 1.5. Control of Human exposure to chemicals 
 
In today’s industrialized world it is imperative to know the safety of chemicals present in 
our everyday life, leading scientists and regulatory authorities to try to safeguard the 
health of present and future generations (Kakkar and Jaffery, 2005). In this perspective it 
has become increasingly important to establish environmental and occupational limits of 
exposure to chemicals in order to contribute to a reduced and safer exposure (Gil and Pla, 
2001). 
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1.5.1. Environmental and Biological Exposure limits 
 
The aim of Occupational Toxicology is precisely the control and prevention of hazards 
arising from workplace exposures (Nielsen and Øvrebø, 2008). Occupational exposure 
limits (OELs) are key tools in this field, since these standards suggests the allowable 
concentrations of harmful substances in the air. Nowadays the general approach used by 
most organizations that propose OEL includes a review of epidemiologic and toxicological 
information to identify potential hazards and determine suitable exposure levels (Haber 
and Maier, 2002). The rationale behind OELs is that if the exposure is sufﬁciently low, 
then no or acceptably small health effects will arise (Ding et al, 2011).  The concept of 
‘‘adverse health effect” is important in OELs setting. According to one definition adverse 
effects are biochemical changes, functional impairments or pathologic lesions that affect 
the performance of the whole organism or reduce an organism’s ability to respond to 
environmental changes. Another deﬁnition describes  an adverse effect as an effect that 
causes an impairment of functional capacity, a decreased ability to compensate for 
additional stress and to maintain homeostasis, an enhanced susceptibility to other 
environmental inﬂuences, or if such impairments are likely to become manifest in the 
near future (Nielsen and Øvrebø, 2008). Neurotoxicity is undoubtedly included in both 
definitions. Focused on the concept of adverse effects, threshold limit values (TLVs) are 
health based established OEL values intended to be guidelines to be used by professional 
industrial hygienists. Actually, most of the several regulatory systems have been 
developed based on the American Conference of Governmental Industrial Hygienists’ 
(ACGIH) established TLVs (Ding et al, 2011). They are namely the TLV–TWAs (time-
weighted average), which are upper control limits for each exposure day and in a 
controlled work environment; the long-term life-time average exposure for each 
individual worker has to be less than the TLV–TWA and applies to an 8-h workday and a 
40-h workweek (Nielsen and Øvrebø, 2008). There are also the health-based Biological 
Limit Values (BLVs) for occupational exposures, established by the Japan Society for 
Occupational Health (JSOH), while the German Commission for the Investigation of Health 
Hazards of Chemical Compounds in the Work Area (MAK-Commission) applies the MAK 
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values as well as Biologischer Arbeitsstoff-Toleranz-Wert (BAT) or Biological Tolerance 
Values. In the European Union (EU), the Scientific Committee on Occupational Exposure 
Limits (SCOEL) has set the Biological Exposure Index  (BEI) for compounds where the OELs 
may not be sufﬁcient to protect against exposures, and where biological monitoring is 
more appropriate to determine the body burden (Nielsen and Øvrebø, 2008). Despite the 
workers are usually exposed to mixtures and not to single chemical compounds to which 
OELs have been set, only few OELs are established for mixtures. The German MAK 
commission refrains from setting up procedures for evaluating effects of mixtures due to 
current methodological limitations. On the other hand, ACGIH approaches consider that 
compounds having a similar toxicological effect on the same target organ have an 
additive effect, in the absence of information saying the opposite. In this case, the effects 
of the mixture is evaluated from the hazard index of each compound {(H.I. (i) = 
[(Concentration of compound (i))/TLV (i)])} and the TLV of the mixture is considered 
exceeded if the sum of all compound’s H.I. exceeds one [Sum H.I. (i) > 1]. JSOH also 
evaluates mixtures from the H.I. index (Nielsen and Øvrebø, 2008).  
 
Despite the general agreement on the need of OELs, signiﬁcant disparities exist in  OEL 
values established by different organizations and concerning the methods used to derive 
them, even for single chemicals (Haber and Maier, 2002), as illustrated by the differences 
of Pb, As and Mn’s values settled by different agencies (Table 1.1). Some authors go 
further censuring that in practice, the ﬁnal values of OELs often depend, not only on 
health risk assessments based on scientiﬁc evidence, but also on socioeconomic factors 
(Ding et al, 2011). The value of harmonizing approaches (where the concept of 
harmonization can be distinct from standardization) is being increasingly recognized, 
(Haber and Maier, 2002). To date, there is at least a trend towards convergence within 
the EU, but still there is no obvious evidence that OELs are becoming globally harmonized 
around the world (Ding et al, 2011).    
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Table 1.1: Occupational exposure limits (OELs) 
     
Agency ACGIH (1) MAK (2) NIOSH (3) OSHA (4)
OEL TLV-TWA (5) MAK (6) REL (7) PEL (8)
Pb 0.05 mg/m3 0.01 mg/m3 0.05 mg/m3 0.05 mg/m3
As 0.10 mg/m3 0.10 mg/m3* 0.2 mg/m3 ** 0.10 mg/m3
Mn 0.2 mg/m3 0.25 mg/m3 1 mg/m3 5 mg/m3
** technical exposure limit; * if less then 10 minutes  
(1) American Conference of Governmental Industrial Hygienists; (2) German MAK-Commission; (3) National Institute for 
Occupational Safety and Health; (4) Occupational Safety and Health Administration; (5) Threshold Limit Value—Time–
Weighted Average, concentration for a conventional 8-hour workday and a 40-hour workweek; (6) Maximale 
Arbeitsplatz-Konzentration; (7) Recommended Exposure Limit; (8) Permissible Exposure Limit. 
 
 
 
1.6. Biomarkers as tools to control the risk of chemical exposure 
 
The establishment and determination of OELs are certainly an important start point to 
access and prevent adverse health effects is workers exposed to chemicals, such as 
metals. However, OELs are mostly established only for single substances and refer 
exclusively to concentrations in the air (Nielsen and Øvrebø, 2008). These factors limits 
most occupational studies to the possible causative associations between the exposure to 
a potential causative agent and the disease outcome in terms of clinically apparent 
disease (Vainio, 1998), which is quite insufficient by itself.  
 
Moreover OELs may avoid signiﬁcant adverse effect in a vast majority of the exposed 
workers, but may not include all the workers (Nielsen and Øvrebø, 2008).  Differently the 
determination of biological limit values (BLV) or biological exposure indexes (BEI), which 
represents the level of a BM that has been directly associated with (or with the lack of) a 
biological effect or disease (ICOH, 2010), can enable more informed risk assessment 
decision making (Kakkar and Jaffery, 2005). Thus, BMs are becoming increasingly 
important in occupational and environmental medicine (Scherer, 2005). In practice, BMs 
are tools that can aid in understanding the prediction, cause, diagnosis, progression, 
regression, or outcome of treatments (Mayeux, 2004), since can be perceived as 
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observable endpoints in a continuum of events leading from exposure to disease 
(Scherer, 2005; Vainio, 1998). This chain of events includes: ‘external dose’, ‘internal 
dose’ (‘absorbed dose’), ‘biologically effective dose’ (‘target dose’), ‘early biological effect’ 
and ‘health effect’ (Scherer, 2005). The measurement of the “internal” dose may provide 
more accurate assessments as regards to individual exposures. Due to the large inter-
individual variability in absorption, distribution, metabolism and excretion of chemicals, 
or their metabolites, individual data may vary extensively as compared with the 
corresponding environmental exposure data (ICOH, 2010). BMs of exposure can be seen 
in this context, being defined as a chemical, or its metabolite, that is measured in a 
compartment or a ﬂuid of an organism (ICOH, 2010; Costa and Manzo, 1995; Mayeux, 
2004; Mutii, 1999). An ideal BM of exposure is chemical-specific, detectable in trace 
quantities, available by noninvasive samples, inexpensive to assay and quantitatively 
relatable to prior exposures (Costa, 1996). By its turn a BM measuring the amount of toxic 
or chemical in a target organ, or its surrogate, generally indicates the “biologically 
effective dose” (Mayeux, 2004). BMs of effect respect to other events in this chain 
process. They can be defined as measurable biochemical, structural, functional, 
behavioral or any other kind of alteration in an organism that, according to its magnitude, 
can be associated with an established or potential health impairment or disease (ICOH, 
2010). These markers can be also obtained from human tissue and excreta with an 
obvious preference for noninvasive samples (Kakkar and Jaffery, 2005).  An important 
sub-class of BMs of effect is the BMs of early disease (or early BMs of disease). This type 
of BM indicates early biochemical or functional alterations, which includes a wide array of 
biological responses, ranging from physiological adaptation to disease, and is more closely 
indicative of a subclinical effect or even an early reversible clinical response (ICOH, 2010). 
These BMs have the potential to give early warnings by ﬂagging the early effects of 
exposure, thus signaling opportunities to arrest disease through timely intervention 
(Vainio, 1998). In addition there is another classification for BMs of effect, the BMs of 
potential harm. These parameters reﬂect physiological and morphological changes in cell 
and tissues as a result of the exposure and it is important to note that these changes are 
not necessarily coupled with changes in cell or tissue function (Mayeux, 2004; Scherer, 
2005). The fact is that BM’s classification is not “hermetic” and may vary with authors. 
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Indeed BMs have also been classiﬁed as antecedent biomarkers (identifying the risk of 
developing an illness), screening biomarkers (screening for sub-clinical disease), 
diagnostic biomarkers (recognizing overt disease), staging biomarkers (categorizing 
disease severity), or prognostic biomarkers (predicting future disease course, including 
recurrence and response to therapy, and monitoring efﬁcacy of therapy) (Quinones and 
Kaddurah-Daouk, 2009). In any case a common concept underlying BMs of effect is that 
they should reflect early and reversible biochemical modifications that precede structural 
or functional damage and may also be predictive of later responses. Thus, the knowledge 
of the mechanism(s) that lead to ultimate toxicity is necessary and extremely important in 
the research of new BMs (Costa, 1996).  
 
However, it is important to note that BMs are not a panacea for preventing all worker 
illnesses and injuries. The ultimate utility of BMs in occupational health and safety is the 
extent to which they lead to the prevention and control of occupational disease. To date 
the full promise of BMs for occupational safety and health has yet to be realized, because 
the last 30 years have focused primarily on development of technologies, validation, and 
elucidation of processes and procedures for molecular epidemiology, analytical chemistry 
and bioinformatics. Even so, during that time there have been various signiﬁcant 
contributions of BMs to occupational health (Schulte and Hauser, 2011).  
 
Neurological disarrays induced by exposure to neurotoxic agents are most frequently 
chronic progressive disorders, where traditional early warning symptoms of the 
development of the disease may be lacking. They may be only clinically apparent long 
after exposure to the initiating factor, being at this point mostly irreversible (Kakkar and 
Jaffery, 2005).  Thus,  neurotoxic  injury  is  thought  to  proceed  from  one  or  more 
primary  biochemical  alterations, through eventual irreversible cytotoxicity to neurons 
and permanent organic lesions (Costa and Manzo, 1995). Considering this assumption, 
tremendous efforts have been made to identify neuropathological and biochemical BMs 
of neurotoxicity prompted diseases. Diagnosis could be established in earlier stages 
providing a valuable timely warning of the risk and enabling patients to have a chance to 
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get an early treatment that may curb the disease progression (Kakkar and Jaffery, 2005; 
Rachakonda et al, 2004). Despite a number of reviews discussing behavioral and 
biochemical markers of neurotoxicity published in recent years, Neurotoxicology seems  
to  be progressing  more  slowly  than  other  fields,  with regard  to  biological  monitoring  
and  development  of  markers  of  exposure  and  health  effects (Costa, 1996; Costa and 
Manzo, 1995). Until some years ago studies in neuroepidemiology most often relied on 
electrophysiological measurements or on neurobehavioral tests, with neurotoxic effects 
frequently inferred from observed behavior (Costa and Manzo, 1995). Limitations exist 
regarding neurobehavioral tests, such as its low speciﬁcity, making its use when alone 
controversial for the establishment of exposure limits. Nowadays, it is considered that 
using these functional tests for monitoring the effects of chemical exposure in individual 
workers should be avoided and should be made carefully even in groups of workers. It is 
becoming increasingly perceptive that studies combining several approaches, including 
neurophysiological, neurochemical and behavioral tests, might provide better integrated 
information necessary to assess health risks (ICOH, 2010). That way, molecular BMs are 
expected to provide a dynamic and powerful approach to comprehend the spectrum of 
neurological disease, with obvious applications on disease prevention, diagnosis and 
disease management (Mayeux, 2004). Even more important is the possibility of their use 
to assess subtle changes such as those occurring due to chronic low-level exposure to 
environmental and/or occupational chemicals (Mutii, 1999). Still, challenges and 
imitations exist, such as: the  complexity and the singularities of the nervous  system; the  
problems associated  with  the  determination of the precise targets for neurotoxic  
action; and the inaccessibility  of the  nervous system for neurochemical  measurements  
(Costa and Manzo. 1995). Prospects for signiﬁcant advances in this ﬁeld will surely arrive 
from mechanistic studies and  from the search  for  neurochemical  parameters  in  
peripheral tissues,  easily  and  ethically  obtained  in  humans, that  can  represent  a  
marker related with the same parameter in the nerve tissue (Costa and Manzo, 1995; 
Mutii, 1999). With respect to BMs of neurotoxicity induced by mixtures of metals a great 
amount of work is expected to be done, since despite the interaction of metals in CNS is 
known from some time, not much is achieved concerning the understanding of the 
molecular mechanisms underlying metal mixtures toxicity (Wang and Fowler, 2008). 
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1.6.1. Development and Validation of Biomarkers 
 
As mentioned before, the methods to be developed for BMs determinations should be 
minimum invasive, analytically speciﬁc, sensitive, simple, rapid, robust and inexpensive 
(Giannelli et al, 2007; Mayeux, 2004; Scherer, 2005). All these requirements are 
sometimes difﬁcult to assemble (Scherer, 2005) and unfortunately the cost is always a 
concern. If an epidemiologic study includes thousands of subjects, the cost can be quite 
high unless the laboratory procedure is automated and relatively simple (Mayeux, 2004).  
Still other limitations on BMs studies exist: 1) it is not possible to say from BM data 
whether the exposure was generated by occupational or non-occupational sources; 2) a 
BM may not be sufﬁciently speciﬁc for assessing exposure to a particular chemical; 3) it is 
difficult to relate some exposure BMs to external exposure levels and even more difﬁcult 
to establish a relationship between exposure BMs and a biologic endpoint (ICOH, 2010).  
 
To meet all these challenges BMs’ validity is a crucial matter and before they can be 
routinely used for workers’ protection, they must be previously tested through suitable 
studies (ICOH, 2010). Once a promising marker candidate is identified, the next step is to 
develop an assay with adequate analytical performance for diagnostic accuracy studies, 
aiming it eventual use in routine clinical practice (Füzéry et al, 2013). Thus, the 
development of a new BM implies the analytical and biological validation. Concerning to 
the analytical validation, selectivity measures the degree to which unrelated matrix 
components cause analytical interference; Repeatability and reproducibility, which are 
factors used to quantitatively express the closeness of agreement among results of 
measurements performed under specific conditions, are used for the precisions’ 
evaluations (Chau et al, 2008). Additionally the analyte stability is an essential parameter 
(Füzéry et al, 2013). Concerning to biological validation, some authors refer three aspects 
of measurement validity: 1) content validity, which shows the degree to which a BM 
reﬂects the studied biological phenomenon; 2) construct validity, which pertains to other 
relevant characteristics of the disease or trait; and 3) criterion validity, which shows the 
extent to which the BM correlates with the speciﬁc disease and is usually measured by 
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sensitivity, speciﬁcity and predictive power (Mayeux, 2004; ICOH, 2010). In fact the 
accuracy (sensitivity and speciﬁcity) of a BM is one of the most important aspects to be 
considered. Clinical sensitivity, which is the ability of the BM to detect truly positive 
subjects as positive (thus avoiding false negative results), is fundamental for preventive 
purposes. Clinical speciﬁcity, the ability to detect truly negative subjects as negative (thus 
avoiding false positive results) is usually more important for diagnostic purposes (Füzéry 
et al, 2013). While a BM of exposure indicates the actual exposure, a BM of effect should 
predict the actual risk of disease, being the predictive value of an effect BM the extent to 
which that particular BM is capable of correctly separating subjects with a likelihood of 
impairment or disease from those without (ICOH, 2010; Mayeux, 2004). The use of the 
statistical tool receiver operator characteristic (ROC) curves allow to determine the 
accuracy of a BM (Mayeux, 2004) and along with other statistical approaches has 
contributed quite importantly to this field. Another important issue is the investigation of 
the distribution of the BM results in the population of interest, namely if its expression is 
influenced by confounding factors such as time of the day, fed/fasted, recent exercise, 
smoking, demographics and how much biological variation occurs within and between 
patients (Jenkins, 2012). 
 
 Many published articles claims to identify BMs, but only fewer have been validated for 
routine clinical practice. Validation requires extensive resources and multidisciplinary 
expertise to establish robust correlations between BMs and population health status. 
Moreover BMs are still not widely applied in workers who are asymptomatic for 
occupational diseases (Schulte and Hauser, 2011). Only highly speciﬁc and validated BMs 
should be used when decisions have to be made on the workers’ job ﬁtness or his/her 
removal from work, in order to avoid misjudgment (ICOH, 2010). To date BMs still need to 
fulﬁll the expectations that have arisen for them and to achieve this, a more holistic 
approach to bring them from the laboratory to the ﬁeld is imperative (Schulte and 
Hauser, 2011). 
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1.6.2. Biomarkers for Pb, As and Mn 
 
To date several BMs have been studied and proposed to access exposure, susceptibility 
and detect adverse health outcomes induced by Pb, As or Mn. 
     
1.6.2.1. Biomarkers of exposure 
 
BMs of occupational exposures are often obtained from measurement of the parent 
compound or its metabolites in biological samples (Nielsen and Øvrebø, 2008), being the 
preferred BMs those readily obtainable in body fluid(s), or excreta (ASTDR, 2007c). 
Concerning to metals, its detection in these biological samples is the most common 
indication of exposure (Phoon, 1998) with body burden generally determined from blood 
or urinary concentrations (Kakkar and Jaffery, 2005) and used to propose BLVs or BEIs.  
 
 
Table 1.2: Biological Exposure Indices (BEIs) for Pb, As and Mn 
Agency ACGIH (1) MAK (2) NIOSH (3) OSHA (4)
BEI
Pb 30 μg/dL blood 70 μg/100 mL urine 60 μg/dL blood 40 μg/dL blood
As 50 ug/g creat 130 µg/L urine 35 µg /L  urine 35 µg /L  urine *
Mn 15 µg/L blood**
* density of urine of 1.024; ** as a warning value   
(1) American Conference of Governmental Industrial Hygienists; (2) German MAK-Commission; (3) National Institute for 
Occupational Safety and Health; (4) Occupational Safety and Health Administration. 
 
 
Although Table 1.2 shows established values proposed for Pb, As and Mn by different 
agencies, these values are frequently reviewed and other BMs continue to be 
investigated.  
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The BMs of exposure to Pb used today are measurements of total Pb levels in tissues or 
body fluids and from these, blood Pb concentration is the most widely used parameter for 
general clinical use and public health surveillance (ASTDR, 2007b; Batterman et al, 2011; 
Fukui et al, 1999). Even so several limitations on the evaluation of Pb body burden should 
be taken in account. The elimination half-time of Pb in blood is approximately 30 days and 
therefore, Pb concentration in blood reflects mainly the exposure history of the previous 
few months. Furthermore, it does not necessarily reflect the larger burden and much 
slower elimination kinetics of Pb in bone. Indeed, the blood comprises only <2% of the 
total Pb burden (Casarett and Doull's, 2007). Another limitation is that blood Pb can be 
influenced by short-term variability in exposure, which may have only minor effects on Pb 
body burden (ASTDR, 2007b). 
 
It would also be desirable if Pb in urine could be a valid substitute to blood Pb levels, as a 
more simple and a less invasive method. Several attempts were done to use urinary Pb as 
a surrogate of blood Pb (Fukui et al, 1999), with measurements of urinary Pb levels 
actually used to assess Pb exposure (ASTDR, 2007b). Occupational studies exist where 
urinary Pb correlated significantly with blood Pb, but caution is advised since: i) despite 
urinary Pb concentration may increase exponentially with blood Pb levels, it can exhibit 
relatively high intra-individual variability even at similar concentrations of Pb in the blood 
(ASTDR, 2007b; Moreira and Neves, 2008); ii) estimation of Pb in blood from urinary Pb 
can be possible on a group basis, but hardly applicable on an individual basis (Fukui et al, 
1999); iii) for low level exposures urinary Pb levels are close to the detection limit of the 
analytical methods; iv) Pb urinary excretion reflects mainly recent exposure; v) and the 
determination of Pb in urine is further complicated by the decrements in kidney function, 
in association with nephrotoxic Pb effects (ASTDR, 2007b).  
 
Pb can also be measured in other tissues. Pb in bone is considered a BM of cumulative 
exposure because the metal accumulates in the skeleton over the lifetime (Casarett and 
Doull's, 2007). Nevertheless, Pb in bone is an invasive and not handy method. Tooth Pb 
have been considered a potential BM for measuring long-term exposure (e.g., years) 
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because Pb that accumulates in tooth dentin and enamel appears to be retained until the 
tooth is shed or extracted. Since Pb is incorporated into human hair these samples has 
been explored as a possible noninvasive approach for estimating Pb body burden. This 
approach is subject to errors from contamination of the hair surface with environmental 
Pb and contaminants in artificial hair treatments. Hair Pb is also a relatively poor predictor 
of blood Pb, particularly at low concentrations (<12 μg/dL). Pb is excreted in human 
sweat, but it has not been widely adopted for monitoring Pb exposures since may reflect 
excretion of Pb in the skin that had not been absorbed into the blood. Indeed, despite Pb 
concentrations in sweat were already found to be elevated in Pb workers, sweat and 
blood Pb concentrations were poorly correlated. Interestingly, effect BMs can be used to 
assess exposure to Pb and include the measurement of BMs of impaired heme 
biosynthesis, such as blood protoporphyrin, erythrocyte ALAD activity and urinary 
coproporphyrin and delta-ALA (ASTDR, 2007b).   
 
Most of the inhaled As (the most relevant path in occupational exposures) is absorbed 
from the lungs or the gastrointestinal tract and is excreted in the urine, mainly within 1–2 
days. Thus, As is rapidly cleared from blood, which is the reason why measurements of 
blood As reflect recent exposures or exposures to high As levels (ASTDR, 2007a; 
Marchiset-Ferlay et al, 2012). Urinary As measurements have been considered more 
reliable than blood, because urinary elimination is the major route for the excretion of 
this metalloid (ASTDR, 2007a; Marchiset-Ferlay et al, 2012, Morton and Mason, 2006). 
Therefore, urinary As has been the most used BM in epidemiological and occupational 
studies as indicators of recent As exposure, by both ingestion or inhalation (Marchiset-
Ferlay et al, 2012). Good correlations have been found between the concentration of As 
in workplace air and the concentration in the urine of workers exposed by inhalation 
(ASTDR, 2007a). Differently from the general view, some authors defend that in chronic 
and continued exposure to As by ingestion through drinking water, steady-state 
concentrations of As in blood and urine are achieved and that these parameters may have 
the potential to serve as BM of past exposure. In these studies strong correlations were 
obtained between the levels of As in blood and urine and also between blood As and As 
concentrations in the water. The authors argue that in long-term exposure situations, 
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blood As receives inputs not only from recent exogenous exposure but also from tissue 
compartments, thus reﬂecting the total internal As burden (Hall et al, 2006). Still 
respecting long term exposure speciation of urinary As may also indicate the extent of 
past cumulative exposure to the metalloid, more specifically by measuring the levels of 
monomethylarsenic (MMA)  and dimethylarsenic (DMA)  (ASTDR, 2007a) resulting from 
metabolic methylation of ingested or inhaled inorganic As  (Chen et al, 2005). Opting for 
As speciation measurements, they provide another advantage as compared with the 
determination of total urinary As, since certain forms of As compounds, arsenobetaine 
and arsenocholine (Irvin and Irgolic, 2004) are excreted unmetabolized in urine after 
ingestion of certain seafoods. "Fish As" is essentially nontoxic and consequently analytical 
methods based on the total urinary As content may overestimate exposures to the As 
species that are of health concern. However, adequate methods for distinguish these 
compounds from other forms of As in urine, such as liquid chromatography  inductively 
coupled plasma mass spectrometry (LC-ICPMS) or high performance liquid 
chromatography (HPLC) may not be available for common laboratories to be applied as a 
routine screening method (Chen et al, 2005). In routine procedures total values of As can 
be chosen as exposure BMs, although prior to collection of the samples some food 
precautions should be taken (Marchiset-Ferlay et al, 2012).  
 
Pertaining to less used biological samples, As accumulates in hair and nails due to its 
afﬁnity for the abundant -SH groups in keratin. Hence, As concentrations in these slow 
growing tissues are considered good measurements of past exposure (Hall et al, 2006).  
These values may increase from several- to over 100-fold following As exposure and 
remain elevated for 6–12 months, with reports mentioning that inhalation exposure of 
workers to about 0.6 μg/m3 of As in the air significantly increased As levels in nails. 
However, there was wide variation between subjects and minimum exposure levels that 
produce measurable increases in As levels in hair and nails have not been yet precisely 
defined (ASTDR, 2007a).  
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Mn levels in biological samples such as blood, urine, feces and hair have been 
investigated as BM of exposure (ASTDR, 2007c). Several works describe the determination 
of Mn levels in the blood and urine of welders, ferroalloy smelters, Mn oxide production 
workers and dry-cell battery workers (Cowan, 2008). Yet the suitability of these BMs is 
highly controversial and what is generally achieved is that the blood and urine levels may 
be used to confirm exposure and possibly manganism (Phoon, 1988). However, they only 
indicate average levels of exposure on a group basis, such as an exposure in an 
occupational setting, (ASTDR, 2007c) but are not suitable to be individually used (ASTDR, 
2007c; Bader et al, 1999; Cowan, 2008). A study by Lucchini et al. (1995) seems to be the 
only evidence that blood and urine Mn levels can be correlated with Mn exposure on an 
individual basis, although this correlation did not exist for cumulative exposure. Also 
blood Mn concentrations appear to be related to intake from food, water, and air, but 
once again with large individual differences (ASTDR, 2007c). Another limiting factor is the 
rapid rate of Mn clearance from the body, because excess Mn in blood is rapidly removed 
by the liver and excreted into the bile. Thus, the levels of Mn in blood has been used as an 
indicator of the previous few weeks of exposure, generally less than one month (ASTDR, 
2007c; Batterman et al, 2011; Santamaria, 2008). Outcomes from occupational studies, 
also indicated that there may have a plateau level of homeostatic control of this metal 
(ASTDR, 2007c) and that blood Mn may be influenced by the dietary intake, which may 
also confound the studies’ results (Santamaria, 2008). Since the urinary excretion of Mn is 
no more than approximately 1% and urinary Mn can only indicate exposure within the 
past few days, it is expected that urinary Mn may not be a sensitive indicator of Mn 
exposure (Batterman et al, 2011; Santamaria, 2008). Accordingly, urinary Mn already 
failed to allow a differentiation between exposed workers and controls (Bader et al, 1999) 
and no studies show a dose-response relationship between urinary Mn and health 
disorders (Phoon, 1988). Some authors recommend that urinary Mn should be 
abandoned as a BM of exposure to Mn (Cowan, 2008).  
 
In alternative, since the feces are the primary route of Mn excretion, in theory the 
determination of fecal Mn concentrations should be valuable. However, there is no 
significant correlation between fecal excretion of Mn and occupational exposure to the 
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metal (ASTDR, 2007c) and the collection method truly limits its use as a BM (Cowan, 
2008). Correlations between exposure levels and Mn concentration in hair were already 
determined (Bader et al, 1999; ASTDR, 2007c). Nevertheless, exogenous contamination 
may yield values that do not reflect the absorbed doses (ASTDR, 2007c).  
 
The lack of BMs of exposure to Mn has made impossible to identify subjects who may be 
in danger of progressive manganism, which is aggravated by the fact that early signs and 
symptoms are not evident to the clinical practitioner. The search for a practically useful 
BM is essential to Mn neurotoxicity research (Cowan, 2008). Until then and despite all the 
limitations, both blood and urine Mn levels have been the most widely used BMs of 
exposure in occupational studies. In this respect the WHO recommends repeated 
screening of subjective symptoms and thorough a regularly clinical examination together 
with estimations of the level of Mn in these biological samples (Phoon, 1988). 
 
 
  External and internal exposure values of Pb, As and Mn  
 
 
 
Table 1.3: Pb, As and Mn levels in air and biological samples 
 
Metal Air Biological samples References
Pb 0.5 µg /m3 , EU 7 - 22 µg/100 g in blood, urban poulations (Ec.europa.EU, 2014; EPA, 2014)
2.7 µg/m3 , US 1985 4 - 270 µg/g creat, urban populations
0.5 µg/m3, US 2012
As <1 to 3 ng/m3 , US remote areas 0.5 - 2 μg/L  in blood and <1 μg/L  in urine, not exposed
20 - 30 ng/m3, US urban areas
8-hour TWA As air concentrations of 48.3 μg/m3 
Mn 0.071 µg/m³, Canada 1-8 µg/L in urine and  4–15 μg/L in blood, not exposed
(ASTDR, 2007a; MAK 
commission, 2005; Marchiset-
Ferlay et al,2012)
(ASTDR, 2007c; Health Canada, 
1979; Santamaria, 2008; Sohler 
et al, 1979). 
2–41 μg/L in blood upon exposure to 5–410 μg As/L in 
drinking water
71 µg/L in urine (range 10–340 µg/l), copper smelters 
16.9 μg/g creat (range, 2.6–50.8  μg/g ),  occupational 
exposure 
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Several reports concerning to concentration values of Pb, As and Mn are available, for 
both air and biological samples (Table 1.3). These works are important since provide 
references that can be used to suggest excess exposure situations. 
 
1.6.2.2. Biomarkers of susceptibility 
 
BMs of susceptibility can be seen as indicators of an inherent or acquired ability of an 
organism to respond to the challenge of exposure to a specific chemical substance 
(Slikker and Bowyer, 2005).  
 
 It  has  been  known  for  centuries  that  there  is  large  variation  in susceptibility  to Pb  
exposure, with  some  individuals  experiencing  toxic effects  at  levels  that  others  can  
sustain  without  any  problem.  Some of  these  differences  may   have  a  genetic  basis   
and namely, polymorphisms  in  genes for  ALAD,  which  is the  major  Pb-binding  protein  
in  the blood  (Bergdahl  et  al.,  1997),  has been  shown  to  affect  not  only  blood Pb 
levels but also its relationship with some toxic effects  (Scinicariello  et  al,  2007).  Indeed 
ALAD2  carriers  have  a  lower risk  of  toxic  effects  than  ALAD1  homozygotes  at  the  
same  level  of exposure (Tian et al, 2013) and some authors suggest that  the effects of 
Pb on neurobehavioral functions tends also to be worse among ALAD1 homozygotes. Chia 
et al. (2004) also reported that workers  with ALAD 1-1 genotypes have signiﬁcantly 
higher urinary delta-ALA and poorer neurobehavioral scores involving motor dexterity 
compared with those who have delta-ALA D1-2/2 -2 genotypes.  
 
Much of the susceptibility to As-related health effects is determined by the large 
interindividual variation in As methylation (Loffredo et al, 2003). The trivalent forms 
metabolites (particularly MMA III) are most associated with adverse health outcomes, 
while DMA shows the lowest retention, constituting the largest portion of metabolites in 
urine (60 –80%). The excreted proportion of MMA and the ratio of MMA:DMA are an 
accurate reﬂection of harmful metabolites being retained in body tissue. The distribution 
of urinary As metabolites is determined to a greater extend by genetic variations and is 
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illustrated by the aggregation of methylation patterns within families (Antonelli et al, 
2014; McClintock et al, 2012).  
 
Also Mn detoxiﬁcation via pancreatic secretion and bile/urine excretion seems to vary 
according to an individuals’ genotypic status. Mn miners experiencing the same exposure 
environment may have different levels of blood Mn due to inter-individual variations in 
genetic polymorphisms.  Thus, harmful effects of Mn cannot be precisely predicted by 
merely elucidating the Mn levels in the exposed population. Simultaneous monitoring 
through the BMs of exposure, effect and susceptibility, may provide a wider view to 
predict the subjects that are more prone to Mn related diseases. Namely a signiﬁcant 
association between the CYP2D6*2 polymorphism (a BM of susceptibility) and the latency 
of chronic Mn poisoning has been reported (Vinayagamoorthy et al, 2010).  
 
1.6.2.3. Biomarkers of effect 
 
The knowledge of the toxicity mechanisms of metals at tissue, cellular and molecular 
levels is crucial for the discovery of new BMs and also for its selection. On the basis of OS, 
dopaminergic, cholinergic and heme synthesis alterations induced by Pb, As or Mn, 
several potential effect BMs will be described. 
 
Lead 
 
Serum PRL has been mentioned as an indicator of the dopaminergic function, which is a 
target of Pb (Meeker et al, 2009). Despite not very well documented, PRL can be 
increased by exposure to Pb (Alessio, 2006; Roses et al, 1989). In vivo studies describe 
elevated serum PRL concentrations in Pb -exposed rats (Govonia et al, 1984) and Pb 
exposure was already inversely associated with PRL among men and pregnant women 
without occupational exposure, but positively associated with PRL among occupationally 
exposed men (Meeker et al, 2009). However, in some other studies PRL levels were not 
altered by Pb (ASTDR, 2007b). The effects of Pb on cholinergic functions have also been 
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consistently reported in the literature, with references that these alterations may 
precede the well-known neurobehavioral and neurophysiological end points observed in 
Pb neurotoxicity (Ademuyiwa et al, 2007). Accordingly, deﬁcits in the performance on 
tests of spatial learning and short-term memory of Pb-exposed rodents were considered 
consistent with dysfunctions of cholinergic innervation (Reddy et al, 2003). It was 
suggested that AChE activity in the erythrocytes could serve as a peripheral surrogate 
dose–effect index of neurotoxicity on cholinergic function in occupational exposure to Pb 
(Ademuyiwa et al, 2007) and indeed, decreased AChE erythrocytic levels were observed in 
workers exposed to this metal (Weiss, 2006). Free radicals can induce AChE activity 
decrease, leading some authors to speculate that the inhibitory effect of Pb on AChE 
observed in the workers could be due to free radicals produced by Pb (Amal and Mona, 
2009).  
 
Pb effects in heme synthesis are also broadly known and documented (Goering and 
Fowler, 1987; Seth et al, 1976) being considered that many of the clinical manifestations 
of Pb poisoning, such as anemia and neuropathy, may be the result of altered heme 
biosynthesis, likewise in seen in inherited porphyrias (Moore, 1998). Over 99% of the Pb 
present in the blood accumulates in erythrocytes, where over 80% is bound to ALAD 
(Ahamed and Siddiqui, 2007). Delta-ALA and ALAD levels in blood are considered one of 
the most reliable indicators of Pb intoxication (Chibe at al, 1996; Reckziegel et al, 2011; 
Rocha et al, 1995), even with relatively low Pb blood concentrations (Reckziegel et al, 
2011). However being achieved that the degree of inhibition of ALAD can be correlated 
with blood Pb concentrations (Thompson et al, 1977) some discussion exist regarding to 
Pb threshold levels. A potential Pb threshold between 3.2 and 4.8 µg/dL has been 
presented, above which ALAD may be inhibited by Pb and below which it may be 
insensitive to Pb or may even be activated (Gurer and Ercal, 2000; Wang et al, 2010). 
Delta-ALA levels of 3 mg/g creatinine in exposed workers were also indicated as a 
threshold to detect levels of Pb in blood equal to or higher than 20 µg/dl. Indeed the test 
results pertaining to one group of studied workers showed a sensitivity of 92% and a 
specificity of 90%, which was considered by the authors as relevant to validate the results 
(Caldeira et al, 2000).  Since the inhibition of ALAD activity results in elevated delta-ALA 
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levels in blood, consequential increase of urinary delta-ALA excretion is expected and in 
fact, urinary delta-ALA have been used in clinical diagnosis of chronic occupational Pb 
intoxication (Wang et al, 2010). Persons working around automobile, Pb batteries and 
leaded gasoline show elevated delta-ALA concentrations in urine (Adaudi and Aliu, 1980). 
Actually, urinary delta-ALA has been used with two purposes: as a BM for Pb exposure 
and as marker of Pb early biologic effect (Ahamed and Siddiqui, 2007), with limits of 5 or 
15 mg/L settled for workers in general (Higashikawa et al, 2000). However caution is 
recommended. Urinary delta-ALA levels augment with increase blood Pb when blood Pb 
levels are above 22.4 µg/dL and rises markedly, when blood Pb concentrations are above 
35.5 µg/dL (Wang et al, 2010), suggesting a nonlinear relationship. Besides, urinary delta-
ALA does not seem to be a sensitive indicator when Pb exposure is low. In other works, no 
relationship between urinary delta-ALA and blood Pb levels has been obtained for Pb 
concentrations in blood bellow 20 µg/dL (Makino et al, 2000). Further studies are 
necessary to examine how heme synthesis is affected by exposure of workers to Pb at low 
levels. 
 
It is also largely described that patients suffering from Pb poisoning show an 
accumulation of porphyrins due to the inhibition by Pb of heme biosynthetic enzymes. 
These enzymes are ALAD, coproporphyrinogen oxidase and FECH (Ahamed and Siddiqui, 
2007; Gurer and Ercal, 2000; Moore, 1998). Typically increased urinary excretion of 
coproporphyrin, as well as accumulation of protoporphyrin in erythrocytes is observed 
(Quintanilla-Vega et al, 1995). Thus, alterations in porphyrin metabolism have provided a 
useful means of detecting and assessing the severity of Pb exposure and poisoning 
(Moore, 1998). 
 
Arsenic 
 
There are practically no studies evaluating the effects of As exposure on PRL release. A 
few works document that exposure to As leads to reductions of DA content in brain areas 
involved in the regulation of PRL release (Bardullas et al, 2009). These outcomes are 
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suggestive that exposure to As could interfere with PRL levels. Recent reports mention 
that sodium arsenite can cause a reduction in plasma PRL levels (Jahan et al, 2012) and  
induces cell death in anterior pituitary cells (Ronchetti et al, 2010).  
 
Both arsenite and arsenate can cause cholinergic dysfunctions in rats in a dose dependent 
manner, with concomitant AChE inhibition (Kobayashi et al, 1987;  Rodríguez et al, 2003; 
Roy et al, 2006) and consequent decreases in cellular metabolism, deformities of cell 
membranes and disturbances in nervous activity (Yousef et al, 2008). Differently one 
study revealed a signiﬁcant increase (20%) in AChE brain activity in As exposed rats, but 
the  explanation  for this different outcome was attributed, to the dose and length of the 
treatment that possibly triggered an hormetic response (Herrera et al, 2013). 
 
Also, increased levels in blood of ALAS (ASTDR, 2007a) and changes in ALAD activity were 
observed upon exposure to both As (III) and (V) (Bhadauria and Flora, 2004) being 
considered that the ALAD activity values in blood could be used to estimate its enzymatic 
activity in the brain (Reckziegel et al, 2011).  
 
 The urinary porphyrin proﬁle is a useful indicator for biological effect resulting from As 
exposure. Signiﬁcant increases of uroporphyrin and coprophorphyrin in mice 
subchronically exposed to As (III) (sodium arsenite) or As (V) (sodium arsenate) by the 
same route and at concentrations of 20 and 50 mg/L were observed. Concerning this 
subject, and after examining other works, discrepancies were noted and explained by 
dissimilar lengths of exposure (Wu et al, 2004). In humans signiﬁcant increases in urinary 
coproporphyrins were found in smelter workers exposed to arsenic trioxide dust, but the 
mean concentration of uroporphyrin was very similar to that of control (Krishnamohan et 
al, 2007). Differently, signiﬁcantly increased urinary uroporphyrin and coproporphyrin 
levels were observed in individuals exposed to As released from a burning contaminated 
coal; correlations of increased uroporphyrin and coproporphyrin with higher urinary As 
were also determined in workers (Ng et al, 2005). Further studies are required to clarify 
this apparent discrepancy among human populations (Wu et al, 2004). 
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Manganese 
 
The investigation of Mn effects on PRL is broadly documented although leading to 
controversial results. Serum PRL has been proposed as an index of Mn occupational 
exposure, through inhalation (Ellingson et al, 2003) and authors defend that the 
parameter is a possible indicator of Mn action on DA neurotransmission (Takser et al, 
2004). Several positive results were obtained such as increased serum PRL levels in 
workers exposed to Mn (ASTDRb, 2007; Ellingson et al, 2003; Meeker et al, 2009), with 
dose–effect relations between PRL and Mn concentrations in blood and urine and the 
estimated external exposure dose (Takser et al, 2004). Namely, low level exposure to Mn 
oxides of workers from a ferro-manganese plant resulted in increased prevalence of 
abnormally high serum PRL values (Ellingsen et al, 2007), with analogous observations in 
Mn exposed welders (Myers et al, 2003b) and in a mining works in central Mexico (Kim et 
al, 2009). It is also referred that environmental exposure to Mn may also contribute to 
abnormally high serum PRL in the general population (Smargiassi and Mutti, 1999). On 
the other hand, other studies show that serum PRL levels were not increased in workers 
chronically exposed to airborne Mn, being impossible to relate serum PRL concentrations 
with atmospheric Mn exposure (Aschner, 2006; ASTDR, 2007c; Kim et al, 2007). Other 
unclear issues respects to a biphasic response of DA due to Mn exposure, reported in 
workers that differently from controls exhibited an absence of a relationship between DA 
and PRL. The authors speculated that this phenomenon could due to loss of normal 
feedback control by Mn exposure and in this view, the mechanism of Mn toxicity was 
presumed to be via disruption of homeostasis between dopaminergic tonic control and 
PRL regulation (Kim et al, 2007). Despite such complex results, mechanistic studies 
establish that Mn stimulates DA autoxidation in dopaminergic neurons and indirectly 
modulates PRL secretion, thereby leading to an increase in circulating PRL levels (ASTDR, 
2007c; Marreiha dos Santos et al, 2011).  
 
The potential of Mn to affect central cholinergic structures was not fully appreciated,  
since most research on manganism has been focused on the involvement of the 
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dopaminergic system. However some salient features of manganism, like the intensity of 
mood disturbances cannot be explained only by the disruption of brain dopaminergic 
systems. Rather, the complex clinical picture of manganism may be consistent with the 
effects of Mn on additional neurochemical systems, foremost the cholinergic system, 
known to be crucial in modulating emotional response and higher cognitive functions. 
Damage to the cholinergic neurons may interfere with the cholinergic–dopaminergic 
balance, leading to instability of mood and even to a manic-depressive psychotic state 
that is observed in some cases of manganism (Finkelstein et al, 2007). Miners long-term 
exposed to exceedingly levels of Mn may exhibit changes in the activity of blood AChE 
and ACh (ASTDR, 2007c) as well as RBC-AChE in other exposed workers (Finkelstein et al, 
2007). 
 
Only a few and unclear results exist regarding to Mn induced hematological effects. In 
one study the analysis of blood from persons chronically exposed to high Mn levels in the 
workplace did not reveal any significant hematological effect. Differently, in vivo studies 
with rats exposed to Mn through diet leaded to find significantly decreased hematocrit 
and hemoglobin levels (ASTDR, 2004). Even less information is available pertaining to 
eventual Mn effects in the heme biosynthetic pathway and one study suggested that Mn 
can actually interfere at this level. More specifically, Mn (II) seems to inhibit ALAS activity 
in liver and brain. Also few references exist concerning Mn and hematological effects: in 
an in vitro study the inhibition of liver and erythrocytes ALAD by Mn was observed 
(Maines, 1980) and in other experiment it was described that this metal can competitively 
inhibit ferrochelatase (FECH) (Hift et al, 2011). The content of these information points 
undoubtedly for the need of studying Mn effects at this level.  
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Cases of metals exposure, biomarkers levels and neurotoxicity 
 
 
 
According to NIOSH, blood Pb values above 40 µg/100 g are indicative of excess exposure, 
with concentrations above 60 µg/100 g requiring removal from the exposure (NIOSH, 
1994).  ACGIH (1998) consider that elevated blood Pb concentration (>10 μg/dL) is an 
indication of excessive exposure in children (ASTDRc, 2007) although neurobehavioral 
impairment was already observed in children with Pb blood levels below 10 µg/dL 
(Canfield, 2003) along with IQ decrements at even lower blood Pb levels (< 5 µg/dL) 
(ASTDR, 2007b). According to MAK urinary As values should remain below 50 µg/L for 
prevention of non-carcinogenic toxic effects. Changes in the peripheral nerves of 
occupationally exposed persons were detected even at a mean As concentration of 71 
µg/L in urine and peripheral neuropathy was observed in 51 persons with urinary As 
concentrations above 100 µg/L (MAK, 2002). Air Mn concentrations producing effects in 
chronically exposed workers may range from about 0.07 to 0.97 mg Mn/m3, while 
workplace inhalation exposure levels producing overt symptoms of manganism have been 
documented for concentrations of 2 to 22 mg Mn/m3 (ASTDR, 2007c). In other studies 
impaired visual reaction time, hand-eye coordination and hand steadiness were detected 
in workers exposed to concentrations of Mn dioxide in respirable dust from 0.021 to 1.32 
mg Mn/m3 (the time of exposure ranged from 0.2 to 17.7 years). Also Bast-Pettersen et al 
(2004) found modifications on neurobehavioral end points in a group of male workers in 
Mn alloy plants with  0.753 mg Mn/m3 in inhalable dust and with Mn levels in blood and 
urine corresponding respectively to 189 nmol/L in blood and 3.9 nmol/mmol urine creat. 
In another study, Myers et al. (2003b) observed changes in several neurobehavioral end 
points in a group of South African Mn smelters. Their mean values were 12.5µg/L in blood 
and 10.5 µg/L in urine, while control workers had mean values of 6.4 µg /L for blood Mn 
and 0.96 µg/L for urinary Mn (ASTDR, 2007c).   
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1.6.3. Biomarker(s) for metal mixtures  
 
 
 
Table 1.4 presents several BMs proposed to control Pb, As and Mn induced toxicity. 
However, being BMs essential tools for the control and prevention of risk of exposure to 
neurotoxic agents, even for single exposures most of the outcomes pertaining to Pb, As 
and Mn BMs are scatter and hardly permits the translation from experimental results to 
humans.  
 
 
Table 1.4: Proposed BMs of effect in peripheral samples for Pb, As, Mn and mixtures of these 
elements. 
Exposure Biological Sample Biomarker References
Pb Serum PRL Govonia et al, 1984; Meeker et al, 2009
Blod erythrocytes AChE Ademuyiwa et al, 2007; Weiss, 2006
Blood ALA and ALAD Chibe at al, 1996; Reckziegel et al, 2011; 
Rocha et al, 1995
Urine ALA Adaudi and Aliu, 1980
Blood erythrocytes Protoporphyrin Moore, 1998
Urine Coproporphyrin Moore, 1998
As Serum PRL Jahan et al, 2012
Blood ALA, ALAS, ALAD ASTDR, 2007a; Bhadauria and Flora, 
2004; Reckziegel  et al, 2011
Urine Uro- and coprophophyrin Krishnamohan et al, 2007; Ng et al, 2005; 
Wu et al, 2004
Mn Serum PRL ASTDR, 2007c; Ellingson et al, 2003; 
Marreiha dos Santos et al, 2011; Meeker 
et al, 2009; Takser et al, 2004
Blood and blood erythrocytes Ach and AChE ASTDRb, 2007; Finkelstein et al, 2007
Pb + As Urine ALA Wang and Fowler, 2008; Whittaker et al, 
2011
Pb+As+Mn+others Serum PRL de Burbure et al, 2006  
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With respect to BMs of effects induced by the mixture of these metals even less progress 
has been achieved and in truth barely any information is available (Zhai et al, 2005), 
despite the knowledge that interactions among metals within organisms surely occurs. 
These events may happen when metals compete for binding locations on speciﬁc 
enzymes or receptors during the processes of absorption, excretion, sequestration or 
even at the target site (Fairbrother et al, 2007). These are events that certainly lead to 
relevant modifications on toxicokinetic and toxicodynamic processes, turning the effects 
different from exposure to each metal alone. Some scarce and sparse studies with  
mixtures of Pb, As, and/or Mn demonstrate the induction of OS in rats receiving through 
drinking water a mixture of eight metals, that included Pb, As and Mn, representative of 
groundwater contamination in different parts of India (Jadhav et al, 2007). Other works 
show that there is an interaction of Pb and As on the monoaminergic systems of the adult 
mouse, with increased DA levels observed in rats co-exposed to this binary mixture (Mejía 
et al, 1997). Depressed levels of DA were found in the brain of rats co-exposed to Pb and 
Mn (Chandra et al, 1981). Changes in the dopaminergic marker serum PRL in children 
were associated with the environmental exposure to a mixture of four metals that 
included Pb, As and Mn (de Burbure et al, 2006). Concomitantly the experimental co-
exposure to Pb and As caused synergistic inhibition of ALAD and increased ALA urinary 
excretion as compared to a single exposure either to Pb or As (Wang and Fowler, 2008; 
Whittaker et al, 2011). 
 
 
 
1.7. Predictive Toxicology, Selection and Integration of BMs 
 
There are approximately 100 billion neurons in the human brain that orchestrate an 
incredibly wide range of motor and internal regulatory functions, such as body 
movement, balance, visual and auditory perception, pleasure, pain and thermal 
sensations, hormonal and metabolic regulation, as well as highly complex behaviors, such 
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as language, memory, learning, and executive functions. Such diverse functional output is 
the product of molecular events occurring in neurons (Wang and Michaelis, 2010).  
 
Predictive toxicology is a new area of Toxicology,  still .progressing and lately focused in 
the development of procedures capable to predict toxic effects (the output) from 
chemical and biological information (the input) (Helma, 2005). Due to several 
particularities of CNS diseases, this science field can be very promising for the application 
of BMs of neurotoxicity. Many neurodegenerative disorders cannot be cured at the 
present time. A major challenge to clinical diagnosis is the increasing recognition that a 
variety of these diseases can mimic each other or coexist, with each one capable of 
contributing to the symptomatic expression of brain failure  (Shy et al, 1993). Moreover, 
knowing that the contribution of chemicals to neurodegeneration is relevant, the 
complex and diverse functions of the nervous system provides a multitude of mechanisms 
by which toxicants can produce injury. This situation becomes even more challenging 
when mixtures of neurotoxic chemicals are involved. One of the most frustrating issues in 
BMs discovery is when markers discovered by one research group cannot be reproduced 
by others. Biological variations may explain this issue, as human beings are extremely 
heterogeneous and because most of the studied diseases are very complex (Shy et al, 
1993). Additionally if the detection of the onset of neurological diseases is the desirable 
situation for purposes of prevention of irreversible dysfunctions, on the other hand the 
earlier the marker in the progression of biological response, the less strongly it can be 
expected to predict later outcomes (Mutii, 1999).   
 
 
1.7.1. Multivariate methodology 
 
In face of all the presented limitations a naïve expectation is that a single BM can capture 
the complex process underlying a neurological illness (Quinones and Kaddurah-Daouk, 
2009) most particularly when considering that each BM alone may have its own 
application for specific stages of disease and when exposure to mixtures of chemicals are 
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a contributing factor (Rachakonda et al, 2004).  The detection of neurotoxicity depends in 
most instances on recognizing patterns of changes rather than any single abnormality 
(Mutii, 1999); lately it is becoming growingly mentioned that  BMs  can  be  combined  
into  panels in order  to  increase  their  predictive  power,  (Robin et al, 2013) capturing 
more accurately a disease state and provide information valuable for diagnosis, 
prognosis, and treatment (Quinones and Kaddurah-Daouk, 2009; Shy et al, 2009). 
Consensus guidelines states that a useful BM should have a biological sensitivity and 
speciﬁcity of more than 80% (Ravid, 2009) and multiparameter analysis through the 
combination of independent markers may improve diagnostic performance over single 
markers that may be lacking in sensitivity and/or speciﬁcity, most particularly with 
respect to early detection of the disease (Etzioni et al, 2003; Prakash et al, 2010). Lately, 
most of the research in predictive toxicology has been devoted to the development of 
algorithms (procedures or formulas for solving a problem) (Helma, 2005), aiming to 
establish robust correlations between BMs and individual’s health status. Metabolomic 
analysis, nowadays focused on the discovery of panels of BMs, together with informatics 
tools are being used to predict a multitude of disorders (Schulte and Hauser, 2011); this 
novel approach is being described in recent works. Some examples are the application of 
multivariate analysis tools to ﬁnd an optimal and minimum panel of BMs to discriminate 
lung cancer patients from high-risk people (Flores-Fernández et al, 2012), to predict 
pathological staging of prostate adenocarcinoma (Etzioni et al, 2003) and to detect early 
stage ovarian cancer through the quantification of multiple blood-borne BM (Edgell et al, 
2010). Also multivariate analysis of brain-speciﬁc proteins and neurotransmitter 
metabolites was already considered as helpful in the differentiation of CNS disorders 
(Ravid, 2009). Several authors recognize the replacing of single-molecule BM analysis by 
metabolomics-based multiparameter diagnostics as representing extremely promising 
advances toward early detection of neurological diseases, such as PD (Ahmed et al, 2010;  
Quinones and Kaddurah-Daouk, 2009); the evaluation of the progression AD using 
discriminant analysis was already performed (Da et al, 2014; List et al, 2013). The use of 
multivariate regression techniques also allowed also identify a distinctive signature of 
highly correlated metabolites in a set of four patients, three of whom had lower motor 
neuron disease (LMND) (Quinones and Daouk, 2009). This perspective is defended by 
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some authors with respect to inhaled complex mixtures (Kakkar and Jaffery, 2005; 
Scherer, 2005; Schulte and Hauser, 2011) and will aso be tested in this work. Metal 
toxicity in people exposed occupationally is a situation demanding immediate attention, 
with further studies on interactions of metal mixtures utilizing BM’s endpoints highly 
warranted (Wang and Fowler, 2008). The integration of exposure and effect BMs is an 
approach that might contribute to detect and diagnose early metal poisoning.  
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Today there is an increasing incidence of neurological diseases, being known that the 
intensification of the exposure to neurochemicals may contribute to the increase of these 
diseases. Metals are among its risk factors and the elements Pb, As and Mn frequently co-
occurs in occupational settings being the presence of this neurotoxic mixture largely 
reported in mining areas (Dahtrak and Nandi, 2009). Yet there is barely no information 
about the levels of occupational exposure to metals and to its mixtures in Portugal, which 
undoubtedly justifies a demand on the realization of studies on such a sensitive matter. 
Suitable markers of neurotoxicity, a crucial tool to prevent the consequent irreversible 
and highly limitative disorders that may affect the exposed workers, are also necessary.  
To date several BMs have been discussed and proposed for the detection of Pb, As or Mn 
induced neurotoxicity, with some achieved progress, but nearly only as regards to BMs 
for each metal alone. However, in vivo metal interactions due to concurrent exposure are 
recognized events and these events occur also in the CNS. Interactions may cause 
modifications on disposition and toxicodynamics and consequently, lead to changes on 
BMs levels.  It is plausible that these changes contribute to retract the infield applicability 
of BMs investigated so far for each metal alone, which is in fact an approach quite 
detached from workers “real life” situation.  
 
The hypothesis of this project is that the exposure to the neurotoxic elements Pb, As and 
Mn simultaneously will originate an effect that may be different from the sum of 
neurotoxic effects of each metal separately. The aim of this work is to identify BMs of 
neurotoxicity which may be used to control and prevent the risk of chronic low levels 
exposure to these elements, thus may contributing to prevent the risk of neurotoxic 
effects in exposed populations providing a better health and quality of life. The levels of 
these elements in blood and urine usually used as BMs in occupational and environmental 
studies provide little information concerning target organs including the brain, one of the 
most susceptible ones. Several markers will be evaluated, with the purpose of select the 
ones which may have a better correlation with the exposure to the metal mixture and 
with its induced neurotoxicity. These BMs may avoid the installation (or progression) of 
neurotoxic effects by evincing the beginning of onset subtle physiological alterations. 
Some information about the levels of metal mixtures in exposed Portuguese workers will 
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also be obtained. There is the expectation that this work will bring benefits for the 
workers’ health and for the companies and contribute for the development of 
Occupational Toxicology, a very important area of safety sciences, in both public health 
and economic terms, in particular in Portugal. 
 
 
2.1. Objectives 
 
The main objective is the selection of BMs to be applied in the control of chronic 
occupational exposure to the mixture of Pb, As and Mn.   
 
The specific objectives are:  
 
1- To evaluate the neurotoxic effects induced by the co-exposure to Pb, As and Mn in a 
rat model;  
 
2- To study the interaction among As, Mn and Pb on their deposition in target organs; 
 
3- To identify the three-metal exposure and predict the severity of neurotoxic effects, 
using a multibiomarker approach; 
 
4- To translate the selected BMs on a preliminary study in a risky population of 
Portuguese miners co-exposed to Pb, As and Mn.  
 
To achieve these objectives it was performed: 
 
 i) a repeated exposure in vivo assay;  
 ii) the application of mathematical models to the experimental data;  
 iii) a preliminary study  in workers exposed to the mixture of the three metals applying  
selected BMS. 
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The Chapter 1 of gives a general background focused on the increase of metal emissions 
in the environment, and the consequent health problems. In this context, the presence of 
Pb, As and Mn as mixtures in occupational setting such as mines, and the neurotoxic 
mechanisms and effects induced by these metals are also referred. BMs as tools to 
control the risk of chemical exposure are described for these three elements, and 
multivariate methodologies through the selection and integration of biomarkers are 
explored as a novel alternative to control human exposure to chemical mixtures. 
 
Chapter 2 covers the general and specific aims of the thesis.  
 
In Chapters 3 and 4 an in vivo assay with Wistar rats is described. The rats were exposed 
to Pb, As or Mn and another group was co-exposed to the mixture of these 3 metals. The 
goal of the experiment was to study deposition interactions among the three elements 
(Chapter 3), evaluate neurotoxic effects (Chapter 4) and identify BMs of exposure and/or 
neurotoxicity in rats co-exposed to the three metals (Chapter 4). Hence the levels of As, 
Mn and Pb were quantified in the brain, liver, kidney, blood and urine as well as the levels 
of other BMs, chosen based on the known mechanism of toxicity of Pb, As or Mn, blood 
and brain AChE, urine and brain delta-ALA and porphyrins profile, serum PRL and urinary 
total porphyrins.    
 
In Chapter 5 a new methodology for selection and combination of BMs was applied using 
multivariate analysis. Modeling experimental data obtained from the in vivo assay (rats 
exposed to Pb, As, Mn or its mixture), several studied BMs were integrated to identify the 
type of exposure and predict the magnitude of neurotoxic effects of each rat (respectively 
by discriminant and multiple regression analysis). It was hypothesized that the integration 
of peripheral BMs of exposure and/or effect could bring improved prediction as 
compared with the customary methodology of using single BMs (Chapter 4).   
 
 In Chapter 6 a preliminary study was performed in a chronically exposed population of 
Portuguese miners aiming to test the selected BMs (Chapters 4 and 5). According to the 
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information given from the mining Company this population was exposed to a mixture of 
the studied metals, Pb, As and Mn. 
 
Chapter 7 includes a final discussion and conclusions and outlines the future work 
perspectives.  
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Chapter 3 
  
Arsenic and manganese alter lead deposition in the rat 
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3.1. Background 
 
In the real world, exposures to complex mixtures are the rule rather than the 
exception with reports on multiple exposures to toxic metals continually emerging 
(Scherer, 2005). It also appears that excess metal exposure may be responsible by the 
appearance of neurotoxic effects in several populations around the world (Wright and 
Baccarelli, 2009) but while much data exists concerning exposure to single elements,  
limited information exists to characterize the neurotoxicity resulting from exposure to 
chemical mixtures (Tiffany-Castiglioni et al, 2006).  
 
Pb, As and Mn are of considerable concern to environmental and public health issues 
(Fairbrother et al., 2007), owing to their inherent toxicity (Dahtrak and Nandi, 2009). 
While Pb and Mn are metals, As is a semi-metal, but aiming simplification purposes 
along the text all the three elements will be referred as metals. Pb and As are present 
in the top ten binary combinations of contaminants in soil and water (Fay and Mumtaz 
1996) with major occupational exposures reported in metal smelters (Binks et al, 2005; 
Mejía et al, 1997). Co-exposures to Pb and Mn have been described in children as well 
as in several occupational cohorts (Shukla and Singhal, 1984). The 3 metals are among 
the major toxicants in mining environments (Dahtrak and Nandi, 2009), with 
concurrent exposures from soil and dust (Reglero et al, 2009; Rodriguez, et al, 1998). 
Thus, considering the actual trend for Pb, As and Mn to be ubiquitous contaminants, 
the likelihood of co-occurrence in many other environmental settings should definitely 
be considered and identified.  
 
Continued exposure to Pb, As and Mn may lead to long-term toxic effects (Dahtrak and 
Nandi, 2009); since these metals readily accumulate in multiple tissues (Martinez-
Finley et al, 2012). Food- and water-borne Pb is distributed to several organs after 
gastrointestinal (GI) absorption (ASTDR, 2007b; Casarett and Doull’s, 2007; 
Gerhardson, 1995; Hodgson, 2010) with prevailing neurological, hematological and 
nephrotoxic effects (El-Safty et al, 2004; Hodgson, 2010). Unabsorbed Pb is excreted 
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predominantly in the feces and absorbed Pb is excreted mainly in the urine (Casarett 
and Doull’s, 2007). Approximately 80-90% of As is absorbed from the GI tract (ASTRD, 
2007a), despite skin and lungs are considered relevant routes in occupational exposure 
(Casarett and Doull’s, 2007). Arsenic, predominantly deposits in the liver (Yu, 1999), 
kidney and brain (Benramdane et al, 1999), triggering nephro- and neurological effects 
(ASTDR, 2007a); its predominant route of excretion is via urine (Hughes et al, 2011). 
Although Mn is an essential element, exposure to high levels may result in toxic effects 
(ASTDR, 2007c). Exposure to Mn by inhalation is the predominant route of exposure in 
occupational cohorts. Mn readily deposits in brain, with half-lives exceeding those in 
other organs (Casarett and Doull’s, 2007). Upon ingestion, Mn is widely distributed via 
plasma, accumulating in mitochondria-rich tissues, such as brain, liver and kidney. High 
Mn levels adversely affect brain and liver function (ASTDR, 2007c). Mn is 
predominantly eliminated by fecal excretion (Casarett and Doull’s, 2007). 
 
The absorption, distribution, metabolism and excretion (ADME) of Pb, As and Mn is 
reasonably well understood but only for single metal exposures. Despite the general 
recognition that each mixture component may affect the toxicokinetics of the other 
mixture components (Simons, 1995), there is a dearth of information on the in vivo 
interaction between these metals (Kakkar and Jaffery, 2005), justifying the need to 
study deposition interactions and consequent modifications arising from resulting 
different toxicodynamics. Moreover, given the existence of common target organs of 
each component of the mixture, such as the brain, potential additive or synergic 
effects in sensitive health endpoints are a matter to deal with serious attention. 
 
Pb and As are non-essential metals for biological functions (Al-Attar et al, 2011). In 
contrast, given its essentiality, a range of biochemical mechanisms (membrane 
transporters) regulate Mn’s uptake and homeostasis (Pittman, 2005). Essential metal 
transporters can be “hijacked” by non-essential metals possessing physicochemical 
similarities (Martinez-Finley et al, 2012). Accordingly, competition between metals 
within a mixture may take place at relevant surface transporters, modifying their 
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uptake and accumulation (Spurgeon et al, 2010). In addition, once within the cells, a 
particular metal may occupy abundant binding sites (Kalia et al, 1984) on 
metalloproteins or target molecules, modifying in turn the compartmentalization of 
other metals, thus leading to aberrant binding and toxicity (Spurgeon et al, 2010). A 
given metal may also induce overexpression of transporters and/or binding proteins 
that alter the uptake of other metals (Kalia et al, 1984; Molina et al, 2011). These 
events may modify the uptake and/or retention of metals in cells, affecting their 
toxicokinetics profile and toxicity (ASTDR, 2000; Creton et al, 2009; Molina et al, 2011). 
 
Since humans are more frequently exposed to toxic mixtures rather than to a single 
element, it is essential to understand how chronic low-level co-exposures modify 
metal deposition and toxicity (ASTDR, 2000). In vivo studies can serve important 
functions such as, the identification of adverse effects induced by chemicals and 
methods for biological monitoring of exposure and early adverse health effects. The 
generation of data from experimental studies to predict health effects in humans is a 
central issue on experimental toxicology (Casarett and Doull’s, 2007). The present 
study was designed to test the hypothesis that tissue Pb levels are modified by co-
treatments with As and Mn, accounting for exacerbated behavioral deficits ascertained 
in the metal mixture-treated rats (Chapter 4). Therefore, a sub-acute in vivo study was 
conducted to determine changes in Pb levels in various organs and fluids in rats 
exposed to Pb, As and Mn alone, and in rats treated with a mixture of these metals. 
 
 
3.2. Experimental procedure 
 
3.2.1. Chemicals 
 
Chemicals were obtained from the following sources: Manganese (Mn) standard for 
Graphite Furnace Atomic Absorption Spectrometry (GFAAS) from Fluka; arsenic (As) 
standard solution for AAS (H3AsO4), di-sodium hydrogen phosphate p.a. (Na2HPO4; ≥ 
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99%), hydrogen peroxide 30% (H2O2), magnesium matrix modifier for GFAAS 
[Mg(NO3)2・6H2O], nitric acid 65% suprapure (HNO3) and hydrochloric  acid  for  ultra-
trace  analysis  (HCl) from Merck; lead acetate trihydrate puriss. [Pb (CH3CO2)2•3H2O], 
lead for AAS standard solution, manganese chloride tetrahydrate (MnCl2•4H2O; 
99.99%), sodium (meta)arsenite purum (AsO2Na; ≥ 99%), bovine serum albumin 
(>98%) and Bradford reagent from Sigma.  
 
 
3.2.2. In vivo study 
 
A repeated exposure assay was performed using male Wistar rats purchased from 
Charles River  Laboratories  ®,  Barcelona, and weighting 165 –206 g.  All experiments 
were carried out in accordance to criteria outlined in the guiding principles of the 
European Community Council Directive (89/609/EEC) for the care and use of 
laboratory animals.  The rats were housed in an independent room with controlled 
temperature, humidity and a 12-h light/dark cycle. Their general condition was 
checked on a daily basis.  All the animals had free access to water and food, supplied 
as pellets and adequate for normal growth, reproduction and maintenance. After an 
acclimatization period of 15 days, the animals were randomly assigned in 5 groups and 
the treatments were done according to the experimental design described in Fig.3.1. 
The administrated doses were chosen based on previous reports showing that rodents 
exhibited behavioral alterations (Reddy et al, 2003; Rodríguez et al, 2010; Vezér et al, 
2005). During the experiment body weight was measured, behavioral assays 
performed through the determination of ambulation and rearing counts and 24h urine 
was collected on ice, using metabolic cages. After centrifugation (2500 rpm, 15’) the 
urine samples were stored at – 80oC.  Prior to sacrifice (24 h after the last dose), rats 
were anesthetized with pentobarbital (20 mg/kg, i.p.) and blood was collected by 
cardiac puncture and divided into two tubes, one for whole blood and  the other for 
serum, which was obtained by centrifugation. Upon sacrifice, brains, kidneys and livers 
were immediately dissected out and all the samples were stored at -80ºC. 
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Group n Treatment Route 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
C 6 Saline sterile solution i.p. (1)
As 7 60 mg/L AsO2Na d.w. 
(2)
Mn 7 10 mg/Kg bw/day MnCl2 i.p.
Pb 7 5 mg/Kg bw/day C4H6O4Pb i.p.
Mixt 6 Mixture solution (3) (3)
bw (4) bw bw   bw
 uc
ba (5) ba
(1)
 intraperitoneal injection; 
(2)
drinking water, ad libitum ; 
(3)
 60 mg/L AsO2Na, d.w. +10 mg/Kg bw/day MnCl2, i.p. + 5 mg/Kg bw/day C4H6O4Pb, i.p.; 
(4) 
body  weight measurement; 
(5)
 behavioral assays; 
(6)
 24 hour urine collection
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Fig.3.1: Experimental design of the in vivo assay. 
 
 
3.2.3. Analyses of Pb, As and Mn 
 
3.2.3.1. Sample preparation 
 
a- Urine (2.5 mL) was digested with 1.25 mL of an acid mixture of 1:1 (v/v) 65% HNO3: 
HCl at 100°C for 30 minutes, in a water bath; b- 80 mg of renal cortex (after removing 
the external kidney membranes) was dried-out for 5 hours at 90oC prior to digestion 
with 1.5 mL of 65% HNO3 at 100°C for 6 hours in a dry heater block; c- 100 mg of blood 
and 80 mg of liver or brain samples were digested by Microwave-Assisted acid 
digestion (900 W, 30’’)  using Parr Microwave Acid Digestion Bombs® with 2.9 mL of 
oxidizing  acid  mixture  containing 4:1  (v/v)  HNO3 65% suprapure: H2O2 30%. The acid 
digested solutions were transferred to volumetric flasks (25 mL) and the volume 
supplemented with deionized water and kept at 4°C until analysis. 
 
All  the  glassware  and  sample  cups  for  GFAAS  were  decontaminated  from  
vestigial metals for at least 24 h in a 15% HNO3 (v/v) solution, rinsed twice with 
distilled water and then twice with deionized water. 
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3.2.3.2. Atomic absorption spectrophotometry 
 
Blood, kidney, brain, liver and urinary Pb, As and Mn concentrations were determined 
by graphite furnace atomic absorption spectrophotometry (GFAAS) (PerkinElmer 
AAnalyst™ 700) equipped with a Graphite  Furnace, a programmable sample dispenser 
(AS 800 Auto Sampler) and WinLab 32 for AA software. Daily calibration curves for 
each element were obtained with standard solutions of Pb, As and Mn and with 
Mg(NO3)2 (0.84 mol/L) used as a chemical modifier, which was added to blanks, 
standards and samples in equal volumes. The quantification limits (QLs) were 3.8 µg 
Pb/L, 22.5 µg As/L and 5.2 µg Mn/L.  
 
Results are expressed as µg Pb, As or Mn per g tissue (for blood, liver and kidney), per 
g brain protein, and as mg Pb, As or Mn per g of urinary creatinine (creat). Urinary 
levels of creatinine were determined by a colorimetric method with a Randox (CR510) 
commercial kit and brain protein contents according to Bradford protein assay (1976) 
using bovine serum albumin as the standard.  
 
 
3.2.4. Statistical Analysis 
 
Statistical analysis was performed with the SPSS 16.0 statistical package for Windows 
(SPSS, Inc., Chicago, IL, USA). Data are expressed as means ± standard deviations (SD). 
All the parameters were compared by one-way analysis of variance (ANOVA) followed 
by post hoc Tuckey’s test to assess differences between groups. ANOVA for repeated 
measures and post-hoc Tuckey’s tests were performed to compare body weight 
increments during the experiment among groups; Pearson correlations were 
determined in the co-treated group to assess relationships among Pb levels changes in 
metabolism and excretion organs and the accumulation of the metal in the brain. Two-
way ANOVA was also performed to test the interactions between Pb, As and Mn. The 
significance of the results was considered when p values were less than 0.05. 
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3.3. Results 
 
 
3.3.1. Body weight 
 
 
Group A PD 4th dose 8th dose
C 190 ± 5 259 ± 4 289 ± 7 300 ± 9
As 186 ± 7 251 ± 19 244 ± 18 242 ± 19
Mn 189 ±7 248 ± 8 229 ± 8 221 ± 8 
Pb 191 ± 4 256 ± 11 252 ± 12 255 ± 15
Mixt 181 ± 2 246 ± 10 234 ± 14 221 ± 19 
Table 2: Body weights measured in the aclimatization period (A), before 
the administration of the doses (PD) and after the administraton of the 
4th and the 8th (last) dose  in C, As, Mn, Pb and As/Mn/Pb mixture 
treated groups. Data are expressed as mean ± SD. 
 
 
 
During the experiment the body weight was measured during the acclimatization 
period, in the beginning, after the administration of the 4th dose and at the end of the 
experiment.  During the acclimatization period all the animals increased their body 
weight. The  body weight of the Mn and Mixt treated groups measured along the total 
period of the experiment, revealed to be statistically different from C group (p < 0.05) 
and this difference was statistically associated with the treatments (F= 22.9; p < 0.05) 
(Table 3.1). In fact, in both treated groups, a body weight decrease was noted when 
the treatments began, while in control group an increase was observed until the end of 
the experiment. It should also be noticed that in spite of the lack of statistical 
Table 3.1: Body weight’s determination in the acclimatization period (A), before the administration of 
the doses (PD) and after the administration of the 4th and the 8th (last) dose in controls (C), As, Mn, Pb 
and As/Mn/Pb mixture treated groups. Data are expressed as mean ± sd. ANOVA for repeated 
measures and post-hoc Tuckey tests were performed to compare body weight increments during the 
experiment among groups: * is p<0.05 versus the C group. 
* 
 
* 
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significance, during the administration period, the body weight of the groups exposed 
to Pb or As stopped to increase and became stationary (Table 3.1).  
 
  
3.3.2. Pb, As and Mn levels  
 
 Blood 
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Figs.3.2. (a), (b) and (c): Blood concentrations of Pb (a), As (b) and Mn (c) of C and As, Mn, Pb and 
Pb/As/Mn mixture treated groups. N=6 each group.  Data represent the mean ± SD. (1) In C, Mn 
and Pb groups, As levels were not quantified since were lower than the QL. All the groups were 
compared by ANOVA and post hoc Tuckey's tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb.  
 
           
Pb, As and Mn concentrations were determined in the blood. All the 3 metals were 
significantly (p<0.05) increased in the respective single metal treated group as well as 
in the metal mixture-treated rats, when compared with controls (Fig.3.2a, b and c). In 
addition, the levels of As, in the As and mixture treated groups were significantly 
(p<0.05) higher than in the other single exposed groups (Fig.3.2b) and the levels of Mn 
in Mn and mixture treated groups exhibited a significant (p<0.05) augment as 
compared with the group treated with As (Fig.3.2c). 
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Figs.3.3. (a), (b) and (c): Kidney concentrations of Pb (a), As (b) and Mn (c) in C, As, Mn, Pb and 
Pb/As/Mn mixture treated groups. N=6 each group.  Data represent the mean ± SD. (1) In C, Mn 
and Pb groups, As levels were not quantified since were lower than the QL. All the groups were 
compared by ANOVA and post hoc Tuckey's tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb. 
            
 
      
Kidney Pb levels in the Pb- and metal mixture-treated groups were significantly higher 
compared to all the other groups. In addition, Pb concentrations in the metal mixture-
treated animals were significantly higher than the Pb treated group (p<0.05)(Fig.3.3a). 
Kidney As concentrations were analogous in the As- and the metal mixture-treated 
groups and significantly higher compared to the other groups (p<0.05)(Fig.3.3b). 
Kidney Mn levels were significantly (p<0.05) higher in the Mn- and metal mixture-
treated groups compared to the control, As-, and Pb-treated groups (Fig.3.3c). In 
addition, kidney Mn concentrations in the As- and Pb-treated rats were significantly 
higher than in the controls (Fig.3.3c).   
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Figs.3.4. (a), (b) and (c): Brain concentrations of Pb (a), As (b) and Mn (c) in C, As, Mn, Pb and 
Pb/As/Mn mixture treated groups. N=6 each group.  Data represent the mean ± SD. (1) In C, Mn 
and Pb groups, As levels were not quantified since were lower than the QL. All the groups were 
compared by ANOVA and post hoc Tuckey's tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb.  
    
 
 
 
Brain Pb levels were significantly higher in the Pb- and metal mixture-treated animals 
compared to all the other groups (p<0.05). Additionally, brain Pb levels in the metal 
mixture-treated group were significantly higher than in the Pb treated rats (p<0.05) 
(Fig.3.4a).  Arsenic levels in the As- and metal mixture-treated rats were significantly 
higher compared to all the other groups (p<0.05) (Fig.3.4b). Brain Mn levels were 
significantly higher (p<0.05) in the Mn- and metal mixture-treated animals compared 
to control, As- and Pb-treated groups (p<0.05) (Fig.3.4c). 
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Figs.3.5. (a), (b) and (c): Liver concentrations of Pb (a), As (b) and Mn (c) in C, As, Mn, Pb and 
Pb/As/Mn mixture treated groups. N=6 each group.  Data represent the mean ± SD. (1) In C, Mn 
and Pb groups, As levels were not quantified since were lower than the QL. All the groups were 
compared by ANOVA and post hoc Tuckey's tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb. 
     
 
 
Liver Pb concentrations were significantly (p<0.05) higher in the Pb- and mixture-
treated rats compared to all the other groups (Fig.3.5a). Moreover, liver Pb levels in 
the mixture-treated group were significantly higher than in the Pb treated group 
(p<0.05) (Fig.3.5a).  Arsenic liver concentrations in the As- and in the metal mixture 
treated rats were significantly higher than in all the other groups, although there was 
no difference between the two groups (p>0.05) (Fig.3.5b). Liver Mn concentrations in 
the metal mixture-treated group were significantly (p<0.05) higher compared to the 
other groups, except the Mn-treated group, where Mn levels were significantly higher 
compared to the As- and Pb-treated groups (Fig.3.5c).   
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Figs.3.6 (a), (b) and (c): Urinary concentrations of Pb (a), As (b) and Mn (c) in C, As, Mn, Pb and 
Pb/As/Mn mixture treated groups. N=6 each group.  Data represent the mean ± SD. (1) In C, Mn 
and Pb groups, As levels were not quantified since were lower than the QL. All the groups were 
compared by ANOVA and post hoc Tuckey's tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb. 
     
 
 
In the metal mixture-treated rats the urinary Pb levels were significantly (p<0.05) 
higher than all the other groups and urinary Pb levels in the Pb-treated group were 
significantly higher compared to the Mn-treated and control groups (Fig.3.6a). Urinary 
As levels in the As- and metal mixture-treated rats were significantly higher compared 
to the other groups (p<0.05) (Fig.3.6b). Urinary Mn concentrations in the metal 
mixture-treated rats were significantly higher compared to the other groups (p<0.05) 
(Fig.3.6c), except the Pb-treated group.  No significant differences were noted for 
urinary Mn levels between the single metal-treated groups and controls. 
 
A significant (p<0.05) Pearson correlation (r=0.827) was determined between Pb 
kidney and brain levels and also between Pb liver and brain concentrations (r= 0.902).   
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Two-way ANOVA was performed to access interactions between Mn and Pb and 
between As and Pb in the blood, liver, kidney and brain of the mixture treated group. 
Statistically significant (p<0.05) interactions were found in all the tissues, except 
between Pb and Mn and Pb and As in the blood and between Pb and As in the kidney.    
 
  
 
3.4. Discussion 
 
Multi-exposure to metals is ubiquitous necessitating the assessment of combined 
potential health risks (ASTDR, 2000; Feron et al, 1995). Indeed, the additive or 
synergistic effects of mixtures of metals may result in the modulation of the total 
accumulated internal dose and changes in the compartmentalization of their 
components (Spurgeon et al, 2010). According to this point of view we considered 
that: i) Pb is a leading toxic agent  in the environment (Migliore and Coppedè, 2009); ii)  
Pb co-occurs with As and Mn  in several environmental settings  (Reglero et al, 2009; 
Rodriguez et al, 1998); iii) a major risk of Pb exposure is  its toxicity to the nervous 
system (Casarett and Doull's, 2013; Hodgson, 2010) and iv) As and Mn are also 
neurotoxic (ASTDR, 2007a and c). Thus, the assessment of in vivo interactions of As 
and Mn with Pb, can provide important insights for the identification of potential 
sensitive endpoints resulting from the exposure to this mixture and possibly clarify the 
origin of its increased neurotoxicity. We hypothesized that the interactions of As and 
Mn with Pb would lead to changes in their deposition in the brain and other tissues 
involved in the deposition process. Therefore, an in vivo assay was performed with 
Wistar rats single exposed to Pb, As or Mn and co-exposed to their mixture; the levels 
of each element were determined in blood, liver, kidney, brain and urine. This work 
revealed that the exposure to the mixture resulted in an increase of Pb concentrations 
in all the analyzed organs that was higher than after exposure to Pb alone, establishing 
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that the exposure to the mixture of Pb, As and Mn induced changes in the deposition 
of Pb.  
 
 
3.4.1. Body weight 
 
Body weight was measured during the experiment, which allowed the detection that 
all the animals had a progressive weight gain during the acclimatization period. During 
the treatments only the control rats continued to increase their body weight (Table 
3.1), while both Pb and As treated groups exhibited a trend to body weight become 
stationary (Table 3.1). These results are in agreement with previous studies where the 
treatment of rats with similar accumulated doses of lead acetate, 25 mg/kg b.w. for 3 
days, leaded to conclude that Pb exposure did not affect the animals’ weight 
(Whittaker et al, 2010); other studies with animals treated with sodium arsenite 3 
mg/kg b.w. for 12 weeks did not reduce significantly the body weight (ASTDR, 2007a). 
The most relevant result is concerning to Mn and mixture exposed groups, as in these 
groups there was a significant decrease of the body weights as compared with the 
controls, which was besides dose-dependent (Table 3.1). The results respecting to the 
Mn exposed group are in compliance with other studies where decreased body weight 
gains were observed in Mn exposed rats (Santos, 2008). Regarding to the mixture 
exposed group an exacerbated body weight decrease would be expected, but the 
decrease observed in these rats was actually similar to the observed in the Mn 
exposed group (Table 3.1). This observation leads to suggest that Mn is the major 
metal responsible for the body weight decrease in the co-exposed group, although by 
reasons that demand further explanation.   
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3.4.2. Metal levels 
  
3.4.2.1. Single exposed rats 
 
In the group exposed to Pb alone the levels of the metal significantly increased 
(p<0.05) in all the analyzed samples, when compared with the controls (Figs.3.2a, 3.3a, 
3.4a, 3.5a and 3.6a). These are expected results since Pb is known to be distributed to 
several organs, including liver brain and kidney, through the bloodstream, and urinary 
excretion constitutes an important route for Pb elimination (Casarett and Doull's, 
2007; Gerhardsson et al, 1995). In the same way As levels were significantly 
augmented (p<0.05) in all the biological samples of the As exposed group, relative to 
the controls (Figs.3.2a, 3.3b, 3.4b, 3.5b and 3.6b), which is also expected since As is 
transported via blood to other tissues (Jemiola-Rzeminska et al, 2007). Actually, being 
the liver a major site for methylation of inorganic As (Casarett and Doull's, 2007) 
although the kidney is a representative organ for its biotransformation and elimination 
(Peraza et al, 2003), As tends to accumulate in these primary target organs (ASTDR, 
2007a) (Figs.3.3b and 3.5b); its accumulation in the brain (Fig.3.4) was also previously 
documented  (ASTDR, 2007a). Urinary elimination is the major route for As excretion 
(De Vizcaya-Ruiza et al, 2009) which is also accordingly with our results, (Fig 3.6b). 
Additionally, significant (p<0.05) increased levels of Mn were found in the tissues of 
the Mn exposed group, except for the liver, (Figs.3.2c, 3.3c, 3.4c and 3.5c) as compared 
with controls. In agreement upon circulation in the blood, Mn is distributed largely to 
the organs rich in mitochondria, with the liver, kidneys and also the brain are among 
the tissues that mostly accumulate this metal (Casarett and Doull's, 2007). However, 
when Mn go into blood after i.p. administration (Fig. 3.1), it does not enter in the liver 
for metabolization before reaching other organs (Leggett et al, 2011), which may 
partially explain why Mn liver levels of the Mn treated group only slightly increased 
and lacked statistical significance (Fig.3.5c). This liver bypass can modify Mn 
disposition, increasing its accumulation in other organs, such as the brain (Casarett and 
Doull´s, 2007; Leggett et al, 2011) and very possibly the kidney (Figs. 3.3c and 3.5c). 
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Less than 1% of systemic Mn is eliminated via urine (Casarett and Doull’s, 2007) 
explaining the analogous urinary Mn concentrations found in controls and Mn exposed 
rats (Fig.3.6c). 
 
3.4.2.2. Rats co-exposed to Pb, As and Mn 
 
Blood 
  
In the co-exposed group the blood concentrations of the 3 elements were significantly 
(p<0.05) higher than controls, but similar to each single treated group (Figs.3.2a, b and 
c). It is plausible that no relevant interactions occurred among these elements during 
absorption, or distribution, otherwise differences in their levels would be detected in 
blood.  With respect to the absence of interactions between Pb and Mn, over 90% of 
Pb and about 66% Mn in the bloodstream is bound to red blood cells (RBC) (Sakai et al, 
1982). However, while the passage through Ca (II) channels is implicated in the uptake 
of Pb (Yokel et al, 2006), Mn uptake mainly occurs by non saturable passive diffusion 
(Weed and Rothstein, 1960). Moreover, once inside the RBCs, Pb primarily binds to 
ALAD, a saturable substrate, and only secondarily to hemoglobin, whereas Mn mainly 
binds to hemoglobin (Kumar and Rochester, 2008; Sakai et al, 1982). It is plausible that 
most Pb bounded to ALAD leaving hemoglobin available for Mn and thus, the 
administrated doses were insufficient to trigger interactions between Pb and Mn in the 
blood (Fig.3.2b). RBCs are also target cells for As compounds, although As mainly 
enters into these cells via a different transporter, the glucose transporter GLUT1 (Liu et 
al, 2006). Though, once inside the RBCs, As predominantly binds to hemoglobin (Kalia 
et al, 2007) and also to ALAD (Kalia et al, 2007) and indeed, despite not significant, a 
decrease was observed in As blood levels of the co-treated group as compared with 
the As treated group (Fig.3.2b).   
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Target organs 
 
The levels of Pb in the liver, kidney and brain of the co-treated group significantly 
increased (p<0.05) when compared with controls and with all the single treated 
groups, including the single Pb treated group (Figs.3.3a, 3.4a and 3.5a). From these 
results, it is reasonable to assume that the exposure to the mixture increased the 
availability of Pb for these organs. The Pb content augments in the co-treated rats 
were the highest in the kidney (5.4 fold), followed by the brain (2.5 fold), while the 
liver had the lowest increase (1.6 fold), (Figs.3.3a, 3.4a and 3.5a). These outcomes 
should be carefully considered when bearing in mind the association of nephro- and 
neurotoxicity with the levels of Pb in these tissues in a dose dependent manner 
(Baranowska-Bosiacka et al, 2012) and the recognition of CNS toxicity as a particularly 
sensitive endpoint (ASTDR, 2007b). Probable interactions might have occurred 
between Pb and Mn in brain and kidney, where the augments of the Pb accumulation 
in co-treated rats were accompanied by a slight, though not statistically significant, 
decrease of Mn (Figs.3.3c and 3.4c). Several putative mechanisms are proposed to 
explain the uptake of Pb in target cells, like the participation of the divalent cation 
metal transporter (DMT1) (Martinez-Finley et al, 2012), Ca (II) channels (Charlet et al, 
2012) and anion exchangers (Lind et al, 2009).  DMT1 is also one of the most known 
mediators in the transport of Mn across membranes and Ca (II) channels are referred 
as well, as involved in its transport (Aschner, 2006; Martinez-Finley et al 2012; Zhu et 
al, 2013). Besides, these transporters are present in the kidney, in the BBB and in brain 
cells (Aschner, 2006; Martinez-Finley et al, 2012; Sanders et al, 2009; Wang et al, 
2009). We raise the possibility that Pb and Mn competed for DMT1 and/or Ca (II) 
channels in these organs and that Pb entered in the kidney and brain cells in higher 
amounts than Mn, due to an eventual higher affinity for both transporters. With 
respect to Ca (II) channels Pb´s molecular similarity with Ca is broadly described 
(Casarett and Doull´s, 2007; Flora et al, 2011). It is also known that a significant 
increase of brain Pb levels appear to be influenced by DMT1 up regulation induced by 
Mn changes in Fe metabolism (Molina et al, 2011). We posit that an overexpression of 
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the DMT1 transporter, possibly triggered by Mn might have leaded to increase the 
uptake of Pb by brain and possibly also by kidney cells (Figs.3.3a and c and 3.4a and c).  
 
An additional mechanism that might explain our results is the increased retention and 
intracellular bioavailability of low doses of Pb in major target organs that is largely 
determined by its complexation with a group of inducible low molecular weight 
glycoproteins, which are inducible by Pb exposure (Gonick, 2011). The kidney is 
particularly rich in these compounds (Gonick, 2011; Smith et al, 1998) and also in the 
brain the co-administration of Pb and Mn can result in altered affinity of Pb binding 
proteins accounting for increased retention of Pb in brain cells.  It should be noted 
however that Pb binding proteins can sequester Pb in a nontoxic form and aﬀord some 
protection against its toxicity, but only until certain limit (Gonick, 2011). We noted that 
the ratio “kidney Pb levels: urinary Pb” of the mixture treated rats was twice the ratio 
calculated for the Pb single treated group (respectively, 121 vs. 58.7). This higher 
retention of Pb in the co-treated rats’ kidney may once again and according to 
Hodgson et al. (2007), suggest nephrotoxicity. This same view may support as well our 
observation of increased behavioral toxicity of the co-exposed rats (Chapter 4).  
 
No alterations were seen in the kidney As levels of As exposed group when compared 
with the co-treated rats. Differently, in the brain we determined significant 
interactions between As and Pb (p<0.05) and As concentrations of the co-treated 
group significantly decreased (p<0.05) when compared with the group exposed to As 
alone (Fig.3.3b). Since GLUT1 is the possible major pathway uptake of As in the BBB 
(Liu et al, 2006) As interaction with Pb seems to have occurred during the binding of 
these elements inside brain cells. Metallothioneins are another type of metal binding 
proteins, where Zn is the dominating metal ion (Nordberg and Nordberg, 2009). 
Studies on the ability of metals to displace Zn from Zn-MT demonstrated that among 
Pb, As and Mn the highest capacity was found for Pb, As had a limited ability to 
displace Zn from MT and Mn had no effect on Zn displacement, at least in the liver 
(Waalkes et al, 1984). Concerning specifically to the brain, MT-3 is the form of MT 
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present in this tissue (Nordberg and Nordberg, 2009) and the confirmation that Pb can 
displace Zn on brain MT waits for further studies. Even so we raise the possibility that 
Pb occupied more MT sites then As leading to changed levels of both metals in this 
organ.    
 
The levels of Pb in the liver of the co-treated group were significantly increased 
(p<0.05) when compared with all the single treated groups (Fig.3.5a) while no relevant 
changes were observed in the levels of Mn or As in this organ in the co-treated group 
(Figs.3.5b and 3.5c). Also significant interactions (p<0.05) were determined between 
Pb and As or Mn. With respect to Mn, we believe that the induction of increased 
expression of DMT1 contributed to increase the levels of Pb in the liver. Concerning to 
As, both arsenite and Pb acetate can enhance Zn-MT accumulation in liver (Albores et 
al, 1992; Yu et al, 2009) and since Pb´s affinity for Zn-MT in the liver is higher than As 
(Waalkes et al, 1984) it is plausible that the presence of As enhanced Pb accumulation 
in the organ. Despite a significant increase of Pb (p<0.05), the liver was the organ 
where this increase was the lowest (1.6 fold) (Fig.3.5a), possibly due to the low levels 
of Pb binding proteins in the liver (Gonick, 2011) and increased delivery of Pb to the 
kidney for excretion (Fig. 3.5a). 
 
The significant (p<0.05) correlations determined between liver or kidney Pb levels and 
the accumulation of Pb in the brain is suggestive that a possible deficient 
metabolization and excretion of the metal contributed to increase its levels in the CNS.   
 
Excretion 
 
A significant (p<0.05) increase on Pb excretion was observed in the mixture exposed 
rats when compared to all the other groups (Fig.3.6a). The general trend for higher 
accumulation of Pb in the organs of the co-treated rats might result in higher amounts 
of Pb in the urine, since it is established that Pb urinary levels are suitable to reflect Pb 
body burden (ASTDR, 2007b). Despite increased Mn excretion was attained in the co-
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treated group, the augment was not statistically different from Mn treated rats 
(Fig.3.6c). Actually urinary excretion is not the main route for Mn elimination (Casarett 
and Doull's, 2007) and also the mechanisms that assure a tighter regulation of the 
levels of this essential metal may explain the results. No relevant increased urinary 
excretion of As was observed due to co-exposure (Fig.3.6b). This is an interesting 
result, considering that urine is the predominant route for As elimination. The major 
fraction of excreted As is present as a GSH conjugate (Leslie, 2012).   Although 
transport of a GSH–Pb complex has yet to be directly demonstrated, such complex may 
represent a transportable form of Pb (Charlet et al, 2012). Furthermore, Pb (as well as 
As and Mn) can deplete GSH (Erikson et al, 2004; García-Fernandez et al, 2002). Should 
GSH-Pb complexation represent a predominant route for Pb excretion, it is plausible 
that the markedly increased Pb kidney levels inherent to the metal mixture-treated 
group reflect additive or synergistic GSH depletion and attenuation of this transport 
modality, resulting in decreased As excretion.  
 
 
  
3.5. Conclusions 
 
Treatment of rats with a metal mixture of Pb, As and Mn modified Pb’s deposition in 
several organs as compared to its deposition in rats treated with Pb alone. The most 
marked increase of Pb levels was observed in kidney and brain. In addition, in the 
metal mixture-treated rats, blood Pb levels fail to reflect increased Pb deposition in 
kidney and brain, raising concern that blood Pb levels may underestimate risk 
associated with Pb-induced kidney and brain damage. Selected endpoints of nephro- 
and neurotoxicity should be investigated to support the proposal of re-evaluation of 
Pb exposure limits in this metal mixture. 
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Chapter 4  
 
Biomarkers as tools to investigate the toxic effects induced by a 
mixture of lead, arsenic and manganese in a rat model 
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4.1. Background 
 
BMs,  as  observable endpoints  in  a  continuum  of  events  from  exposure  to  
disease,  are  becoming increasingly  important tools  for  the detection  and diagnosis  
of  early  toxicity (Kakkar  and Jaffery,  2005;  Scherer,  2005) as well as studies of the 
interactions among metals (Wang and Fowler, 2008). To date, the control of a mixture 
exposure has been mostly performed through the BMs of exposure and/or effect used 
in routine for each single metal of the mixture (ASTDR, 2000). Despite the existence of 
several BMs for Pb, As or Mn induced toxicity (Cowan et al, 2009; Heitland and Köster, 
2003; Higashikawa et al, 2000), practically no information exists concerning the 
interactions of these three metals with the potential changes on animals or human 
neurotoxicity.  
 
 
4.1.1. Biomarkers of exposure 
 
 Blood Pb concentration is the most used BM of exposure to Pb (ASTDR, 2007b; 
Batterman et al, 2011; Fukui et al, 1999; Patrick, 2006), although this parameter 
reflects mainly the history of the previous few months of exposure (Casarett and 
Doull’s, 2007). Several  attempts  have  been  made  to  use  urinary  Pb  as  a surrogate 
of blood Pb levels,  but this approach is of limited value since it is not  applicable on  an  
individual  basis  (Fukui  et  al,  1999). Since As is rapidly cleared from blood, 
measurements of blood As, reflect exposures only within a very recent past or to 
relatively high-levels of the metal (ASTDR, 2007a; Marchiset-Ferlay et al, 2012).  
Urinary As measurements are considered a reliable exposure BM, because urinary 
elimination is the major route for its excretion (de Vizcaya-Ruiza et al,  2009). Blood 
and urinary Mn levels can only indicate average levels of exposure on a group basis, 
not being suitable to be used individually (ASTDR, 2007c; Bader et al, 1999; Cowan, 
2008). Moreover, urinary Mn levels are even less valuable BMs, since elimination of 
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Mn occurs primarily via biliary excretion to the feces (ASTDR, 2007c; Batterman et al, 
2011; Santamaria, 2008). 
 
 
4.1.2. Biomarkers of effect 
 
The study of the mechanisms of metals neurotoxicity is the starting point to select BMs 
of neurotoxic effects (Costa, 1996); several authors have reported how the changes in 
different systems, such as the cholinergic, dopaminergic and even the hematopoietic 
system (Bhadauria and Flora, 2004; Maines, 1980; Montes et al, 2011; Patrick, 2006; 
Pohanka, 2014) can be involved in neurotoxicity. 
 
Cholinesterases can be inhibited by heavy metals (Vidal-Liñán et al, 2014), existing 
however an elevated number of published dissimilar results pertaining to Pb, As or Mn 
effects in brain AChE activity. Pb can dose dependently inhibit AChE activity in brain 
cells and in vitro, when at high concentrations the metal seems to inﬂuence protein 
folding through a process involving direct contact with the enzyme (Richetti et al, 
2011). Paradoxically, AChE activity in the brain of zebra fish is inhibited even at low Pb 
concentrations, being suggested that the effect of Pb could be mostly due to 
interference with brain metabolism/physiology leading to an indirect effect on AChE 
activity (de Lima et al, 2013). The  exposure  to As  decreases  the  activity of AChE, but 
a signiﬁcant  augment  in  its brain  activity was also found (Herrera et al, 2013).  It is 
the proposal of some authors that ACh would accumulate in an initial phase, causing 
an increase in AChE, in order to degrade the excess of the neurotransmitter, but due to 
a prolonged effect of As on synaptic receptors, less ACh would be produced causing a 
progressive decrease in AChE (de Lima et al, 2013). Mn exposure may also produce 
differential effects on AChE, with experimental high sub-acute Mn doses inducing 
increased brain AChE activity, whereas a decreased activity of the enzyme was also 
observed in a long term chronic treatment (Michalke and Fernsebner, 2013). AChE is 
highly expressed in the CNS, is present in the skeletal muscle end plate and can also be 
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peripherally found in erythrocytes, where its function is not fully understood  (de Lima 
et al, 2013, Worek et al, 1999). There has been a conviction that its measurement 
could serve as a peripheral surrogate dose–effect index of neurotoxicity on cholinergic 
function. However butyrylcholinesterase (BChE), another cholinesterase, is also 
present in tissues were AChE can be found, such as muscles, brain and also in plasma 
(Marek et al, 2011). Therefore, caution is advisable when interpreting results 
pertaining to whole blood determinations and methods ensuring the determination of 
AChE alone are definitely advisable. 
 
The dopaminergic system is a major target for environmental neurotoxicants, such as 
metals and DA is known to regulate the release of the hormone PRL (Montes et al, 
2011). Decreased DA receptor density in the pituitary was already found in rats upon 
exposure to Pb, consistent with the elevated serum PRL concentrations (Smith et al, 
1998). Also As can  affect dopaminergic functions (Rodríguez et al, 2010) but few 
information exist about the effects of As on PRL release, while elevated serum PRL 
upon Mn exposure have been mentioned as suggesting DA disturbance (Montes et al, 
2011). Generally to date, the results pertaining to the effect of metals on human 
serum PRL are still confusing, since negative studies on the association of PRL levels 
with exposure to neurotoxicants are also published. Moreover, PRL can be affected 
differently by different chemicals and the same chemical may cause different effects 
on PRL, depending on the exposure levels (Alessio, 2006). Exposure to multiple metals 
was already associated with PRL changes (Meeker et al, 2009). 
  
The interference with enzymes of heme biosynthesis, ALAS and ALAD, leads to 
increased delta-ALA in circulating blood and urine (Gurer and Ercal, 2000). The best-
known  hematological  effect  of  Pb  is  the  interference  with  ALAD  (ATSDR, 2007c;  
Patrick,  2006), which is also highly  sensitive to As (Bhadauria  and  Flora, 2004). 
However little is known about the potential of Mn to interfere with heme biosynthesis. 
Anyway, it is achieved that delta-ALA accumulates especially in the liver and in the 
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brain (Onuki et al, 2004) where may cause CNS damage and peripheral neuropathy 
(Ryter and Tyrrel, 2000).  
 
When heme metabolism disorders occur, such as the induced by metals, 
characteristically porphyrin levels increase in blood and urine (Fleck et al, 2003; Solinas 
and Vajda, 2008; Quintanilla-Vega, et al, 1996).  Excessive accumulation of these heme 
precursors in the body have been considered responsible for neuropathy and 
neuropsychiatric symptoms that occur in hereditary hepatic porphyrias,  despite the 
exact pathogenic mechanism is not clear (Ennis et al, 2003; Simon and Herkes, 2011). 
Pb exposure typically results in protoporphyrin accumulation in the erythrocytes and 
increased urinary excretion of coproporphyrin (Quintanilla-Vega, et al, 1996).  Changed 
excretion patterns of urinary porphyrins, uro- and coproporphyrins have also been 
observed in vivo upon exposure to As via drinking water (Krishnamohan et a, 2007; Wu 
et al, 2004) and also in exposed workers (Ng et al, 2005; Krishnamohan et al, 2007). 
Despite the lack of information respecting to the eventual effect of Mn in heme 
biosynthesis or changes induced in urinary porphyrins, a few reports mention altered 
levels in liver and brain (Maines, 1980). Because different metals can exert their effects 
at different points of the metabolic pathway of the heme biosynthesis, changes in the 
urinary porphyrin profile can be used to differentially diagnose some specific metal 
exposures, with authors  suggesting that porphyrins can be promising BMs of toxicity 
induced by metal mixtures (Wang and Fowler, 2008).   
 
Pb, As and Mn co-occur in specific occupational settings and the three elements have 
the shared feature of inducing neurotoxicity. Considering these informations the 
present study was designed to assess the changes on neurotoxic effects induced by the 
co-exposure to Pb, As and Mn, through the evaluation of neurobehavioral and 
neurochemical changes in rats single metals exposed and in rats co-exposed to the 
mixture. To achieve this goal, motor activity assays were performed and several brain 
and peripheral biomarkers were determined. 
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4.2. Experimental Procedure 
 
 
4.2.1. Chemicals 
 
Chemicals were obtained from the following sources:  2-Propanol for HPLC (C3H8O; 
99.5%),  5,5 –dithiobis (2-nitrobenzoic  acid)  (DTNB), acetylthiocholine  (ATCh), diethyl 
ether (C4H10O), ethanol (C2H6O), ethopropazine, ethyl acetate (C4H8O2), ethyl 
acetoacetate p.a. (C6H10O3), methanol HPLC grade (CH4O; ≥99.9%), phosphoric  acid  
(H3PO4), sodium phosphate dibasic (Na2HPO4), sodium phosphate monobasic 
(NaH2PO4) and Triton X 100 from  Sigma–Aldrich;  perchloric acid (HClO4), potassium  
dihydrogen  phosphate  (KH2PO4),  delta-aminolevulinic  acid standard,  sodium acetate 
(C2H3NaO2), and p-dimethylaminobenzaldehyde (C9H11NO)  from  Merck; acetic acid 
(C2H4O2)  and hydrochloric acid p.a. (HCl; 37%)  from Panreac;  Iodine resublimed from 
BDH; Pure  standards of  uro-,  hepta-, hexa-, penta-  copro- and  protoporphyrins (10 
nM) where obtained from  Porphyrin products, Frontier Scientific. 
 
 
4.2.2. In vivo assay 
 
A repeated exposure in vivo assay (8 days) with Wistar rats was performed as 
described in Fig.3.1 (Chapter 3).  
 
 
4.2.3. Behavioral assays 
 
Motor  activity  was  assessed  before  the  beginning  of  the  experiment  and  24-h 
after the administration of the last dose, through  open-ﬁeld behavior evaluation 
(Marreilha dos Santos et al, 2011) (Fig.3.1, Chapter 3). The tests were carried out in  an  
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open-ﬁeld apparatus consisting of a white box with a surrounding 30-cm-high opaque 
wall,  the  floor  measuring  60  cm  ×  90  cm  and  divided  in  equal  squares  by  black 
lines.  Immediately  after  placement  in  the  center  of  the  open-ﬁeld,  the  rats’ 
movements  were  scored  for  five  minutes.  Two  behavioral  parameters  were 
determined:  the  number  of  squares  crossed  with  all  paws  (ambulations)  and  the 
number of times that both forelegs were raised from the floor (rearings). The rats were 
tested individually, and after each session, the open field was thoroughly cleaned with 
humid cleaning tissue.  
 
 
4.2.4. Pb, As and Mn levels in brain, blood and urine 
 
Determinations were performed as previously described in Chapter 3.  
 
 
4.2.5. Acetylcholinesterase activity in brain and blood 
 
Brain and total blood AChE activities were determined according to an adaptation of 
Ellman’s method (1961) by Worek et al (1999) (Naik et al, 2008). This method is  based  
on  the  formation  of  a  yellow  5-thio-2-nitrobenzoate  anion produced  in  the  
reaction  between  5,5 -dithiobis-(2-nitrobenzoic  acid)  (DTNB)  and thiocholine,  after  
AChE-mediated  hydrolysis  of  ATCh.  The procedure consisted in the addition of 0.9 
mL of buffer sodium phosphate dibasic/sodium phosphate monobasic (0.1 M) pH 7.4 
and 0.1 mL of 5% Triton to 50 mg of brain homogenates in a Potter-Elvehjem. The  
reaction  was  initiated  after  the  addition  of  0.05  mL  of DTNB ( 0.33  mM)  in the 
presence of 20 µM ethopropazine (an inhibitor of BChE)  and  0.05  mL  of  ATCh (1.56  
mM),  which  was  used  as  substrate.  The reaction was measured for 3 minutes by 
the increase of absorbance in intervals of 10 sec at 412 nm, using a Hitachi 
spectrophotometer.  For blood determinations, readings were performed at 436 nm to 
reduce interference by hemoglobin. The activity of AChE was calculated according to 
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the following formula: AChE activity = (Δ average*0.0015)/ (0.00017* tissue weight), 
with Δ = absorbance tn – absorbance tn-1 and t = time. A calibration plot with R2=0.96 
was used and precision expressed as coefficient of variation (CV %) was 12.2%. The 
results are expressed as nmol AChE/min/g brain protein and nmol AChE/min/g blood. 
 
 
4.2.6. Prolactin in serum 
 
Serum PRL was quantified by an enzyme immunoassay (Citomed ®). Plates were read 
in an Anthos Zenyth 3100 microplate detector. The QL was 0.6 ng/mL. 
 
 
4.2.7. Delta-aminolevulinic acid  in brain and urine 
 
One  mL  of  supernatant  (2500  rpm,  10’)  from  each  sample  (urine  or  brain 
homogenates) was added to 1 ml of acetate buffer (pH 4.6) and 0.2 mL of 
acetoacetate. The samples were mixed (5’’) and incubated (100oC, 10’) followed by the 
addition of  3  mL  of  ethyl  acetate,  agitation  (15’’)  and  centrifugation  (2000  rpm,  
3’).  A colorimetric reaction was started with Ehrlich reagent and the obtained organic 
phase. Delta-ALA  concentrations  were  determined  at  553  nm  with  an  Hitachi 
spectrophotometer. Calibration curves were generated daily with a delta-ALA 
standard. The QL was 0.012 mg delta-ALA/L and the  results are  expressed  as  mg  of  
delta-ALA  per  g  of  urinary creatinine or per g of brain protein.  
 
Urinary levels of creatinine were determined by a colorimetric method with a Randox 
(CR510) commercial kit, and brain protein contents according to the method described 
by Bradford (1976).  
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 4.2.8. Total porphyrins in urine 
 
70µL of acetic acid and 1750 µL of diethyl ether were added to 700µL of each urine 
sample, agitated (15’’) and centrifuged (2500 rpm, 2’).  After the centrifugation, 
1750µL of an iodine chloridric solution (1% in HCl 5%) was added to the organic phase 
and after new agitation and centrifugation the aqueous phase was placed in a water 
bath (37oC, 5’). Absorbances were measured at 380nm and 430nm, corresponding to 
impurities’ maximum absorbances, and at 401nm, in a Hitachi spectrophotometer. 
Total porphyrins are expressed in µg/g creat and were calculated according to the 
expression proposed by Soulsby and Smith (1974): Porphyrins (µg/L) = [2 x A401 – (A430 
+ A380)] x 2,093 x 1,064 x 1000, and corrected for creat.  
 
 
4.2.9. Brain and urinary porphyrin profile 
 
For the analysis of brain and urinary porphyrin profile, 20 µL of HCL 10 M was added to 
750 µL of each sample (urine or brain homogenates), agitated in the vortex and kept in 
the dark for 30’. After centrifugation (2500 rpm, 10’) the supernatant was stored at -
80oC until analysis (Woods et al, 2004). Given that porphyrins are photosensitive 
compounds, during the handling of all the samples protection from light was assured.  
 
Chromatographic porphyrin analysis was performed by High Performance Liquid 
Chromatography (HPLC) in a Hewlett Packard Agilent 1100 HPLC system equipped with 
a quaternary pump, solvent degasser, fluorescence detector and sampler (50 µL). 
Separation was accomplished on a LiChrospher 100 Merck RP18 column (125mm x 
4mm, 5μm), fitted with an identically packed column (4 x 2 mm) maintained at 
ambient temperature. The mobile phase consisted of methanol 100% (solvent A) and 
sodium phosphate monobasic (50 mM), pH 3.5 (solvent B). A gradient was used 
starting at the mobile phase A:B (30:70%) until 3 min, changed linearly to A:B (80:20%) 
until 10 min, maintained equal for 3 more minutes and after, the column was 
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equilibrated with 30% of solvent A for 5 min. The flow rate was 1.0 mL/min. The 
fluorescence detector was set at an excitation wavelength of 395nm and an emission 
wavelength of 620nm. Data acquisition, processing and instrument control was 
performed by a Chemstation software. 
 
A dried porphyrin standard (10 nM) was recovered with HCl (3M) and several dilutions 
of this stock solution were used to obtain a calibration plot with R2=0.9998. The 
determined QLs  were: 7.7 nmol/L for uroporphyrins, 10.2 nmol/L for heptaporphyrins, 
11.0 nmol/L for hexaporphyrins, 10.6 nmol/L for pentaporphyrins, 17.2 nmol/L for 
coproporhpyrins and 10.9 nmol/L for protoporphyrins.  
 
All the results are expressed as nmol of porphyrin per g of urinary creat or per g of 
brain protein.  
 
 
4.2.10. Statistical analysis 
 
Data are expressed as mean ± SD.  Statistical analysis was performed using SPSS 16.0 
statistical package for Windows (SPSS, Inc., Chicago, IL, USA). After verification of data 
adequacy for parametric methods, normal distribution by Kolmogorov-Smirnov test 
and homogeneity of variance with Levene’s test, non-parametric analysis revealed to 
be a better statistical approach. All groups were compared by Mann-Whitney tests. 
The significance of the results was considered when p values were less than 0.05. 
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4.3. Results 
 
 
4.3.1. Behavioral assays 
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Figs.4.1 (a) and (b): Pb, As and Mn and Pb/As/Mn mixture effects in motor activity, ambulation (a) 
and rearing (b) counts. Data represent the mean ± SD of ambulation and rearing counts before (PD) 
and after the treatments in C, As, Mn, Pb and Mixt groups. N=6 each group. All the groups were 
compared by Mann-Whitney U tests: *, ^, º, » and # are p < 0.05 versus PD, C, As, Mn and Pb.  
       
 
Two  parameters  of  motor  activity  were  determined,  ambulation  and  rearing,  
prior  to treatments  and  24  h  after  the  last  dose.  In  the  Pb  treated  group  a  
trend  towards decreased  motor  activity  was  observed  when  compared  with  the  
control  group  and with  the  PD  group  (Figs.4.1a  and  b).  The  As  treated  group  
revealed  similar  trends  to those found in the Pb treated group, but with statistical 
significance for ambulation (p< 0.05) (Fig.4.1a). The Mn treated rats exhibited a 
significant decrease in ambulation and rearing compared with the two control groups 
(p < 0.05) (Figs.4.1a and b). Rats treated with  the  metal  mixture  showed  a  decrease  
in  both  motor  parameters  that  were significantly  different  from  all  the  other  
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groups  (p  <  0.05)  (Figs.4.1a  and  b),  except  for rearing activity when compared with 
the Pb treated group (p < 0.05) (Fig.4.1b).   
 
 
 
4.3.2. Brain biomarkers  
 
 Acetylcholinesterase activity in brain 
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Fig.4.2: Brain AChE activity in Pb, As and Mn and Pb/As/Mn mixture treated groups. A control (C) 
group was also used. Data represent the mean ± SD and n=6 each group. All the groups were 
compared by Mann-Whitney U tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and Pb. 
 
 
Rats treated with Pb or Mn exhibited a significant (p < 0.05) decrease in the activity of 
the enzyme with respect to controls and the As group (Fig.4.2). Inversely the activity of 
AChE in the brain of the As single treated rats was significantly (p< 0.05) increased as 
compared with controls (Fig.4.2). Brain AChE activity of the group exposed to the 
mixture was significantly (p< 0.05) lower than controls and As treated rats (Fig. 4.2).  
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Brain delta-aminolevulinic acid levels 
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Fig.4.3: Brain concentrations of delta-ALA in Pb, As and Mn, and Pb/As/Mn mixture treated groups. 
A control (C) group was also used. Data represent the mean ± SD and n=6 each group. All the 
groups were compared by Mann-Whitney U tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and 
Pb.  
 
 
 
 
      
Brain  delta-ALA  concentrations  were  significantly  increased  in  the  Pb  and  As  
treated groups compared with the control (p< 0.05), whereas in the Mn treated group,  
delta-ALA  brain  levels  were  similar  to  controls  (p > 0.05)  (Fig.4.3).  The highest 
concentrations of brain delta-ALA were observed in the metal mixture treated group, 
with levels significantly increased compared to all the other groups (p< 0.05) (Fig.4.3). 
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   Porphyrins profile in brain 
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Figs. 4.4 (a), (b), (c), (d), (e) and (f): Uroporphyrin (a), heptaporphyrin (b), hexaporphyrin (c), 
pentaporphyrin (d), coproporphyrin (e) and protoporphyrin (f) levels in the brain of controls (C) and 
Pb, As, Mn and Pb/As/Mn mixture treated groups. N=6 each group. Data represent the mean ± SD. 
All the groups were compared by Mann-Whitney U tests: *, ^, º and » are p < 0.05 versus C, As, Mn 
and Pb. 
 
 
The porphyrin profile was analyzed in the brain of controls and exposed animals. With 
respect to the Pb treated group, its comparison with the controls leaded to note a 
decrease in uroporphyrin concentrations (Fig.4.4a), along with augments in the levels 
of hexa-, copro- and protoporphyrins (Figs.4.4c, e and f). All these differences lacked 
statistical significance, except those concerning to the coproporphyrins 
concentrations, where a significant difference was noted relatively to the controls and 
the As treated group (p<0.05). The As exposed group had very slight and not significant 
(p>0.05) increases of penta- and coproporphyrins (Figs.4.4d and e), when compared 
with the controls. Increased levels of penta-, copro and protoporphyrins were 
observed in the brain of the Mn exposed group as compared with controls (Figs.4.4d, e 
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and f). These differences observed were not significant (p>0.05) probably due to the 
high SD values attained for the group exposed to this metal. In the mixture exposed 
group the levels of uroporphyrins were lower than all the other groups, although this 
difference was significant only when compared with the controls (p<0.05) (Fig.4.4a). A 
trend for a slight increase of copro and protoporphyrins of the mixture treated group 
was also observed as compared with the control group (Figs.4.4e and f).  
 
 
4.3.3. Peripheral Biomarkers 
 
Acetylcholinesterase activity in blood 
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Fig.4.5: Total blood AChE activity in Pb, As and Mn and Pb/As/Mn mixture treated groups. A control 
(C) group was also used. Data represent the mean ± SD and n=6 each group. All the groups were 
compared by Mann-Whitney U tests.  
 
 
No significant difference was found among groups concerning to AChE activity in the 
total blood (Fig. 4.5). 
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 Serum prolactin levels 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
50
55
60
C As Mn Pb Mixt
n
g 
P
R
L/
m
L 
se
ru
m
^
* 
*
* 
  
Fig.4.6: Serum PRL levels in Pb, As and Mn and Pb/As/Mn mixture treated groups. A control (C) 
group was also used. Data represent the mean ± SD and n=6 each group. All the groups were 
compared by Mann-Whitney U tests: *, ^, º, and » are p < 0.05 versus C, As, Mn and Pb. 
 
 
 
 
 
 
In the Pb treated group the levels of serum PRL were significantly (p<0.05) lower than 
the As treated group (Fig. 4.6). Serum PRL levels were found to be significantly 
increased in As and in Mn single treated rats when compared with controls (p< 0.05) 
(Fig 4.6). The rats treated with the mixture exhibited an increase of serum PRL 
concentrations that was significantly (p< 0.05) different than the controls (Fig. 4.6). 
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Urinary delta-aminolevulinic acid levels 
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Fig.4.7: Urinary concentrations of delta-ALA in Pb, As and Mn and Pb/As/Mn mixture treated 
groups. A control (C) group was also used. Data represent the mean ± SD and n=6 each group. All 
the groups were compared by Mann-Whitney U tests: *, ^, º, and » are p < 0.05 versus C, As, Mn 
and Pb.  
 
 
 
 
 
Delta-ALA-U levels were analyzed and corrected for creatinine content.  The  Pb  and 
metal mixture treated rats showed a significant increase in urinary delta-ALA levels 
compared with  all  the  other  groups  (p < 0.05)  (Fig.4.7).   
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 Urinary total porphyrins 
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Fig.4.8: Urinary concentrations of total porphyrins in Pb, As and Mn and Pb/As/Mn mixture treated 
groups. A control (C) group was also used. Data represent the mean ± SD and n=6 each group. All 
the groups were compared by Mann-Whitney U tests: *, ^, º, and » are p < 0.05 versus C, As, Mn 
and Pb. 
 
 
 
 
Total urinary porphyrins were determined, leading to the observation that all the 
single exposed rats had total urinary porphyrins significantly (p<0.05) higher than the 
controls (Fig. 4.8) and that the mixture treated group exhibited a significant (p<0.05) 
augment of this urinary parameter, when compared with the controls and all the single 
exposed groups (Fig. 4.8). 
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Urinary porphyrin profile 
 
 
0
0,001
0,002
0,003
0,004
0,005
0,006
0,007
0,008
C As Mn Pb Mixt
n
m
o
l u
ro
po
rp
hy
ri
ns
 /
g 
cr
e
at
0,0000
0,0005
0,0010
0,0015
0,0020
0,0025
0,0030
0,0035
C As Mn Pb Mixt
n
m
o
l h
ep
ta
po
rp
hy
ri
ns
/ g
 c
re
a
t
*
0,0000
0,0005
0,0010
0,0015
0,0020
0,0025
0,0030
C As Mn Pb Mixt
n
m
o
l h
ex
ap
o
rp
hy
ri
ns
/g
 c
re
at
0
0,002
0,004
0,006
0,008
0,01
0,012
C As Mn Pb Mixt
n
m
o
l p
en
ta
po
rp
hy
ri
ns
/g
 c
re
at
0,000
0,050
0,100
0,150
0,200
0,250
C As Mn Pb Mixt
n
m
o
l c
o
pr
o
po
rp
hy
ri
ns
/g
 c
re
at
0,0000
0,0002
0,0004
0,0006
0,0008
0,0010
0,0012
0,0014
C As Mn Pb Mixt
n
m
o
l p
ro
to
po
rp
hy
ri
ns
/g
 c
re
at
*
*
*
* *
*
*^º
»
*^º
*^
º
*^º
*
*^º»
*^º»
*^º»
a)
b) c)
d) e) f)
 
Figs.4.9 (a), (b), (c), (d), (e) and (f): Uroporphyrin (a), heptaporphyrin (b), hexaporphyrin (c), 
pentaporphyrin (d), coproporphyrin (e) and protoporphyrin (f) urinary levels of controls (C) and Pb, 
As, Mn and Pb/As/Mn mixture treated groups. N=6 each group. Data represent the mean ± SD. All 
the groups were compared by Mann-Whitney U tests: *, ^, º   and » are p < 0.05 versus C, As, Mn 
and Pb. 
 
 
The determination of the urinary porphyrin profile of the Pb treated group leaded to 
observe significant (p<0.05) decreases in the levels of uroporphyrins (Fig.4.9a) as 
compared with controls and in the levels of protoporphyrins when compared with 
controls and the other single exposed groups (Fig.4f). It was also noted that this group 
had significant (p<0.05) augments of heptaporphyrins as compared with controls 
(Fig.4.9b), of pentaporphyrins as compared with controls and the other single treated 
groups (Fig.4.9d) and also of coproporphyrins as compared with Mn exposed animals 
(Fig.4.9e). The rats treated with As showed significant (p<0.05) decreased levels of 
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uroporphyrins, when compared with the controls (Fig.4.9a) as well increased levels of 
all the other determined porphyrins, although the augments observed in hexa- and 
protoporphyrins were not statistically significant (Figs.4.9b, c, d, e and f). In 
comparison with the controls, significant (p<0.05) decreased levels of uro- and 
coproporphyrins were detected in the Mn treated rats (Figs.4.9a and e). Augments of 
hepta- and pentaporphyrins were also observed in the Mn group as compared with the 
control group (Fig.4.9b and d) despite lacking  statistical significance (p>0.05). 
Concerning to the mixture exposed group, the levels of uroporphyrins were 
significantly (p<0.05) lower than all the other groups, with exception to the Pb treated 
group (not statistically significant) (Fig.4.9a). The urinary heptaporphyrins were 
significantly (p<0.05) higher than controls (Fig.4.9b); In addition, hexa-, penta- and 
coproporphyrins values were significantly (p<0.05) higher than all the other groups 
(Figs.4.10c, d and e). A trend toward an increase of protoporphyrins was also observed 
concerning to all the other groups, although this augment was only statistically 
significant (p<0.05) when compared with the group exposed to Pb (Fig.4.9f). 
 
4.3.4. Biomarkers correlations 
 
Biomarkers in brain 
 
Table 4.1: Relationships between metal levels in brain (Br) and delta-ALA, AChE activity and 
uroporphyrin Br levels, in Pb, As, Mn and Pb/As/Mn mixture treated groups. Data represent 
significant correlations expressed by Spearman's rho values (p<0.05). 
 
 
Group Metals ALA-Br AChE-Br Uro-Br
As As-Br - - -
Mn Mn-Br - - -
Pb Pb-Br - - -
Mixt As-Br 0.627 -0.689 -0.743
Mn-Br 0.811 -0.638 -0.735
Pb-Br 0.783 -0.610 -0.837
Spearman's rho
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Spearman’s rho correlations were also determined between brain metal levels and 
delta-ALA, AChE activity and uroporphyrins in brain, leading to observe that no 
significant correlation was attained upon single exposure (Table 4.1). Inversely, in the 
mixture treated group, delta-ALA brain levels had a significant and positive correlations 
(p<0.05) with the three metals (ρ=0.783, ρ=0.627 and ρ=0.811, respectively pertaining 
to Pb, As and Mn brain levels) (Table 4.1). AChE activity in brain, showed a significant 
and negative correlation with Pb brain levels (ρ=-0.610; p<0.05), As brain levels (ρ=-
0.689; p<0.05) and with Mn concentrations in brain (ρ=-0.638; p<0.05). Also, 
significant (p<0.05) negative correlations were determined between brain 
uroporphyrin levels and the concentrations of the three metals in this organ (ρ=-0.837, 
ρ=-0.743 and ρ=-0.735, respectively Pb, As and Mn levels) (Table 4.1). 
 
Brain and peripheral biomarkers 
  
Table 4.2: Relationships of peripheral BMs, urinary (U) As and delta-ALA levels, and Pb and Mn 
concentrations in blood (B), with their respective concentrations in brain (Br), in Pb, As, Mn and 
Pb/As/Mn mixture treated groups. Data represent significant correlations expressed by Spearman's 
rho values (p<0.05).  
 
 
Group Metals As-U Mn-B Pb-B ALA-U
As As-Br 0.828 - - -
ALA-Br - - - -
Mn Mn-Br - 0.741 - -
ALA-Br . - - -
Pb Pb-Br - - 0.682 -
ALA-Br - - - -
Mixt As-Br 0.839 - - -
Mn-Br - 0.838 - -
Pb-Br - - 0.643 -
ALA-Br - - - 0.788
Spearman's rho
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The single treated groups showed significant positive correlations between peripheral 
BMs and the concentrations of each respective metal in the brain, namely between Pb 
levels in blood and brain (ρ=0.682; p<0.05) in the Pb treated group, As levels in urine 
and brain (ρ=0.828; p<0.05) in the As treated group and Mn concentrations in blood 
and brain (ρ=0.741; p<0.05) in the Mn group (Table 4.2). The group exposed to mixture 
showed also positive and significant correlations between blood and brain Pb 
concentrations (ρ=0.643; p<0.05), urinary As and As levels in the brain (ρ=0.839; 
p<0.05), blood and brain Mn levels (ρ=0.838; p<0.05) and urinary and brain delta-ALA 
concentrations (ρ=0.788; p<0.05) (Table 4.2). 
 
 
 
4.4. Discussion 
 
Excessive  exposure  to  metals  can  lead  to  brain  dysfunction  (Kordas  et  al, 2010) 
being established that Pb, As and Mn induce neurotoxic effects (Gerhardson et al, 
1995; Health Canada, 2008, Rodriguez et al, 2003). Yet, despite the mixture of these 
elements is known to coexist in the environment, in particular in several occupational 
settings, the  combined  effects  of  metal  mixtures  is  largely  unknown  (Tiffany-
Castiglioni et al, 2006; Wang and Fowler, 2008). Herein, we evaluated the changes of 
neurotoxic effects in response to rats’ treatment with each studied metal and with the 
mixture of Pb, As and Mn, through behavioral assays and several BMs were also 
determined. More specifically, rearing and ambulation counts were performed in 
motor activity assays and the following brain and peripheral biomarkers were 
determined: Pb, As and Mn levels in brain, blood and urine; brain and blood AChE 
activity; brain and urinary delta-ALA levels and porphyrin profile, urinary total 
porphyrins and serum  PRL concentrations. 
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4.4.1. Motor activity 
  
 
Open-field  spontaneous  motor  activity  assessment  is  a  sensitive  and  reliable 
behavioral  test;  it  has  been  previously  used  to  assess  Pb,  As  or  Mn-induced 
neurotoxicity (Marreilha dos Santos, 2011; Moreira et al, 2001; Sansar et al, 2011). In 
this  study,  all  single  metal  treated  rats  showed  decreased  motor  activity  
compared with the controls, although not attaining statistical significance for either 
the motor parameters (rearing and ambulation) in the Pb treated group, neither for 
rearing in the As treated group (Figs.4.1 a and b). Conflicting results on ambulation and 
rearing activities in  Pb-exposed  rats  have  been  previously  noted  (Chandra  et  al,  
1981;  Reddy  et  al, 2003;  Rocha  et  al,  2001;  Rodrigues  et  al.,  1996),  consistent  
with  our  inability  to ascertain  a  clear  and  significant  effect  on behavioral changes 
in  the  Pb  treated  group. While reductions in these parameters have been previously 
reported as dose dependent (Chandra et al, 1981), the eventual existence of Pb 
threshold levels for a clear manifestation of behavioral effects possibly exists. With  
respect  to  As  and  Mn,  our  results  corroborate  previous  reports,  consistent  with 
decreased  motor  activities  (Rodríguez  et  al.,  2010;  Vezér  et  al.,  2005), which were 
already associated with induced motor damages (Rodríguez et al, 2010; Vezér et al, 
2005).  Our  data  also show  that the  treatment  with  the  3-metal  mixture decreases 
ambulation and rearing activities compared with all the  other groups (Figs.4.1a  and  
b).  This  is  in agreement with earlier reports, where rats simultaneously co-treated 
with Pb and Mn showed  a  significant  decrease  in  motor  activity  compared  with  
single  metal  treated animals  (Chandra  et  al.,  1981).  Motor  deficits  due  to  As  
exposure  have  also  been described  (Mejía  et  al.,  1997).  Combined, all data allows 
us to conclude that Pb, As and Mn mixture treatment exacerbates motor dysfunction 
in the rat. 
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4.4.2. Brain biomarker levels  
 
Metals 
 
 It is well established that Pb, As and Mn perturb brain function (ATSDR, 2007a and c; 
Marreilha dos Santos et al, 2011).  In  the  present  study, Pb,  As  and  Mn  brain levels 
were  significantly  higher  in  each single  treated  group, as compared  with  the 
control (Fig. 3.4a, b and c, Chapter 3) corroborating early reports, where increased 
brain Pb, As or  Mn  levels upon exposure to these metals were associated  with  
neurobehavioral  deficits (Donoghue, 2004; Landrigan et al., 2006; Ramteke et al, 
2009; Reckziegel et al, 2011;  Rodríguez et al, 2003 and 2010). Notably, Pb  brain levels  
in  the  metal  mixture  treated  group  were significantly  higher  than  in  any  of  the  
other  groups  (Fig.3.4a, Chapter 3).  Consistent  with  our results,  higher  brain  Pb  
levels  were  previously  reported  in  rats  exposed  to  the  binary mixtures  of  Pb/Mn  
and  Pb/As,  compared  to  rats  only  exposed  to  Pb  (Chandra  et  al 1981;  Mejía  et  
al,  1997).  Combined,  these  observations  suggest  that  co-exposure  to Pb  and  
other metals  increase  brain  Pb  accumulation.  It  has  yet  to  be  determined 
whether  this  effect  is  associated  with  upregulation  of  Pb-specific  transporters, 
increased  leakiness  of  the  neurovasculature  and/or  reduced  clearance  of  Pb in 
brain. In addition, As and Mn brain concentrations  in  rats  treated  with  the  metal  
mixture  were  higher than  in  controls (Fig. 3.4b and c , Chapter 3). These  results  
suggest  an  association  between  brain  co-accumulation  of  these  three metals and 
decreased motor activity in rats co-exposed to this mixture. 
 
Acetylcholinesterase activity 
 
The rats exposed to Pb exhibited a significantly (p<0.05) decrease in brain AChE activity 
(Fig. 4.2), according to in vitro, in vivo and epidemiological studies, demonstrating the 
inhibitory effects of Pb on the enzyme (Ademuyiwa et al, 2007; de Lima et al, 2013; 
Finkelstein et al, 1998; Reddy et al, 2003) with whole brain AChE activity showing 
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marked depletions (Tripathi et al, 1997). Concerning to As, while decreased brain AChE 
activity occurred in rats exposed to 25 or 100 mg As/dL in drinking water for 4 months 
(Rodriguez, et al, 2003), sodium meta-arsenite (50 mg/L) via drinking water for 42 days 
to pregnant rats provoked a 20% increase in the activity of the enzyme. This difference 
was attributed to the dose and length of treatments (Herrera et al, 2013). In this work 
the As treated rats showed a significantly (p<0.05) increase of brain AChE activity 
(22%) as compared with controls (Fig. 4.2), possibly expressing a hormetic response 
upon exposure to an As low dose (Fig. 3.1, Chapter 3) (Herrera et al, 2013). Agreeing 
with mechanistic evidences of Mn induced toxic effects in cholinergic neurons 
(Finkelstein et al, 2007), such as decreased brain AChE activity (Santos et al, 2012), the 
activity of the enzyme significantly (p<0.05) decreased in Mn treated rats when 
compared with the controls (Fig.4.2). Yet, it is to mention that Mn exposure may 
produce differential effects on brain AChE activity with descriptions of its increased 
activity (21%)  (Liapi et al, 2008). A complex figure seems to involve the relationships 
between Mn and cholinergic functions, where tight regulation mechanism to maintain 
the levels of this essential metal (Ascnher and Dorman, 2006) and genetics may be 
among modulating factors (Santos et al, 2012). No correlations between AChE activity 
in brain and the levels of metals in the organ were attained upon single exposures. 
Since Pb, As and Mn affect cholinergic functions (Ademuyiwa et al, 2007; Finkelstein et 
al, 2007; Roy et al, 2006) and brain AChE activity actually changed (Fig. 4.2), possibly 
the doses administrated were not enough to attain a clear relationship between 
cholinergic disarrays and metal accumulation in brain. Moreover, Mn has selectivity for 
dopaminergic neurons (Ellingsen et al, 2003) possibly in detriment to cholinergic 
neurons. 
 
The mixture treated group decreased AChE brain activity values, with respect to 
controls (p<0.05), but this change was similar in Pb and Mn single treated rats (Fig 4.2). 
Interactions among the three metals in the brain resulted in increased Pb and Mn 
accumulation, with concomitant decreased As levels in this organ (Fig.3.4a, Chapter 3). 
The final effect of As-induced increased brain AChE activity, concomitantly with Pb- 
and Mn- inhibition of the enzyme can explain why AChE activity decreased without 
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additivity or synergism (Fig. 4.2). The significant correlations (p<0.05) of the three 
elements concentrations in the brain with the activity of AChE (Table 4.1) support this 
suggestion.  Additionally, upon exposure to the mixture the combined effect of Pb and 
Mn on the cholinergic system was plausibly enough to contribute to the decrease of 
motor activity via AChE inhibition. 
 
Delta- aminolevulinic acid 
 
Pb  interferes  with  heme  synthesis,  promoting  ALAS  and  inhibiting  ALAD  activity,  
consequently increasing  blood  delta-ALA  levels  (Ennis  et  al.,  2003) and As also  
decreases  blood  ALAD activity (Bhadauria  and  Flora,  2004). In agreement with the 
information that delta-ALA can accumulate in the CNS (Demasi et al, 1996), in  the  
present  study  Pb  and  As  treated rats  showed  increased  levels of this compound in 
the brain,  as  compared  with  the  controls  (Fig.4.3). However, no  correlations  
between  brain  delta-ALA  and  the  levels  of  each  of  these metals  in response to 
single metal treatment were noted (Table 4.1). It is likely that in Pb treated  rats  the  
administered  doses  were  insufficiently  high  to  reach  the  requisite brain  levels  
that  trigger  significant  delta-ALA  accumulation.  Consistent with this observation, the 
treatment failed to cause a significant behavioral dysfunction (Table 4.1 and Figs.3.2a  
and  b, Chapter 3). Practically no information exists on the effects of Mn on delta-ALA 
brain levels and our results showed that Mn treated rats and controls have similar 
delta-ALA levels in brain (Fig.4.3), leading to think that at least for the administrated 
doses the metal does not have a relevant effect at this level.  
 
In the metal mixture treated group, delta-ALA brain levels were the highest and 
significantly different (p<0.05) from all the other treatment groups (Fig.4.3). Moreover, 
brain delta-ALA concentrations were correlated with increased brain Pb, As and Mn 
levels (Table 4.1). Moreover brain Pb concentrations were higher in rats treated with a 
mixture of these metals than after single  metal  exposure,  which suggests  that  Pb  
plays  a  key  role  in  the  excessive accumulation  of  brain  delta-ALA. It  is  recognized  
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that  the bioavailability  of  Pb  in  tissues  may  be  affected  by  the  presence  of  high  
affinity  Pb-binding proteins (Rocha et al, 1995). A higher retention of Pb in the brain 
along with the presence of As, may possibly explain why brain delta-ALA 
concentrations increased in this group more than upon single exposures. Delta-ALA´s 
deleterious effects in the brain have been broadly described (Ennis et al., 2003) and 
common  neurotoxic  mechanisms  are  shared  with  Pb,  As  and  Mn;  these  include 
interference with GABAergic systems and the induction of OS, conditions known to 
interfere with motor behavior (Adonaylo and Oteiza, 1999; Anderson et al, 2008;  
Demasi  et  al,  1996;  Erikson  et  al,  2004;  Flora  et  al,  2005;  Jomova  and  Valko,  
2011; Lelli et al, 2005; Milatovic et al, 2009; Reckziegel  et al, 2011; ; Rodríguez  et  al,  
2010;  Struzynska  and  Sulkowski,  2004).  Given  the  existence  of  shared 
mechanisms  for  delta-ALA,  Pb,  As  and  Mn  induced  neurotoxicity,  the  behavioral 
changes are likely multifactorial and stem from (1) the increase of Pb levels in brain 
and its deposition along with As and Mn, and (2) the accumulation of delta-ALA. 
 
Porphyrin profile 
 
Approximately  85%  of  heme  is synthesized  in the  bone  marrow and  the  remaining  
15%  is  produced  in the  liver  and  other  tissues, including the brain (Quintanilla-Vega 
et al, 1996; Maines, 1980); The presence of ALAS and other heme biosynthesis 
enzymes in this organ is previously reported, as well as its ability to carry out 
hemeprotein activities (Quintanilla-Vega et al, 1996); in our study, in all the groups, 
including controls, porphyrins were present in the brain(Fig 4.4). The group exposed to 
Pb had significantly (p<0.05) increased coproporphyrin levels in the brain as compared 
with the controls (Figs.4.4e and f), being known that coproporphyrinogen oxidase is 
inhibited by Pb (Ahamed and Siddiqui, 2007; Gurer and Ercal, 2000; Moore, 1998). No 
significant modifications were observed in As or Mn exposed groups despite data 
exists indicating that the presence of Mn in the brain can result in increased porphyrin 
levels (Maines, 1980). In addition, the mixture treated group exhibited a significant 
(p<0.05) decreased concentration of uroporphyrins as compared with the controls (Fig. 
  
127 
 
4.4a). The levels of brain porphyrins result from the balance of intricate processes, 
such as the control of their entrance from circulation and the regulation of its synthesis 
inside this organ, with several mechanisms ensuring the homeostasis of heme 
metabolism (Maines, 1980). Moreover, both neurons and  glia synthesize  different  
porphyrins  at  different  rates and the degree  and  the  extent  of  inhibition  of  
porphyrins  production  can  also  be  very different  between these cells (Juknat, 
1995). These informations lead to realize that the final outcome is a complex pattern 
of results, attained in this work by a trend for an accumulation of heme precursors in 
the brain of treated rats, although without very marked changes of individual 
porphyrins. 
 
 
4.4.3. Peripheral biomarkers 
 
The use of peripheral BMs, generally in blood and urine, is a common method to 
access modifications in inaccessible organs such as the brain, with the additional 
advantage that they represent simpler and cheaper methods to evaluate neurotoxicity 
in humans, surrogating the application of batteries of neurobehavioral tests. In this 
perspective, the levels of metals in blood and urine, urinary delta-ALA, total porphyrins 
and the porphyrin profile, blood AChE activity and serum PRL were determined.  
 
Metals in blood and urine 
 
Concerning to single exposed groups, positive and significant (p<0.05) correlations 
were determined: in Pb treated rats between Pb blood concentrations and Pb levels in 
brain; in the As treated group between urinary and brain As levels; and in the Mn 
treated group, Mn blood concentrations correlated with the levels of the metal in the 
brain (Table 4.2). Blood Pb concentration is actually one of the most widely used 
parameters for general clinical use and public health surveillance (ASTDR, 2007b) in 
detriment of urinary Pb, since excretion via urine is not the main route of Pb excretion 
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(Casarett and Doull’s, 2007). Urinary elimination is the major route for excreting As 
and thus urinary As measurements have been considered more reliable than blood As 
levels and are the most used BM to assess exposure (ASTDR, 2007a; Marchiset-Ferlay 
et al, 2012).  With respect to Mn, although the weak suitability of using its blood or 
urinary levels as BMs (Phoon, 1988), urinary Mn seems to be the weakest parameter, 
since urinary excretion of Mn represents no more than approximately 1% (Santamaria, 
2008). In this work, for both single and co-treated groups, the levels of peripheral 
metal levels, blood Pb and Mn and urinary As, correlated significantly (p<0.05) and 
positively with the concentrations of each respective metal in the brain (Table 4.2), 
suggesting that these non-invasive BMs can be used to indirectly assess their levels in 
this organ. 
 
Acetylcholinesterase activity in blood 
 
With respect to the whole blood AChE activity no significant differences were attained 
between groups, due to the high standard deviation values (Fig 4.5). AChE is found 
mostly in the nervous tissue and is also present in the membrane of red blood cells 
(RBCs). There is considerable confusion in literature where authors often report that 
they had measured AChE in human plasma with ACh as substrate, where in fact they 
had measured also the activity of BChE, which is also present in the plasma (Pohanka, 
2014; Worek et al, 1999). Therefore, when using whole blood samples it is crucial to 
assure that AChE alone is being measured. Methods using BChE speciﬁc inhibitors such 
as ethopropazine, which was used in this work, allows the determination of AChE 
activity in human whole blood (Naik et al, 2008). Also intriguing, is the fact that the 
same methodology was applied simultaneously to rats and humans’ whole blood, 
leading to observe significant differences between exposed humans and controls 
(Chapter 6).  There is also a great lack of published information regarding to the effect 
of these metals in blood AChE activity of rats and thus, further studies are needed to 
confirm these results. Even so, some questions can be raised such as if the results 
observed in humans were due to exposure to other metals. 
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 Serum prolactin 
 
Increased serum PRL in response to Pb exposure was previously related to depression 
of the inhibitory dopaminergic influence on pituitary PRL release in humans (Takser et 
al, 2004). However, the group treated with Pb did not show a significant modification 
of serum PRL concentrations (Fig. 4.6), which might be attributed to the used low 
doses. The levels of the hormone in serum increased significantly (p<0.05) in As 
treated rats, when compared with the controls. Little information exists respecting to 
the effects of As in PRL, except a recent report describing that 100 and 200 mg/L of 
sodium arsenite given to rats by drinking water for 28 days resulted in decreased 
plasma levels of PRL in a dose dependent manner (Jahan et al, 2012), which disagrees 
with our results. Possibly the use of plasma instead of serum could explain this 
difference, due to the presence of coagulating factors in the samples (Stuijver  et al, 
2012).  Mechanistic evidences support the results obtained in this work, such as the As 
effects in the dopaminergic system where induced OS can promote DA auto-oxidation, 
the association of DA decrease with changes in motor activity upon exposure to As 
(Mejía et al, 1997) and the inverse relationship between DA and serum PRL levels 
(Marreilha dos Santos et al, 2011).. Biochemical mechanisms underlying Mn toxicity 
include DA auto-oxidation (Smargiassi and Mutti, 1999) with elevated serum PRL upon 
exposure to the metal, suggestive of DA disturbances involving the hypothalamus–
hypophysis axis (Montes et al, 2011). Accordingly, Mn treated rats had significantly 
(p<0.05) increased serum PRL levels relatively to controls (Fig 4.6).   
 
The mixture treated rats exhibited an increase of PRL serum levels that was 
significantly (p<0.05) higher than controls, but was not different from the levels found 
in the groups exposed to each metal alone (Fig. 4.6). Pb was the metal present in the 
brain of mixture treated rats at higher concentrations (Fig. 3.4a, Chapter 3), and 
probably counteracted As and Mn effects on the hormone (Fig. 4.6). However, no 
correlations were observed between serum PRL and the levels of the three metals in 
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the brain. Further studies using brain BMs are necessary to elucidate in which degree 
this peripheral parameter can indicate metal levels brain status. 
 
Urinary delta-aminolevulinic acid 
 
Pb treated rats were the only single exposed group for which urinary delta-ALA levels 
changed significantly (p<0.05), augmenting with respect to controls and the other 
single exposed groups (Fig. 4.7). This modification was not correlated with brain delta-
ALA concentrations (Table 4.2) possibly because of the low dose used in the 
experiment.  
 
In a different way, the metal mixture treatment leaded to increased delta-ALA levels in 
urine, which were higher than the sum of the levels for each of the three single metals 
treated groups (Fig. 4.7), suggesting that the mixture treatment leads to delta-ALA-U 
changes that exceed the additive effects of the individual metals. In fact, along with 
the known effects of Pb on the accumulation of delta-ALA, its increased urinary 
excretion is described in As exposed subjects (Marchiset-Ferlay et al, 2012). Plausibly in 
the co-exposed rats, a decrease in heme levels induced delta-ALA accumulation 
through negative feedback control. These   events   might   not   be   enough   to   
signiﬁcantly   modify   delta-ALA   urinary   levels   of   single   exposed   As   rats, but   
may  explain the results observed for the mixture exposed group. Additionally, the 
observed increased delta-ALA excretion in urine may also be supported by the 
information that delta-ALA reabsorption is a saturable process and takes place only 
under low delta-ALA concentrations (O’Flaherty et al, 1981).   In this case, in the 
mixture group, and in accordance with our results, we believe that the reabsorption is 
minimal as the secretion pathway is dominating. In addition urinary delta-ALA levels 
correlated significantly (p<0.05) with brain delta-ALA levels (Table 4.2) suggesting the 
suitability of this peripheral BM to be used to assess delta-ALA in brain. In vitro 
experiments established that brain delta-ALA is slowly metabolized once incorporated 
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into neurons (Juknat et al, 1995). Therefore, we posit that blood-borne delta-ALA may 
enter in the brain, leading to its accumulation in the co-treated group.  
 
Urinary porphyrins 
 
Disorders  of  heme  metabolism,  characterized  by  accumulation  of  porphyrins  and  
their  precursors,  can be  induced  by exposure  to  certain  chemicals. Thus, 
alterations  in  the  heme  biosynthetic  pathway are  often  used  as  an  index  of  
exposure  and preclinical  damage  to  a  variety  of  toxic  agents (Quintanilla-Vega et 
al, 1996). Therefore, total porphyrins were determined with the purpose of 
preliminary evaluate if the 3 metals could interfere with heme biosynthesis and if in 
co-treated rats the magnitude of changes were enough to further investigate 
porphyrin profiles. All single exposed groups had significant (p<0.05) increased 
excretion of these heme precursors when compared with the controls (Fig.4.8), which 
can indicate increased total porphyrins body burden. These results confirm that Pb and 
As interfere with heme synthesis (Krishnamohan et al, 2007, ASTDR, 2007b) and show 
for the first time that Mn induce modifications in the excretion of  porphyrins. 
Additionally, the co-exposure to the three metals resulted in increased total porphyrin 
urinary levels, which were significantly (p<0.05) augmented with respect to controls 
and were also significantly (p<0.05) higher than after exposures to each element alone 
(Fig.4.8). These results suggest the convenience of studying the profile of heme 
precursors in the urine. 
 
Urinary porphyrins profile 
 
Pb  is  one  of  the  most  studied metals  with  regard  to  its  toxic  effects  on  the  
heme biosynthesis  pathway. The group exposed to Pb exhibited  changes in the 
urinary porphyrin profile, such as  a significantly (p<0.05) decrease of uroporphyrins 
(Fig.4.9a) as compared with controls, possibly due to delta-ALA accumulation resulting 
from ALAD inhibition (Fig.4.9e) (Quintanilla-Vega et al, 1996). The metal can also 
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impair markedly coproporphyrinogen oxidase leading to increased urinary excretion of 
coproporphyrin (Gurer and Ercal, 2000), which increased significantly (p<0.05) in the 
Pb treated group as compared with Mn treated animals (Quintanilla-Vega, et al, 1996). 
Since Pb interference with FECH may provoke protoporphyrin accumulation in 
erythrocytes (Quintanilla-Vega, et al, 1996), the significant (p<0.05) decrease of urinary 
protoporphyrins in Pb exposed rats (Fig. 4.9f) demands further explanation. Previous 
works indicate that urinary porphyrin concentrations has the potential for use as an 
early warning indicator for chronic As exposure (Ng et al, 2005; Quintanilla-Vega et al, 
2006), with coproporphyrinuria described in smelter workers (Krishnamohan et al, 
2007) as well as significant modifications in uroporphyrin and coproporphyrin 
concentrations in urine in other human populations (Ng et al, 2005), although with 
discrepancies pertaining to the direction of these changes (Wu et al, 2004). An altered 
urinary porphyrin profile was also observed in the As treated group, where 
uroporphyrins decreased significantly (p<0.05) when compared with the controls 
(Fig.4.9a), along with a significant (p<0.05) increase of penta- and coproporphyrin 
excretion (Figs.4.9d and e), which may represents augmented body burden of these 
heme precursors. Barely no information exists on the effects of Mn in the heme 
biosynthetic pathway, except a reference mentioning that in vitro the metal may 
inhibit  FECH  (Hift et al, 2011) and in vivo, ALAS in the brain(Maines, 1980). Urinary 
uro- and coproporphyrins decreased, as compared with the controls (p<0.05) (Figs.4.9a 
and e) and thus, this work is one the few studies developed on this issue, suggesting 
that Mn can interfere with the synthesis of heme and enhances the need of further 
investigations. The most marked urinary porphyrin profile modifications were 
observed in the mixture exposed rats. In this group, uroporphyrin levels were 
significantly (p<0.05) lower than the other groups, despite lacking statistical 
significance (p>0.05) when compared with Pb treated rats (Fig.4.9a) and hexa, penta 
and coproporphyrins were significantly (p<0.05) higher than all the other groups 
(Figs.4.9c, d and e), suggesting that combined effects of Pb, As and Mn may result in 
higher heme synthesis disorders.   
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No significant correlations were obtained between brain and urinary levels of each 
porphyrin since despite a trend for an accumulation of heme precursors in the brain of 
exposed rats not very marked changes of individual porphyrins were attained. 
Circulating heme precursors can enter the brain being known that delta-ALA and PBG, 
mainly accumulated in the liver, can cross the BBB (Andrade et al, 2013). In  vitro 
studies show also that exogenous delta-ALA  can  be  taken  up  by  neuronal cells  and  
be metabolized to  PBG  and  porphyrins (Juknat et al, 1995) and indeed, the group 
treated with the mixture exhibited an accumulation of delta-ALA in the brain (Fig. 4.3). 
However, a tight regulation of brain porphyrin levels exists as well. The brain is 
normally fairly well protected from changes in plasma delta-ALA concentration by the 
very low BBB permeability to this compound and by a saturable efﬂux mechanism 
present at the choroid plexus (Ennis, 2003). Thus, the final outcome is very acceptably 
a complex pattern of results and may explain why individual porphyrins urinary levels 
poorly reflect changes in brain porphyrins.  
 
 
   
4.5. Conclusions 
 
This work established that the co-exposure to As, Mn and Pb induce increased 
behavioral toxicity and brought also insights of mechanistic interest, concerning to 
consequences of Pb, As and Mn interactions in vivo on neurotransmitter and heme 
precursors levels. Indeed the co-exposure to these elements induces modifications in 
the brain such as decreased activity of AChE and increased accumulation of delta-ALA, 
which can act as a neurotoxin and accumulate more than upon single exposures. In 
addition, changes in blood and urinary metal levels, increased serum PRL and urinary 
delta-ALA and total porphryrins were found. The obtained results are suggestive of the 
suitability of these parameters to be used as peripheral BMs of exposure and/or 
neurotoxicity upon exposure to the mixture of Pb, As and Mn, which will be 
investigated in the next chapter.  
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Chapter 5 
 
Multibiomarker approach to identify the exposure to chemicals 
and predict the severity of neurotoxic effects 
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5.1. Background 
 
Human biomonitoring has been increasingly recognized as a pragmatic methodology to 
control exposure to environmental/occupational pollutants (Pino et al, 2012). 
Neurotoxic effects induced by metals can be devastating on mental and physical 
functioning (Cannon and Greenamyre, 2011) leading to an urgent need to improve 
prevention, which assuredly involves the correct identification of the chemicals to 
which each person is exposed and/or the detection of earlier disease events. Yet, when 
metal concentrations in blood or urine are determined, these values do not give any 
information about the neurotoxic outcomes of each subject (Feron et al, 1995; Kordas 
et al, 2010). Therefore, great attention has been given to BMs of effect which can 
reﬂect physiological and morphological changes in cell and tissues resulting from the 
exposure and can be applied in exposed populations (Costa and Manzo, 1995). BMs 
are particularly useful in the evaluation of nervous system progressive diseases that 
manifest their symptoms long after the exposure to the initiating factors (Kakkar and 
Jaffery, 2005). In addition, due to the large variation  in susceptibility  to chemicals  
exposure, some  individuals  may experience  toxic effects  at  levels  that  others  can  
sustain  without  any  problem (Bergdahl  et  al,  1997). Hence the evaluation of the 
magnitude of the neurotoxic effects in each subject is also vital. Paradoxically, the  
research  of  the neurotoxicity theme  seems  to  be more  slow than  other  fields  with 
regard  to  biological  monitoring  and  the  development  of  markers  of  exposure  
and of  health  effects. The  complexity  of  the  nervous  system  and  its peculiarities, 
as well as the fact that CNS disorders can arise from the dynamic disarray of several 
gene regulatory networks, proteins and metabolic alterations reﬂecting huge complex 
perturbations, are responsible  for  this  limited  advancement (Costa and Manzo, 
1995). Besides, when pertaining to exposures to mixtures of metals with the inherent 
multi-mechanisms of metal toxicity, the knowledge about interactions of metal 
mixtures and BM endpoints are highly lacking (Wang and Fowler, 2008).  
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The growing need for a rigorous evaluation of new BMs is leading to the recognition 
that the use of appropriate statistical techniques is essential for the accurate 
evaluation of their clinical relevance. Several methodologies are used to select the 
most adequate BMs of exposure and/or effect on the determination of health risk in 
exposed populations. Correlation analysis is a common method, where it is determined 
whether a significant correlation exists between the levels of a biological parameter or 
endpoint(s) of disease and the exposure to specific chemical(s) (Casarett and Doull´s, 
2007).  In addition, an accurate BM must have the capacity to adequately identify or 
differentiate one condition (or outcome) from another.  The diagnostic accuracy of a 
BM is most commonly measured by the calculation of its sensitivity and specificity. 
Sensitivity is the proportion of patients who are  correctly  categorized  as  exposed  or  
having  disease,  among  those  who  truly  are exposed or have the disease; specificity 
is the proportion of patients who are correctly categorized as non-exposed or not 
having the disease, among all subjects who truly don’t have the exposure or disease 
(SØreide, 2009). In this context, receiver-operating characteristic (ROC) curve analysis 
is emerging as a useful statistical tool to assess BMs’ accuracy (Cai and Pepe, 2002; 
Doecke et al, 2012; Shin et al, 2013; SØreide, 2009) and has been previously applied 
for BMs of exposure to Pb (Sakai, 2000). 
 
Concomitantly, some authors consider a naïve expectation that a single BM can 
capture the intricate process underlying a CNS illness (Quinones and Daouk, 2009) 
most particularly, when the illness is induced by more than one chemical, including 
mixtures of metals. Rather, exposed populations should be studied using a 
combination of exposure and effect BMs, to efficiently detect and diagnose early metal 
poisoning (Kakkar and Jaffery, 2005; Zhai et al, 2005). Lately the integration of BMs 
promise an improved diagnostic performance over single markers that may be lacking 
in sensitivity and/or speciﬁcity; this novel approach is being tempted in the early 
detection of CNS diseases through the use of multivariate statistical techniques (Ravid, 
2009) such as discriminant and multiregression analysis (Da et al, 2014; List et al, 2013; 
Quinones and Daouk, 2009). Nevertheless, despite the promised improvements, 
analyzing several BMs can be laborious spending time and money, due to the need of 
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collecting more than one biological sample (e.g. blood and urine) and the use of more 
than one analytical technique. In this view, porphyrins constitute a group of distinct 
compounds (Fig. 1.1) intermediates of heme biosynthesis, which can be integrated as a 
multiparameter BM. The determination of a porphyrin urinary profile simply requires 
the collection of one urine sample (a noninvasive method) and one single HPLC 
analysis.  In fact, Pb, As and Mn can induce porphyrins accumulation, that results from 
the interference with specific points of the heme metabolic pathway and when in 
excess, heme precursors are neurotoxic. These informations are suggestive that the 
integration of the several porphyrins might reflect global neurotoxic outcomes 
resulting from the action of each component of the mixture, possibly representing a 
promising alternative in the context of BMs integration. 
 
The aim of this work was to generate predictive models to select and subsequently     
combine peripheral BMs. These BMs would first identify the type of exposure and 
after, predict the magnitude of neurotoxic effects induced by the mixture of Pb, As and 
Mn in an individual basis.  The integration of peripheral BMs of exposure and/or effect 
is hypothesized to improve the prediction as compared with the traditional 
methodology based on the scrutiny of single BMs.    
 
 
 
5.2. Methodology 
 
Two procedures were created, the first one integrating the levels of the 3 metals in 
blood and/or urine, urinary delta-ALA and total porphyrins, blood AChE activity and 
serum PRL (procedure I) and the second one using the urinary porphyrin profile 
(procedure II). In each procedure the BMs were combined through statistical tools to 
create a 2 phase’s prediction model, with phase 1 aiming to identify the type of 
exposure of each rat and phase 2 aiming to predict the severity of motor impairment. 
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To generate procedure I, the BMs were previously selected as described in the next 
section. 
 
 
5.2.1. Selection of biomarkers  
 
 
Data obtained from the in vivo assay with rats exposed to Pb, As, Mn or the mixture of 
the three metals were used to evaluate which BMs could better:  
 
1)  Distinguish Pb, As, Mn or Pb+As+Mn treated rats from controls; 
2) Correlate with behavioral outcomes. 
 
The BMs selected in 1) were further integrated as BMs of exposure and the BMs 
selected in 2) were combined as BMs of effect. 
 
 
The evaluation of each BM’s capability to distinguish exposed rats from controls was 
performed by the estimation of areas under ROC curves. The  ROC  curve  is  a plot of 
sensitivity, indicating the number of true positives (on the vertical axis) and specificity, 
indicating the number of true negatives (on the horizontal axis) for all possible  
thresholds  of  a  BM  in  the  study  data  set  (Akobeng  et  al,  2007;  Shin  et  al, 
2009).  Whereas  a  BM´s  area  value  close to  1  indicates an excellent  BM,  a  curve  
that lies  close  to  the  diagonal  (Area  =  0.5)  has  no  information  content  and  
therefore  no diagnostic utility.  More than one ROC curve can be present in the same 
plot and thus the absolute areas under each curve were compared to determine which 
BM had the better diagnostic performance (Warnock and Peck, 2010). Correlation 
analysis was performed by the determination of Spearman´s rho coefficients. 
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5.2.2. Integration of BMs 
 
Phase 1 
 
Discriminant analysis was performed to build the phase 1 of each procedure (I and II). 
This statistical tool allows: the identification of variables that better discriminate two 
or more different groups of individuals; the use of these variables to create a 
discriminant function that represents in parsimonious manner the differences among 
the groups; and the use of discriminant functions to classify new individuals in the 
groups (Maroco, 2010). In fact discriminant analysis undertakes the same task as 
multiple linear regression by predicting an outcome using weighted combinations of X 
values (Muhameed and Saleh, 2014) (in this case the several BMs), but the outcomes 
are predicted for categorical variables (in this case the type of exposure, to Pb, As, Mn 
or its mixture). This is achieved through the generation of classification functions 
where different function coefficients of each BM are obtained for each group of rats. 
After applying all the functions to a subject under analysis, the group with the higher 
value of the classification function corresponds, according to the model, to the group 
where the subject belongs (Maroco, 2010). Discriminant analysis is known to be very 
robust to data assumption violations, such as the lack of normality, homogeneity of 
variances among groups and the absence of multicollinearity, but only if two 
conditions are guaranteed: the dimension of the smallest group must be smaller than 
the number of predictor variables and for each variable the means in each group 
cannot be proportional to its variances (Maroco, 2010). After verifying that these two 
conditions were assured, several combinations of the selected BMs were tested, 
achieving a compromise between the use of a minimum number of BMs and the 
maximization of predictive performance of the model, which was evaluated through 
the examination of canonical discriminant function graphics and classification results 
tables. The best solution was accomplished when the following BMs were used: in 
procedure I, urinary Pb, As and delta-ALA and the levels of Pb and Mn in blood; in 
procedure II all urinary porphyrins, uro-, hepta-, hexa-, penta-, copro- and 
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protoporphyrins. After this phase it was possible to identify if each rat was not 
exposed, single exposed to Pb, As or Mn or exposed to the mixture of the three metals.  
 
 
Phase 2 
 
The second phase of each procedure intended to evaluate the severity of the motor 
impairments of each rat, through the prediction of the number of ambulations and 
rearings. Multiple linear regression was performed, modeling the single response 
variable Y (ambulation or rearing counts) as a linear combination of the X variables 
(Helma, 2005) (the BMs). Neper logarithmic (ln) transformation was applied in all the X 
variables to approach them to regression model assumptions. Again, several 
combinations of selected BMs were tested, achieving the following compromise: 
absence of multicollinearity among the X variables, verified by the examination of 
Variance Inflation Factors (VIF) and tolerance values tables; minimization of the 
number of selected BMs; and maximization of the predictive performance of the 
model, evaluated through the examination of significance values (p<0.05) in ANOVA 
tables and R2 values (Maroco, 2010). In procedure II, the levels of porphyrins in the 
brain were also integrated and evaluated with respect to their capability to predict 
motor activity in order to confirm the suitability of using the urinary porphyrins with 
the same purpose.      
 
The same analysis was performed using each BM alone, for comparison with the 
multiparameter approach (appendix 1 and 2).   
 
For all the statistics the significance of the results was considered when p values were 
less than 0.05. 
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5.3. Results 
5.3.1. Selection of biomarkers 
Phase 1 
Biomarkers discrimination between exposed rats and controls 
 
                            
C vs Pb group C vs As group
C vs Mn group C vs Mixt group
(A=93%)
(A=100%)
(A=100%)
(A=100%)
(A=97%)
(A=100%)
(A=100%)
(A=97%)
a) b)
c) d)
(A=100%)
(A=100%)
 
Figs.5.1 (a), (b), (c) and (d): The ability of peripheral BMs, Pb and Mn levels in blood (B), urinary (U) 
As, serum (S) PRL and urinary (U) total porphyrins (PorfT) and delta-ALA to discriminate between 
control rats (C) and the Pb treated group (a), C and the As treated group (b),  C and the Mn treated 
group (c) and C and the mixture Pb/As/Mn treated group (Mixt). Curve's area (A) under the 1-
Specificity (x) vs Sensitivity (y) axis are plotted by ROC (Receiver Operating Characteristics) analysis: 
areas are directly proportional to the BMs discriminant capabilities. A=100% indicates that all 
subjects were true positives and true negatives; N=6 each group. All the presented areas are 
significant (p<0.05). 
  
144 
 
Areas under the ROC curves were determined for all the peripheral BMs to evaluate 
their ability to differentiate controls from Pb, As, Mn or Pb/As/Mn mixture treated 
rats. In the Pb treated group significant area values (p<0.05) were noted for urinary 
delta-ALA (A=100%), total porphyrin levels (A=100%) and also for blood Pb levels 
(A=93%), showing the ability of these BMs to discriminate controls from Pb treated 
rats (Fig.5.1a). Urinary As or total porphyrin levels significantly (p<0.05) distinguished 
controls from As treated rats (A=100% for both BMs) as well as serum PRL (A=97%) 
(Fig.5.1b). Mn treated rats were significantly (p<0.05) differentiated from controls 
through the levels of Mn in blood (A=100%) or serum PRL (p<0.05) (A=97%)  (Fig.5.1c). 
Urinary delta-ALA or total porphyrins discriminated between controls and mixture 
treated rats with statistical significance (p<0.05) both exhibiting areas of 100% 
(Fig.5.1d).  For all the exposed groups no significant areas were observed when using 
urinary Pb or Mn levels, or As concentrations or AChE activity in blood (data not 
shown). 
 
 
Phase 2 
Correlations between brain biomarkers and motor activity  
 
Table 5.1: Relationships between Pb, As, Mn, delta-ALA and AChE activity in the brain (Br), and 
motor activity, ambulation and rearing counts, in Pb, As, Mn and Pb/As/Mn mixture treated 
groups. Data represent significant correlations expressed by Spearman's rho values (p<0.05). 
  
Group Motor activity As-Br Mn-Br Pb-Br ALA-Br AChE-Br
As Ambulation counts -0.737 - - -0.728 -
Mn - -0.555 - - -
Pb - - -0.601 - -
Mixt -0.816 -0.811 -0.797 -0.783 0.745
As Rearing counts -0.614 - - -0.713 -
Mn - -0.623 - - -
Pb - - -0.664 - -
Mixt -0.829 -0.847 -0.868 -0.791 0.709
Spearman's rho
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Significant correlations between brain BMs and motor activity parameters (ambulation 
and rearing) were determined. In the Pb treated group,  brain  Pb  concentrations  
were inversely correlated  with  both  motor  activity  parameters (respectively ρ=-
0.601 and ρ=-0.664  for  ambulation  and  rearing  counts;  p<0.05)  (Table  5.1). 
Negative Spearman´s coefficients were also determined in the As treated group, 
between As and delta-ALA brain levels  and  motor  activity (respectively ρ=-0.737  and 
ρ=-0.728  for  ambulation  counts  and  ρ=-0.614  and  ρ=-0.713  for  rearing  counts; 
p<0.05) (Table 5.1). In Mn treated rats, brain Mn levels correlated inversely with motor 
activity (ρ=-0.555 and ρ=-0.623 for ambulation and rearing counts; p<0.05) (Table 5.1).  
Additionally, in the mixture treated group, brain Pb, As and Mn levels correlated 
significantly with ambulation counts (ρ=-0.797, ρ=-0.816  and ρ=-0.811; p<0.05) and 
with rearing counts (ρ=-0.868, ρ=-0.829 and ρ=-0.847; p<0.05) (Table 5.1) as well as 
delta-ALA and AChE activity in brain (respectively ρ=-0.783 and ρ=-0.745, for 
ambulation counts and ρ=-0.791 and ρ=-0.709 for rearing counts; p<0.05) (Table 5.1).  
 
Correlations between peripheral biomarkers and motor activity 
 
Table 5.2: Relationships between peripheral BMs, urinary (U) As, delta-ALA and total porphyrins 
(PorfT)  concentrations, serum (S) PRL and Pb and Mn levels in blood, and motor activity, 
ambulation and rearing counts, in Pb, As, Mn and Pb/As/Mn mixture treated groups. Data 
represent significant correlations expressed by Spearman's rho values (p<0.05). 
 
 
Group Motor activity As-U Mn-B Pb-B ALA-U PRL-S PorfT-U
As Ambulation counts -0.816 - - - -0.799 -0.757
Mn - - - - -0.610 -
Pb - - - -0.626 - -0.674
Mixt -0.893 - - -0.827 - -0.909
As Rearing counts -0.698 - - - -0.677 -0.697
Mn - -0.663 - - -0.636 -
Pb - - - - - -
Mixt -0.833 -0.670 - -0.780 - -0.896
Spearman's rho
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Several significant correlations were determined between peripheral BMs and motor 
activity parameters. The Pb exposed group exhibited negative associations of urinary 
delta-ALA and total porphyrin levels with ambulation counts (respectively ρ=-0.626 
and ρ=-0.674; p<0.05) (Table 5.2). Respecting to As treated rats, urinary As, serum PRL 
and total urinary porphyrins correlated inversely with ambulation counts (respectively 
ρ=-0.816,  ρ=-0.799 and ρ=-0.757; p<0.05) and with rearing counts (respectively ρ=-
0.698,  ρ=-0.677 and ρ=-0.697; p<0.05) (Table 5.2). In the Mn treated group 
correlations were determined between serum PRL and ambulation counts (ρ=-0.610; 
p<0.05) as well as Mn levels in blood and serum PRL correlations with rearing counts 
(respectively ρ=-0.663 and ρ=-0.636; p<0.05) (Table 5.2). The mixture treated group 
exhibited significant correlations of urinary As, delta-ALA and total porphyrin levels 
with ambulation counts (respectively ρ=-0.893, ρ=-0.827 and ρ=-0.909; p<0.05) and 
also of urinary As, delta-ALA, total porphyrin levels and Mn concentrations in blood 
with rearing counts (respectively ρ=-0.833,  ρ=-0.780, ρ=-0.896 and ρ=-0.670; p<0.05) 
(Table 5.2). 
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5.3.2. Integration of biomarkers 
 
Assessment of the type of exposure 
   CF(C)   CF (As)        CF (Mn)           CDF (Pb)               CF (Mixt)
The rat is:
Estimation of motor impairment severity 
P
h
as
e 
 1
Mixt:
(Procedure I)
Individual assessment of exposure and severity of neurotoxic effects induced by Pb, As, Mn 
or the mixture of  Pb/As/Mn 
If the highest value is obtained with
     Not Exposed Exposed to Pb Exposed to the mixture 
of Pb/As/Mn
Exposed to As Exposed to Mn
P
h
as
e 
2
If the rat is exposed to:
As:
Mn:
Pb:
Rearing counts (Mixt) = 7.3* ln Pb B - 15.5* ln Mn B -3.0* ln As U - 3.7* ln Porf T U - 39.3 
(R 2 =0.933; p<0.05)
Ambulation counts (As) = -5.77 ln As U + 4.46 ln Porf T U - 7.46 ln PRL S + 67.25 
(R 2 =0.791; p<0.05)
Rearing counts (As) = -3.57 ln As U + 1.22 ln Porf T U - 2.94 ln PRL S + 35.90 
(R 2 =0.644; p<0.05)
Ambulation counts (NS)
Rearing counts (Mn) =  -6.35 ln Mn B + 5.25 ln Porf T U -0.09 ln PRL S + 65.28
(R 2 =0.627; p<0.05)
Ambulation counts (Pb)  = 9.27 ln Pb B + 1.7 ln Pb U -5.90 ln Porf T U -0.54 ln ALA U + 14.24 ln PRL S - 0.11 AChE B - 79.09 
(R 2 =0.729; p>0.05)
Rearing counts (Pb)  = 11.12 ln Pb B + 3.68 ln Pb U -7.36 ln Porf T U + 0.99 ln ALA U + 19.36 ln PRL S + 2.55 AChE B - 92.39 
(R 2 =0.862; p>0.05)
Ambulation counts (Mixt) = -2.3* ln Pb B - 2.5* ln Mn B -4.6* ln As U - 2.6* ln Porf T U - 11.6 
(R 2 =0.935; p<0.05)
Classification
Functions:
CF (C) = 9.3*As U + 22.3*Pb U + 23.7*Pb B - 0.4*Mn B - 108.4*ln ALA U - 323.5
CF (As) = 13.5*As U + 17.8* Pb U + 16.3*Pb B - 0.03*Mn B - 95.2*ln ALA U - 245.4
CF (Mn) =  6.0*As U + 17.7*Pb U + 15.6*Pb B + 7.7*Mn B - 94.9*ln ALA U - 252.8
CF (Pb) = 10.4*As U + 18.8*Pb U + 24.7*Pb B - 0.2*Mn B - 92.0*ln ALA U - 248.8
CF (Mixt) = 17.6*As U + 16.0*Pb U + 22.4*Pb B + 0.5*Mn B - 68.0*ln ALA U - 158
Determination of Pb U, Pb B,  As 
U, Mn B and ALA U 
Determination of 
Porf T U and PRL S
Determination of 
Porf T U and PRL S
Determination of 
Porf T U, PRL S and  
AChE B 
Determination of  
Porf T U
 
Fig. 5.2: Procedure I proposed an individual assessment of the type of exposure and evaluation of motor 
activity deficits. Phase 1 allows to identify the type of exposure of each rat (to Pb, As, Mn or the mixture of 
these metals) through the determination of Pb and Mn in blood (B) and urinary (U) Pb, As and delta-ALA 
levels. Five classification functions (CF) were generated: for non exposed rats [CF (C)] and for exposures to 
Pb [CF (Pb)], to As [CF (As)], to Mn [CF (Mn)] or to the mixture of the three metals [CF (Mixt)]. The CF with 
the highest value indicates the type of exposure predicted by the model. Phase 2 evaluates motor 
impairment through the estimation of motor activity, ambulation and rearing counts. Depending on the 
type of exposure, after determination of total porphyrins in urine (Prof T U), serum prolactin (PRL S), Pb in 
blood (B) and/or AChE B activity, ambulation and rearing counts of each rat are predicted. R2 coefficients 
and significance (p) values of each regression are also represented. NS means “Not significant”. 
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Assessment of the type of exposure 
   CF(C)   CF (As)        CF (Mn)            CF (Pb)               CF (Mixt)
The rat is:
Estimation of motor impairment severity 
(R 2 =0.808; p<0.05)
Ambulation counts (NS)
Rearing counts (Mn)  =  5.54 ln Uro U - 2.068 ln Hepta U + 3.08 ln Copro U + 2.25 ln Proto U + 68.71 
(R 2 =0.796; p<0.05)
(Procedure II)
     Not Exposed Exposed to As Exposed to Mn Exposed to Pb Exposed to the mixture 
of As/Mn/Pb
P
h
as
e 
1
Individual assessment of exposure and severity of neurotoxic effects induced by Pb, As, Mn 
 or the mixture of  Pb/As/Mn 
P
h
as
e 
2
If the rat is exposed to:
As:
Mn:
Pb:
If the highest value is obtained with
Ambulation counts (As)  = 9.70 ln Uro U - 9.40 ln Hepta U + 5.78 ln Penta U + 17.25 ln Copro U + 107.86  
(R 2 =0.889; p<0.05)
Rearing counts (As)  = 7.20 ln Uro U - 8.45 ln Hepta U + 8.75 ln Penta U + 13.30 ln Copro U + 114.87  
(R 2 =0.685; p<0.05)
Mixt:
Ambulation counts (Pb)  = -1.45 ln Uro U - 6.55 ln Hepta U + 2.96 ln Proto U - 7.69  
(R 2 =0.690; p<0.05)
Rearing counts (NS)
Ambulation counts (Mixt) = -4,93* ln UroP U - 1,68*ln PentaP U - 11,43*ln CoproP U + 6,93*ln ProtoP U + 61,24      
(R 2 =0.789; p<0.05)
Rearing counts (Mixt) = 8,12* ln UroP U - 1,02*ln PentaP U - 0,04*ln CoproP U - 4,89*ln ProtoP U + 27,62  
Classification
Functions:
CF (C ) = 9604.47*Uro U- 5196.93*Hepta U-2143.38*Hexa U-2246.37*Penta U + 131.18*Copro U-3948.99*Proto U-31.33 
CF (As) = -402.66*Uro U+ 1568.97*Hepta U-1088.04*Hexa U-3051.03*Penta U + 42.20*Copro U+13281.41*Proto U-8.13
CF (Mn) =  -309.87*Uro U+ 1377.48*Hepta U-3251.21*Hexa U-766.24*Penta U - 6.71*Copro U+10860.40*Proto U-4.73
CF (Pb) =  561.73*Uro U+ 3046.54*Hepta U-15104.72*Hexa U+753.93*Penta U + 119.99*Copro U-1919.35*Proto U-6.20
CF (Mixt) = -291.73*Uro U+ 3637.26*Hepta U-15393.19*Hexa U+9030.12*Penta U - 59.58*Copro U-9216.42*Proto U-21.98
Determination of the urinary 
porphyrins profile
 
Fig. 5.3: Procedure II proposed the individual assessment of the type of exposure and evaluation of motor 
activity deficits. Phase 1 allows the identification of the type of exposure of each rat (to Pb, As, Mn or the 
mixture of these metals) through the determination of the urinary (U) profile, the levels of Uro-, Hepta-, 
Hexa-, Penta-, Copro- and Protoporphyrins. Five classification functions (CF) were generated: for non 
exposed rats [CF (C)] and for exposures to Pb [CF (Pb)], As [CF (As)], Mn [CF (Mn)] and to the mixture of the 
three metals [CF (Mixt)]. The CF with the highest value indicates to the type of exposure predicted by the 
model. Phase 2 evaluates motor impairment through the estimation of motor activity, ambulation and 
rearing counts. Depending on the type of exposure, after the combination of porphyrins levels, ambulation 
and rearing counts of each rat are predicted. R2 coefficients and significance (p) values of each regression 
are also represented. NS means “Not significant”. 
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5.3.3. Evaluation of the procedures 
 
5.3.3.1. Integration of biomarkers of exposure (Phase I) 
 
Procedure I 
 
 
Table 5.3: Identification of the type of exposure (to Pb, As, Mn or the mixture of Pb/As/Mn) of each 
rat through its levels of Pb and Mn in blood and urinary Pb, As and delta-ALA concentrations, by 
discriminant analysis. The table represents the type of exposures predicted by the model and the 
real exposures (Group). 
 
 
 
C As Mn Pb Mixt
C 6 5 0 1 0 0
As 6 0 6 0 0 0
Mn 6 0 0 6 0 0
Pb 6 0 0 0 6 0
Mixt 6 0 0 0 0 6
96.7% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
Discriminant analysis was performed to access if the type of treatment administrated 
to each rat could be correctly identified through the combination of several BMs, the 
levels of Pb and Mn in blood and the concentrations of Pb, As and ALA in urine. Table 
5.3 shows that the type of exposure of 96.7% of the rats was properly identified. In fact 
from the whole group of 30 animals, only one was classified erroneously as being 
exposed to Mn when in reality it was a control rat (Table 5.3).  
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Predicted type of 
exposure
 
Fig. 5.4: Graphical representation of each rat classification according to the type of exposure, 
through the integration of its Pb and Mn levels in blood and urinary Pb, As and ALA concentrations 
by discriminant analysis. A centroid value was calculated for each group and the results are plotted 
by the canonical discriminant functions.   
 
 
 
 
Fig 5.4 evidences a clear discrimination of Pb, As and mixture treated groups, even 
despite Pb treated rats were closer to the Mn group and to controls comparing with 
the other 2 groups. A restricted and well individualized area was attained in the Mn 
exposed group, however slightly overlapping with controls (Fig 5.4). 
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Procedure II 
 
 
 
Table 5.4: Identification of the type of exposure (to Pb, As, Mn or to the mixture of Pb/As/Mn) of 
each rat, through its urinary (U) porphyrin profile, the levels of uro-, hepta-, penta-, copro- and 
protoporphyrins. Discriminant analysis was performed. The table represents the type of exposures 
predicted by the model and the real exposures (Group).  
 
 
 
C As Mn Pb Mixt
C 6 6 0 0 0 0
As 6 0 5 1 0 0
Mn 6 0 1 5 0 0
Pb 6 0 0 1 5 0
Mixt 6 0 0 0 0 6
90.0% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
 
Discriminant analysis was performed to evaluate if the type of treatment 
administrated to each rat could be correctly identified through its urinary porphyrin 
profile. Table 5.4 shows that 90.0% of the rats were correctly classified. In the Pb 
exposed group, the classification attributed by the model matched with the 
administrated treatment in 5 animals, but 1 rat treated with Pb was identified 
erroneously as exposed to Mn (Table 5.4). Also 5 of 6 rats treated with As were 
identified as belonging to the As treated group but 1 subject was incorrectly included 
in the group exposed to Mn,  as well as 1 of the 6 rats treated with Mn was wrongly 
classified as being exposed to As (Table 5.4). Differently, the group (membership) 
predicted by the model was correct in all the controls and mixture treated rats (Table 
5.4). 
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Predicted type of 
exposure
 
Fig. 5.5: Graphical representation of each rat classification according to the type of exposure, 
through its urinary porphyrin profile by discriminant analysis. A centroid value was calculated for 
each group and the results were plotted by the canonical discriminant functions.   
 
 
 
 
The analysis of the graphic in Fig.5.5, allow us to note that both controls and mixture 
treated rats were clearly separated between them and from all the single exposed 
groups. On the other hand, there wasn’t a clear separation among the three single 
exposed groups. Mn treated rats’ area overlapped with the area corresponding to the 
As and to the Pb treated animals. Even so, a separation between As and Pb groups was 
attained (Fig. 5.5). 
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5.3.3.2. Integration of biomarkers of neurotoxic effects (Phase 2) 
 
Procedure I 
 
Table 5.5: Prediction of motor activity, ambulation and rearing counts of rats exposed to Pb, As, Mn 
or the mixture of the three metals through the integration of BMs, the levels of Pb, Mn and AChE 
activity in blood, PRL in serum and urinary levels of Pb, As, ALA and total porphyrins. Data were 
analyzed by multiple linear regression. All the values estimated by the model (predicted) are 
compared with the number of movements observed in each rat. 
13 As 12 8 4 18 14 4
14 As 9 12 3 16 19 3
15 As 15 20 5 20 28 8
16 As 15 20 5 19 23 4
17 As 8 2 6 17 14 3
18 As 15 12 3 21 13 8
4 ± 1 5 ± 2
19 Mn 22 17 14 3
20 Mn 15 14 19 5
21 Mn 30 19 28 9
22 Mn 14 18 23 5
23 Mn 8 16 14 2
24 Mn 6 17 13 4
5 ± 3
25 Pb 25 22 3 28 24 4
26 Pb 18 18 0 21 23 2
27 Pb 11 9 2 6 5 1
28 Pb 22 21 1 31 31 0
29 Pb 22 29 7 22 27 5
30 Pb 21 18 3 25 21 4
3 ± 3 3 ± 2
7 Mixt 2 1 1 1 0 1
8 Mixt 3 5 2 8 12 4
9 Mixt 0 2 2 5 5 0
10 Mixt 13 4 9 14 12 2
11 Mixt 8 4 4 9 5 4
12 Mixt 12 7 5 20 7 13
4 ± 3 4 ± 4
Motor activity
Average error: Average error:
Average error: Average error:
Abs Error
Average error: Average error:
Average error:
Ambulation counts Rearing counts
Predicted Observed Abs Error Predicted Observed
Rat                      
(code number)
Group
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In Table 5.5, the predicted number of ambulation and rearing movements of each rat 
were calculated using the formulas presented in Fig. 5.2 and compared with the 
movements observed after the administration of the last doses of the several metals. 
In rats treated with Pb, the use of a linear combination of Pb and AChE activity in 
blood, serum PRL and Pb, delta-ALA and total porphyrins in urine resulted in an 
average absolute error between predicted and real counts of 3 ± 3 ambulation 
movements expressed as mean ± sd, which corresponds to 9% of the mean value of 
ambulation counts observed in controls. An absolute error of 3 ± 2 rearing counts (9% 
of the mean value of rearing counts observed in controls) was determined (Table 5.5). 
The motor activity of the rats exposed to As was predicted through the integration of 
As and total porphyrins in urine and serum PRL, showing prediction deviancies of 4 ± 1 
(11%) for ambulation activity and 5 ± 2 (16%) for rearing counts (Table 5.5). The higher 
errors were detected in the Mn treated group, where using Mn levels in blood, serum 
PRL and urinary total porphyrins resulted in an average deviancy of 5 ± 3 (16%) in 
predicting rearing counts, whereas no significant multiregression equation could be 
obtained to predict ambulation activity. Concerning the group treated with the mixture 
the errors in predicting motor activity through Pb and Mn blood concentrations and As 
and total porphyrins in urine were 4 ± 3 (11%) for ambulation and 4 ± 4 (13%) for 
rearing counts (Table 5.5). More detailed data are presented at Table A3.1 in appendix 
3. 
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Procedure II 
 
 
Table 5.6: Prediction of motor activity, ambulation and rearing counts, of rats exposed to Pb, As, 
Mn or the mixture of the three metals through its different urinary porphyrins. Data were analyzed 
by multiple linear regression. The values estimated by the model (predicted) were compared with 
the number of movements observed in each rat. 
13 As 9 8 1 18 14 4
14 As 13 12 1 21 19 2
15 As 14 20 6 20 28 8
16 As 20 20 0 23 23 0
17 As 6 2 4 15 14 1
18 As 12 12 0 14 13 1
2 ± 3 3 ± 3
19 Mn 22 4 14 10
20 Mn 15 4 19 15
21 Mn 30 7 28 21
22 Mn 14 0 23 23
23 Mn 8 0 14 14
24 Mn 6 3 13 10
16 ± 5
25 Pb 19 22 3 24
26 Pb 19 18 1 23
27 Pb 15 9 6 5
28 Pb 17 21 4 31
29 Pb 30 29 1 27
30 Pb 20 18 2 21
3 ± 2
7 Mixt 3 1 2 6 0 6
8 Mixt 7 5 2 6 12 6
9 Mixt 4 2 2 7 5 2
10 Mixt 2 4 2 5 12 7
11 Mixt 10 4 6 11 5 6
12 Mixt 0 7 7 7 7 0
4 ± 2 5 ± 3
Motor activity
Average error:
Average error:
Ambulation counts Rearing counts
Average error: Average error:
Abs Error Predicted Observed Abs Error
Average error: Average error:
Predicted Observed
Rat                     
(code number)
Group
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The individual estimation of the motor activity of rats exposed to Pb through uro-, 
hepta and protoporphyrin levels in urine resulted in a prediction average error of 3 ± 2 
(9%) for ambulation counts, but no significant regression was obtained to predict 
rearing movements. In As treated rats the combined urinary levels of uro-, hepta-, 
penta- and coproporphyrins allowed to predict the ambulation activity with an error of  
2 ± 3 (6%) movements and the rearing activity with an error of  3 ± 3 counts (9%) 
(Table 5.6). Mn treated, rats had only their rearing movements significantly predicted 
through the integration of uro-, hepta-, copro- and protoporphyrin concentrations in 
urine, however with an absolute error of 16 ± 5 counts (50%) (Table 5.6). The 
integration of urinary uro-, penta-, copro- and protoporphyrins in the mixture treated 
rats predicted motor activity with errors of 4 ± 2 (11%) and 5 ± 3 (16%) respectively for 
ambulation and rearing counts (Table 5.6). More detailed data are presented at Table 
A3.2 in appendix 3. 
 
 
Table 5.7: Prediction of motor activity, ambulation and rearing counts of rats exposed to the 
mixture of Pb/As/Mn through its brain porphyrin levels, uro-, penta-, copro- and protoporphyrins. 
Data were analyzed by multiple linear regression. The values estimated by the model (predicted) 
were compared with the number of movements observed in each rat. 
 
Rat Group
(code number)
7 Mixt 4 1 3 7 0 7
8 Mixt 6 5 1 9 12 3
9 Mixt -2 2 4 4 5 1
10 Mixt 9 4 5 13 12 1
11 Mixt 4 4 0 3 5 2
12 Mixt 6 7 1 7 7 0
2 ± 2 2 ± 2Average error: Average error:
Motor activity
Ambulation counts Rearing counts
Predicted Observed Abs Error Predicted Observed Abs Error
     
Ambulation activity (count) = 21,41* ln UroP Br - 40,42*ln PentaP Br - 8,67*ln CoproP Br - 17,95*ln ProtoP Br- 304,86           (R2=0,823; p<0.05)
Rearing activity (count) = 17,89* ln UroP Br - 34,46*ln PentaP Br - 13,73*ln CoproP Br - 2,62*ln ProtoP Br- 212,68                 (R2=0,880; p<0.05)
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Brain levels of the same urinary porphyrins previously used in the mixture exposed rats 
to predict their motor activity, were also able to estimate ambulation and rearing 
counts showing average errors of 2 ± 2 (6%) for ambulations counts and 2 ± 2 (6%) for 
rearing movements (Table 5.7). No significant regressions were determined using brain 
porphyrin concentrations, to predict motor activity upon single exposures. More 
detailed data are presented at Table A3.3 in appendix 3. 
 
 
 
5.4. Discussion 
 
Although adverse health effects induced by heavy metals have been known for a long 
time, exposure to these elements still remains and is even increasing in some areas of 
the world (Järup, 2003). Pb, As and Mn can occur as mixtures in specific environmental 
contexts (Dahtrak and Nandi, 2009) being well known the neurotoxic effects induced 
by these three metals (Sansar et al, 2011; Yadav, 2009; Weiss, 2005). In this 
perspective BMs have been revealing to be particularly useful to identify exposures 
and detect induced nervous system progressive diseases, which manifest their 
symptoms long after exposure to the initiating factor. These markers can be obtained 
from human tissue and excreta preferentially by noninvasive methods (Kakkar and 
Jaffery, 2005); blood and urine parameters are already employed to gain information 
about the CNS in both healthy and diseased states (Mayeux, 2004). Recently it is 
becoming clear that surveying the several changes in metabolic pathways, using panels 
of BMs, is more likely to provide a wealth of information that may be difﬁcult to 
capture by looking only at one pathway or one BM (Kakkar and Jaffery, 2005). The 
application of statistical models on multiple BM data sets, using discriminant function 
analysis or multivariate regression techniques, is being used lately to classify groups of 
interest (e.g., disease or control, pre- or post-drug exposure) and identify disease 
signatures (Kaddurah-Daouk and Krishnan, 2009). In this work, prediction procedures 
were designed, through modeling experimental data from rats exposed to Pb, As, Mn 
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or their mixture, aiming to predict the type of exposure and the magnitude of 
neurotoxic effects induced in each rat.  
 
 
5.4.1. Selection of biomarkers of exposure  
 
The ability of each BM to discriminate exposed rats from controls was accessed 
through ROC analysis. As  far  as  single  metal  treatments,  urinary delta-ALA changes  
were observed  in  the  Pb  treated  group  and a  significant area under a ROC curve 
(A=100%; p<0.05) (Fig.5.1a) was obtained for this BM. Over 99% of Pb present in the 
blood accumulates in erythrocytes, where more than 80% is bound to ALAD (Ahamed 
and Siddiqui, 2007); ALAD blood levels may be used as an effect BM, but 
simultaneously constitute one of the most sensitive indicators of exposure to Pb, 
largely supplanting the measurement of Pb blood concentrations. Even so, Pb blood 
concentration is also a reliable BM of exposure to Pb (ASTDR, 2007b) and accordingly 
exhibited also a significant capability to distinguish Pb treated rats from controls 
(A=93%; p<0.05) but exhibiting an area smaller than blood Pb (Fig.5.1a).  Total urinary 
porphyrins also appeared to be a promising BM of exposure to Pb when considering 
the significantly increased (p<0.05) levels relatively to controls (Fig.4.8, Chapter 4) and 
the significant (p<0.05) areas of 100% under a ROC curve (Fig.5.1a). However similar 
results were obtained upon As or mixture exposures (Figs.5.1b and d and Fig.4.8, 
Chapter 4) indicating that the BMs could not distinguish Pb from As exposures. In fact, 
As urinary levels revealed to be the better BM to identify exposures to As (A=100%; 
p<0.05) (Fig.5.1b and Fig.3.6b, Chapter 3). Urinary elimination is the major route for As 
excretion, being urinary As measurements more reliable than blood determinations 
(ASTDR, 2007a; Marchiset-Ferlay et al, 2012) and used as a key BM of exposure to this 
element (Kakkar and Jaffery, 2005). Serum PRL also increased significantly (p<0.05) in 
this group (Fig.4.6, Chapter 4), but its area under the ROC curve was smaller (A=97%; 
p<0.05) then urinary As’ area (Fig.5.1b). Besides, because similar results for serum PRL 
were attained upon exposure to Mn (Fig.5.1c and Fig.4.6, Chapter 4) the BM reveals to 
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be unsuitable to distinguish between As and Mn exposures. The observation of Fig. 
5.1c indicates that  blood Mn (A=100%;p<0.05) was the best BM to identify Mn 
exposures, even with previous studies mentioning that Mn blood levels can only be 
used on a group basis, not being suitable to be individually used (ASTDR, 2007c; Bader 
et al, 1999; Cowan, 2008). Mn concentrations in blood also showed to be a better 
indicator than its urinary level (Santamaria, 2008).  
 
The metal mixture treatment leaded to increased delta-ALA and total porphyrins levels 
in urine (Figs. 4.7 and 4.8, Chapter 4), with ROC curve analysis revealing that both 
parameters could reliably differentiate co-exposed rats from controls (A=100%; 
p<0.05) (Fig.5.1d). The increased levels of delta-ALA in urine were higher than the sum 
of the levels for each of the three single metals treated groups (Fig. 4.7, Chapter 4), 
suggesting  that  the  mixture  treatment  leads  to  urinary delta-ALA changes  that  
exceed  the additive  effects  of  the  individual  metals. Thus, delta-ALA concentration 
in urine may serve as a better BM of exposure to the metal mixture then total urinary 
porphyrins. Moreover, despite urinary delta-ALA levels do not distinguish Pb from the 
mixture exposure, total urinary porphyrins do not allow to differentiate among Pb, As 
and mixture treated groups.  
 
Considering that metal levels are intrinsically specific to the type of exposure and that 
urinary delta-ALA concentrations were accurate (A=100%)  and less group-unspecific 
then urinary total porphyrins (Fig.5.1), Pb and Mn blood levels, urinary As and delta-
ALA concentrations were selected to be combined to identify the type of exposure. 
 
 
5.4.2. Selection of biomarkers of neurotoxic effects 
 
The several BMs were tested with respect to their correlation with neurotoxic 
outcomes induced by Pb, As, Mn or the mixture of the 3 metals. While Pb, As, and Mn 
metal levels in brain were significantly (p<0.05) correlated with decreased motor 
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activity of each respective single exposed group (Table 5.1), significant correlations 
were also noted between the three metals brain levels and decreased motor activity in 
the metal mixture treated group (Table 5.1); this is consistent with studies reporting 
diminished motor activity in rats co-exposed to Pb/Mn or Pb/As (Chandra et al, 1981; 
Mejía et al, 1997). However, when pertaining to the feasibility of metal levels in 
peripheral samples to indicate neurotoxicity, no correlation between Pb blood levels 
and motor activity was observed possibly due to the low doses used; concerning to 
Mn, blood Mn was significantly (p<0.05) correlated only with rearing counts (Table 
5.2), possibly due to the role of different dopaminergic receptors in the mediation of 
both behaviors (Saldivar-Gonzalez et al, 2009). In fact, only urinary As correlated 
(p<0.05) with both parameters of motor activity (Table 5.2). Respecting to the mixture 
treated group, despite of Pb and Mn levels in blood and urinary As were significantly 
(p<0.05) correlated with the accumulation of the three metals in the brain (Table 4.2, 
Chapter 4), no robust associations with motor activity were attained (Table 5.2).  
Indeed only As urinary levels correlated significantly (p<0.05) with both parameters of 
motor activity and Mn blood levels were merely correlated with statistical significance 
(p<0.05) with rearing counts (Table 5.2). Even so, despite the apparent little value of 
these BMs to evaluate the neurotoxicity when used alone, the intrinsic role of these 
parameters to express the presence of the metals, leaded us to select them to be 
combined in the phase 2 of the prediction models. 
 
Pb, As and Mn interfere with the heme biosynthetic pathway (Ahamed and Siddiqui, 
2007; Hift et al, 2011; Wu et al, 2004) and when these events occur, accumulation and 
increased urinary excretion of delta- ALA and porphyrins can happen (Adhikari et al, 
2006; Guolo et al, 1996). When in excess these compounds can act as toxins (Hift et al, 
2011; Krishnamurthy et al, 2007) and may be responsible for clinical and pathological 
pictures observed in porphyrias, which includes central and peripheral nervous system 
disorders (Kumar, 2012). In Pb treated rats, urinary delta-ALA levels were only 
significantly correlated (p<0.05) with decreased ambulation counts (Table 5.2), maybe 
because of the low dose used in the experiment. Brain delta-ALA concentrations in the 
As treated group were significantly correlated (p<0.05) with decreased motor activity, 
  
161 
 
suggesting that the behavioral changes were induced by the As itself ( Fig. 4.1, Chapter 
4 and Table 5.1) and/or by delta-ALA (Fig. 4.3, Chapter 4). Also increased urinary 
excretion of delta-ALA in this group correlated with motor activity (Table 5.2)   It is also 
plausible to posit that the decrease in motor activity in Mn treated animals is 
secondary to the accumulation of Mn in the brain (Table 5.1 and Fig.3.4, Chapter 3). In 
the mixture treated group, significant correlations (p<0.05) were found between 
motor activity and brain and urinary delta-ALA, suggesting that the accumulation of 
this compound interfered with behavior performance (Tables 5.1 and 5.2). 
Concomitantly, urinary total porphyrins correlated significantly (p<0.05) with motor 
activity in As or mixture exposed groups (Table 5.2) as well as in rats treated with the 
low Pb dose, with respect to ambulation counts (Table 5.2). Some authors defend that 
porphyrins are promising BMs of toxicity induced by metal mixtures because different 
metals can inhibit different enzymes of the heme biosynthetic pathway (Woods et al, 
2009; Wang and Fowler, 2008). In this work total urinary porphyrins were accumulated 
in co-exposed rats more than after exposure to each metal alone (Fig.4.8, Chapter 4). 
These results suggest that heme parameters are promising to be integrated for the 
evaluation of neurotoxicity in exposed rats.  
 
Serum PRL is becoming increasingly used as a measure of the dopaminergic function in 
environmental and occupational studies (Meeker et al, 2009; 240, Takser et al, 2004), 
since PRL release is regulated by the neurotransmitter DA (Marreiha dos Santos et al, 
2011).  The 3 metals, Pb, As and Mn can interfere with the dopaminergic system, which 
plays an important role in motor activity, with specifically dopaminergic receptors D1 
and D2 involved in the mediation of ambulation, being rearing behavior mediated 
through D4 receptor (Rodríguez et al, 2010; Saldivar-Gonzalez et al., 2009; Takser et al, 
2004). However, when compared with controls, Pb exposed rats had only a slight 
increase in the serum PRL levels (Fig.4.6, Chapter 4), which were not correlated with 
ambulation or rearing movements. However, concerning to As treated rats, the 
significant negative correlation (p<0.05) of serum PRL with motor activity justifies the 
selection of this BM for further integration (Table 5.2 and Fig.4.6, Chapter 4). This is 
actually an important result given the scarce information about the effects of As on 
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serum PRL concentrations (Jahan et al, 2012). Mn seems to have selectivity for 
dopaminergic neurons and, despite controversial, modifications in serum PRL levels 
have been shown to be induced by Mn (Ellingson et al, 2003). According with this 
information, increased serum PRL (Fig.4.6, Chapter 4) correlated significantly (p<0.05) 
with the motor activity of Mn treated rats (Table 5.2). In the mixture treated rats, Pb 
was the metal with the higher concentration in the brain (Fig.3.4, Chapter 3), and 
probably its limited influence on serum PRL, counteracted As and Mn effects on this 
hormone (Fig.4.6, Chapter 4). This final effect might explain the absence of correlation 
between serum PRL and motor activity of co-treated rats, which decreased more 
markedly than after single exposures (Fig. 3.2, Chapter 3). Also, and according with our 
results, we posit that As and Mn may contribute more than Pb to impair motor activity 
via dopaminergic pathway dysfunction; it seems that in the mixture exposed group, 
motor activity dysfunction occurred via multi-mechanisms leading to such a complex 
figure. Considering the interpretation of our results, serum PRL levels were also 
selected to be tested in the phase 2 of the model. 
 
Regardless the involvement of the cholinergic system in muscular contraction and 
locomotion (Bowler et al, 2006) the dopaminergic system plays a prominent role in the 
modulation of motor activity (Bardullas et al, 2009). No correlations of AChE activity in 
brain with levels of metals in this organ or motor activity were observed in the single 
treated groups. Differently, in co-treated rats, AChE brain levels correlated significantly 
(p<0.05) with motor activity (Table 5.1), but this correlation had not occurred with its 
blood concentrations. It is plausible that AChE activity alterations did not relevantly 
contributed to the observed motor dysfunctions in single exposed groups; The activity 
of this enzyme in the blood does not seem to be suitable to indicate the neurotoxicity 
induced by Pb, As, Mn or its mixture.   
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5.4.3. Using single selected biomarkers to identify exposure and predict 
the magnitude of neurotoxic effects 
 
  
Delta-ALA and total porphyrins levels in urine showed to be accurate BMs of exposure 
to Pb, but not exclusively for this group (Figs.5.1a, b and d); Pb blood levels were less 
accurate then urinary levels (Fig.5.1a). Differently, urinary As exhibited accuracy to 
access exposure only for the As treated group (Fig.5.1b), Nevertheless indicates 
neurotoxicity also for mixture treated group (Table 5.2). Mn levels in blood showed to 
be a more accurate BM than serum PRL to access Mn exposure (Fig.5.1c) and only for 
the Mn treated group. However, Mn blood levels correlated significantly (p<0.05) only 
with ambulation counts (Table 5.2). The PRL levels in serum were found to be 
promising as a BM of neurotoxicity induced by Mn, requesting further studies with DA 
measurements in the brain. Both urinary delta-ALA and total porphyrins showed to be 
accurate BMs of exposure in rats exposed to Pb, As or the mixture of Pb/As/Mn and 
not only for one group (Figs.5.1a, b and d). Delta-ALA levels revealed to be reliable 
BMs of neurotoxicity induced by this mixture but also significantly (p<0.05) correlated 
with motor activity in the Pb treated group. These parameters were not exclusive for 
the mixture exposed group (Table A2.1, appendix 2) 
 
In general the investigated BMs were not satisfactory when used alone, regarding to 
the following compromise: accuracy to distinguish among Pb, As, Mn and Pb/As/Mn 
mixture treated rats; to indicate neurotoxicity; and to be exclusive of only one group. 
Moreover respecting to neurotoxicity, they were applied only in a group basis. In 
addition, and concerning to brain porphyrins or their urinary profile, no porphyrin 
alone correlated with motor activity of all the exposed groups. The obtained results 
points towards the pertinence of testing them in combination.  
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5.4.4. Integrating biomarkers 
 
Two procedures were generated and compared between them, as well as with single 
BMs methodologies. In both, the peripheral BMs were integrated to generate a 2 
phase’s prediction model, with phase 1 aiming to identify the type of exposure of each 
rat, and phase 2 aiming to subsequently predict the magnitude of motor disarrays. In 
procedure I the levels of the 3 metals in blood and/or urine, urinary ALA and total 
porphyrins, blood AChE activity and serum PRL were the integrated BMs, whereas 
procedure II combined several urinary porphyrins.  
 
5.4.4.1. Identification of the type of exposure 
 
Concerning to the phase 1 of both procedures, discriminant analysis was performed 
after testing several combinations of BMs, which were used to generate 5 classification 
functions, corresponding each function to one type of exposure: not exposed 
(controls), exposed to Pb, As, Mn or their mixture (Figs.5.2 and 5.3). Regarding to 
procedure I, it is not surprising that the inclusion of Pb, As and Mn levels in the model 
resulted in a good discrimination among groups, since the detection of metals in 
biological samples is the most common indication of their exposure (Phoon, 1998) and 
body burden is generally determined using blood or urinary concentrations (Kakkar 
and Jaffery, 2005). Fig 5.4, illustrates that both Pb and As groups formed separated and 
well defined clusters, did not overlapped with controls and plus the type of exposure 
of all Pb or As treated rats was identified correctly (Table 5.3). Even so, Pb treated rats 
were closer to controls than As or mixture treated animals (Fig.5.4), possibly because 
the Pb low dose administrated in the experiment (Fig. 3.1, Chapter 3) did not allow a 
marked detachment from non-exposed rats. In fact, it is truth that urinary Pb levels 
have been used to assess Pb exposure, but only on a group basis (Fukui et al, 1999). 
This low Pb dose might explain the need of using both blood and urinary Pb levels in 
the classification functions (Fig.5.2). The Mn treated group exhibited the worst 
discrimination, with a poor separation from controls (Fig. 5.4); in addition one control 
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rat was categorized incorrectly as being exposed to Mn (Table 5.3). Accurate BMs of 
exposure to Mn are still lacking and to date it is generally achieved that blood and 
urine levels can be used to confirm exposure, but they are not suitable to be used on 
an individual basis (ASTDR, 2007c; Bader et al, 1999; Cowan, 2008), while we aimed to 
assess exposures individually. Certainly integrating blood Mn levels in the classification 
functions (Fig.5.2) improved the model just because this weak BM contributed 
together with others to predict the exposure. There is a need of better BMs of 
exposure to Mn to be integrated in these models. The mixture treated rats formed a 
well-defined cluster which was clearly separated from all the other groups (Fig. 5.4). 
Moreover, the type of exposure predicted by the model was correct for all the mixture 
exposed rats (Table 5.3). Indeed, the presence of the three metals is represented in 
the classification functions (Fig.5.2) and urinary delta-ALA changes plausibly played a 
relevant role on the discrimination of co-exposed rats. In fact, the urinary excretion of 
delta-ALA in co-treated rats exceeded the additive  effects of the individual metals 
(Fig.4.7, Chapter 4) and the previous results suggest that this BM alone could serve a 
sensitive peripheral BM of exposure to the mixture (Andrade et al, 2013).    
 
The urinary porphyrin profile was also integrated to differentiate among exposures to 
Pb, As, Mn or the mixture of Pb/As/Mn (procedure II) and allowed to distinguish 
between Pb and As exposed groups, when considering that no wrong classifications 
(Table 5.4) neither an overlap occurred between these groups (Fig.5.5). Actually, 
significant differences (p<0.05) between these groups were attained in the porphyrin 
profile, regarding to uro- and protoporphyrins (Fig.4.9a and f, Chapter 4). However, in 
Fig.5.5 the values of Pb and As groups were closer, possibly due to the inhibition of a 
common enzyme, coproporphyrinogen oxidase (Ahamed and Siddiqui, 2007; Ng et al, 
2005). Indeed, a similar magnitude of increased coproporphyrin excretion, as 
compared with controls, was noted in both exposed groups (Fig.4.9e, Chapter 4). The 
integration of the urinary porphyrins profile barely distinguished Mn exposure from 
exposures to Pb or As (Fig.5.5), with 2 rats treated with Mn wrongly classified, one as 
fitting in the As treated group and another as belonging to the Pb treated group (Table 
5.4). The most relevant change observed in Mn treated rats was a pronounced 
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decrease in coproporphyrins, which is a porphyrin also affected by Pb and As. 
Differently, the profile of the heme precursors in urine differentiated all the mixture 
exposed rats not only from controls but also from all single treated animals. The 
treatment administrated to every co-exposed rat was identified correctly (Table 5.4) 
and a clear separation of this group from all the other groups is revealed in Fig.5.5. 
Indeed hexa-, penta- and coprophorphyrin levels in this group were significantly 
(p<0.05) increased as compared with all the other groups (Fig.4.9c, d and e, Chapter 4) 
as well as uroporphyrins were significantly (p<0.05) decreased with respect to the 
other groups, excepting the Pb treated group (Fig.4.9a, Chapter 4).  These results are in 
agreement with authors that indicate porphyrins as promisors BMs of mixtures of 
metals (Wang and Fowler, 2008).  
 
5.4.4.2. Predicting the magnitude of neurotoxic effects 
 
In both procedures (I and II), phase 2 was applied aiming to predict the severity of 
induced neurotoxic effects in each rat. Being motor activity in open-ﬁeld a behavioral 
test accepted as sensitive, reliable and efficient to evaluate neurotoxicity (Santos, 
2008), this endpoint was evaluated 24 h after the administration of the last dose to the 
5 groups, through the determination of ambulation and rearing counts. Using 
multiregression analysis, linear combinations of BMs were used to estimate, in each 
exposed group, the number of ambulation and rearing movements of each rat.   
 
In procedure I while the same BMs were applied in different exposures, others BMs 
were exclusive of one group (Fig.5.2). Respecting to BMs used in more than one type 
of exposure, the inclusion of each metal level in the multi-regression equations 
revealed useful to estimate the motor activity in all the single exposed groups (Fig. 
5.2); for the co-treated rats the combination of the three metal levels, urinary As and 
Pb and blood Pb and Mn levels, improved the prediction capability of the model 
(Fig.5.2), even when not all the peripheral metal concentrations correlated with 
behavior (Table 5.2). It seems that the integration of weak BMs results in a global 
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enhanced performance.  Despite not all the correlations between total urinary 
porphyrins and motor activity in single exposed groups were significant, urinary total 
porphyrins revealed to be useful when present in the multiregression equations of all 
the groups as an X variable (Fig.5.2). The significant (p<0.05) increase of total 
porphyrins in urine observed in Mn exposed rats (Fig.4.8, Chapter 4) did not correlate 
with motor activity (Table 5.2), but paradoxically improved the prediction of rearing 
movements by multiregression, certainly demanding further explanation. Along with 
the concentrations of the three metals, it was only necessary to include total 
porphyrins in urine in the regression equations to significantly (p<0.05) estimate the 
motor activity in co-treated rats (Fig.5.2). The integration of urinary delta-ALA levels 
instead of the total porphyrins leaded to similar outcomes (not shown results), 
however slight better predictions were achieved using total porphyrins. 
 
Serum PRL was used in multi-regression equations to predict motor activity in all single 
exposed groups (Fig. 5.2) including Pb, despite the previous apparent unsuitability of 
this BM to indicate neurotoxicity upon Pb exposure (Fig. 4.6, Chapter 4). Also blood 
AChE activity was integrated to predict the motor activity of Pb treated rats (Fig.5.2), 
when the mean values of this parameter were actually different from controls, but no 
statistical difference was attained due to the huge magnitude of the standard 
deviation values (Fig.4.5, Chapter 4). In truth, given the low Pb administrated doses, 
the best fit (R2) of the multi-regression equations (which moreover was not statistically 
significant) was only attained when all the available BMs were integrated (Fig.5.2). 
Again, possibly weak BMs already excluded under traditional single BM approach 
interpretations may effectively have some value when combined with others. 
Moreover, a BM considered weak on a group basis, should not necessarily be rejected 
if destined to be applied integrated in an individual basis.    
 
In Procedure II, the integration of urinary porphyrins leaded to observe several 
significant (p<0.05) multi-regression equations estimating the motor activity of single 
exposed groups (Fig.5.3). However no significant regressions with ambulation or 
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rearing counts were obtained when the levels of the same porphyrins in the brain 
were integrated. Thus, the presented data regarding to rats treated with only one 
metal should be considered with some reservations. 
  
In co-treated rats there was a trend for a decrease in motor activity higher than after 
single exposures (Fig.3.2a and b, Chapter 3), but this alteration did not correlate with 
the levels of each brain porphyrin; this alterations were not evinced enough, possibly 
due to brain regulation mechanisms of porphyrin levels and to the use of low to 
moderate metal doses in this experiment. Remarkably, when porphyrins that only 
exhibited slight modifications in the brain (uro-, penta-, copro- and protoporphyrins) 
(Fig.4.4a, d, e and f, Chapter 4) were taken together through linear combination, they 
predicted significantly (p<0.05) the values of motor parameters in the rats (Table 5.7). 
These results suggest a relevant role of porphyrins on neurotoxicity induced by the co-
exposure to the mixture of Pb, As and Mn. In addition, porphyrins for which some 
alterations were observed in the brain were also changed in the urine (Figs.4.4 and 4.9, 
Chapter 4), suggesting that the integration of the urinary porphyrin profile may 
express modifications in brain porphyrin levels. This is a meaningful outcome when 
considering the purpose of using peripheral porphyrin levels to detect changes in such 
an inaccessible tissue in humans. Indeed the linear combination of the urinary levels of 
these porphyrins (uro-, penta-, copro- and protoporphyrins) also estimated 
significantly (p<0.05) the number of ambulation and rearing counts (Table 5.7). This 
work shows that both brain and urine porphyrins can predict the magnitude of motor 
alterations in the co-treated rats. 
 
For both procedures all the integrated BMs were tested with respect to their capability 
to predict exposures and motor activity when applied alone (Tables A1.1-15, appendix 
1 and Tables A2.1-6, appendix 2). However, none BMs alone had the capability to 
distinguish the 5 groups of rats with a % of wrong cases lower than after its integration 
(Tables A1.1-15, appendix 1). As far as motor activity is concerned, some significant 
correlations were obtained with single BMs, but apart from metal levels, they were not 
  
169 
 
exclusive of one type of single exposure (Table A2.1, appendix 2). Actually the urinary 
levels of hexaporphyrins were group specific for co-treated rats and a significantly 
(p<0.05) regression with motor activity was observed (Table A2.1, appendix 2), but 
again with general higher errors in predicting motor activity then after using multi-
regression equations (Table A2.6, appendix 2).  When using the levels of metals alone 
the errors were generally higher than upon their integration (Tables A2.2- 5, appendix 
2).    
 
 
 
5.5. Conclusions 
 
In phase 1, the combination of urinary Pb, As, delta-ALA and blood Pb and Mn levels 
identified the type of exposure (procedure I) better than the integration of urinary 
porphyrins (procedure II), as  97% versus 90 % of cases were classified correctly. Even 
so, despite the use of the urinary porphyrin profile resulted in 10% of wrong cases, 
such practical alternative should not be rejected to be further studied. Concerning the 
prediction of motor disarrays (phase 2) due to the absence of correlation of brain 
porphyrins with motor activity some reserve is attributed to the integration of these 
heme precursors (Procedure II) to predict the magnitude of motor disarrays upon 
single exposures. Differently the combination of metal levels, urinary total porphyrins, 
serum PRL and/or blood AChE activity (procedure I) seemed to be a valid approach for 
single exposed subjects. On the other hand, both procedures (I and II) predicted the 
magnitude of motor impairments induced by the mixture of Pb, As and Mn in each rat. 
The combination of urinary porphyrins resulted in slight lower errors and offers the 
possibility of using an exclusively safe and non-invasive method of urine sample 
collection and the determination of the several BMs by a single and quick HPLC 
analysis. It is also suggested that weak and/or unspecific BMs can gain global strength 
when combined with others.  
 
  
170 
 
Generally the combination of exposure and/or effect BMs in rats exposed to Pb, As, 
Mn or this metal mixture allows a correct identification of the type of exposure as well 
as a reasonable evaluation of motor activity impairments of individual subjects. 
Therefore, the integration of BMs revealed to be a better predictive tool than the 
traditional approach focused on the search of a strong BM to be used alone.  The 
outcomes arising from this work raises the possibility that exposures can be identified 
and that the severity of neurotoxic effects induced by this mixture can be semi-
quantitatively predicted in humans, opening a door for the chance of detection of 
neurotoxic outcomes in a pre-clinical and still potentially reversible stage. The research 
on BMs integration methodologies seems certainly promising to assess “real-life” 
scenarios of exposure to chemical mixtures.  
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Chapter 6  
 
Preliminary study in a Portuguese risky population: 
biomonitoring miners co-exposed to lead, arsenic and 
manganese 
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6.1. Background  
 
Humans  are  environmentally exposed  to  a  range  of  chemicals, through air,  water,  
soil   and food, all  contributing  to  a  complex  exposure  in  daily  life (Kossowska et al, 
2013). In addition, in several occupations other types of exposure occur during the 
performance of job duties and actually, for centuries, the work environment has 
significantly contributed to an increased risk of adverse health effects due to chemical 
hazards (Casarett and Doull’s, 2007). In both situations, exposure to metals are 
frequently related to the development of toxicity and pathological conditions (Farina 
et al, 2012) and even low level metal exposures  may  induce  long-term neurological  
health  risks (Christensen, 1995), which are increasingly worrying during the last 
decades (Kossowska et al, 2013; Meyer-Baron et al, 2012). Most frequently, heavy 
metals occur as mixtures (Farina et al, 2012) and mixed  exposures  may  have  a  large 
impact  on  human  health since the induced effects  may  be  higher  than  simply  
adding the  effects  of  the  individual  components (Kossowska et al, 2013).  
 
 
6.1.1. Exposure to metals in urban environments 
 
In the cities, people may be exposed to more toxic elements via ingestion and 
inhalation of contaminated particulates, compared with rural or non-industrialized 
areas (Huang et al, 2014). The problem of atmospheric contamination by air-borne 
particulate matter containing heavy metals has notably worsened in the last few years 
due to the increase in motor vehicles, urban constructions, heat installations and 
industry (Cavanagh et al, 2009; Fernandez et al 2000). Moreover, urban areas are the 
most densely populated regions of the world because of their strong industrial and 
economic activities. After abolition of leaded gasoline, decreased Pb levels in the air 
and in blood of exposed populations were detected in several world regions (ASTDR, 
2007b). Yet, Pb is still a major source of pollution in urban soils (Cheng et al, 2014) and 
studies performed on the characterization of atmospheric particulates and particle-
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bound transition metals in some cities (e.g. in the center of Athens, Greece) indicated 
that Pb was among the largest components in various airborne particulate matter 
fractions (Valavanidis et al, 2006). The accumulation of As in urban environments is 
most often attributed to fossil fuel combustion, particularly in coal, metal-processing 
industries and mining activities (Cheng et al, 2014). Areas with high environmental As 
concentration include  certain regions in Australia,, Indonesia, Italy and an electronic 
waste recycling area of a China province (Huang et al, 2014).  Bangladesh is grappling 
with the largest mass poisoning of a population in history because ground-water used 
for drinking has been contaminated with naturally occurring inorganic As (Smith et al, 
2000). Arsenic was also found among the most abundant metals present in water-
soluble extracts of particulate matter in Christchurch and Auckland, in New Zeeland 
(Cavanagh et al, 2009) and water contaminations with As were also detected near 
Panasqueira, Lousal and S. Domingos mines, in Portugal (Grangeia et al, 2011; Ferreira 
da Silva et al, 2009a and Pereira et al, 2004). With respect to Mn, human exposure 
from natural and anthropogenic activities may arise from the release of this metal into 
waterways through the erosion of rocks and soils, mining activities and industrial 
waste, such as dry-cell batteries. Almost 80% of industrial emissions of Mn are 
attributable to iron and steel production facilities (ASTDR, 2007c). Also due to the use 
of methylcyclopentadienyl manganese tricarbonyl (MMT) as an additive in gasoline in 
countries like Argentina, Australia, Bulgaria, Canada and Russia, atmospheric Mn 
concentrations are increasing (Bolté et al, 2004; Gulson et al, 2006); indeed, elevated 
levels of this metal in children's blood have been detected in regions where the 
additive is allowed (Batterman et al, 2001; Gulson et al, 2006). When considering that 
there are no frontiers for pollution, Mn exposure to general population may become a 
relevant matter in a near future.  
 
Therefore, complex co-contaminations of trace metals exist in many cities, with Pb, As 
and Mn as their components, while great variations from one city to another may 
exist, depending on the type of major industries in the urban area. To illustrate in a 
study of the metal content of the urban soil of 31 cities in China, it was observed that 
among the 10 metals exhibiting the highest levels, Pb occupied the 5th position and As 
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the 8th (Cheng et al, 2014). Scalp hair samples collected from Guangzhou  (China) urban 
population, showed signiﬁcant higher levels of Pb, As and Mn as compared with a non-
exposed population, in the same way as previously reported in other studies in 
Karachi, Pakistan (Huang et al, 2014). Metals are also an important component of 
urban particulate matter in Mexico City (Mexico), with children living in this area 
exhibiting accumulation of ultraﬁne metal containing particulate matter in the nasal 
respiratory tract, that included Pb, As and Mn. Brain  inﬂammation, cognitive  deﬁcits  
and  brain  magnetic  resonance imaging  (MRI)  structural  abnormalities were also 
detected, leading the authors to express their concern with respect to “interactions”  
or  “joint  toxic  actions” among metals  (Calderón-Garcidueñas et al, 2013).   
 
 
6.1.2. Exposure to metals in occupational settings 
 
Millions of workers are employed in manufacturing, mining, construction and other 
industries where signiﬁcant amounts of airborne metals and metal compounds are 
generated (Ashley, 2009).  The particles produced in these milieus are of major 
concern when compared with  particulate in outdoor environment due to :i) higher  
concentrations inside industries; ii) the particles may contain more toxic  compounds 
and in higher concentrations; iii) the  majority  of  the  people  spend  more  time  in  
the  work-place  (33%  of  the  day)  than  in  the  outdoor. Therefore,  exposure  to  
pollutants  in  the  workplace  is  more  relevant  than  outdoor pollution and  despite 
the technological  requirements imposed  by  safety  regulations, workers  continue  to  
be  excessively  exposed  to  dangerous chemicals, not  only  due  to  the  
ineffectiveness  or  inexistence  of  equipment  that  promotes  the  extraction  of  
particles  or individually protects  the  workers, but  also  due to  the  negligence  of  
the subject  himself (Félix et al, 2013). The variety of metals to which workers can be 
exposed may cause occupational illness (Ashley, 2009; Félix et al, 2013) and although 
occupational settings are nowadays safer , efforts still exist towards the recognition of 
the causal link of exposures to chronic diseases and/or diseases with long latencies 
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(Casarett and Doull’s, 2007), such as the neurotoxic outcomes (Ashley, 2009).  Since   
the   late   2000s,   neurological   disorders from long term low level exposures became 
a major topic and with the aim of  detecting earlier changes in neurological functioning 
in workers exposed to neurotoxic  chemicals, several studies have been and are still 
conducted (Meyer-Baron et al, 2012). With respect to miners, the most commonly 
studied occupational health problems are silicosis, coal workers' pneumoconiosis, 
asbestosis and other diseases, but there are very few studies that correlate adverse 
health effects with the exposure of miners to toxicants present in their work 
environment.  Pb, As, Mn and Pb co-occur in occupational settings like mines (Dahtrak 
and Nandi, 2009), and may provoke adverse health effects in the workers, including 
the neurological, contributing to reduce economic productivity (Landrigan et al, 2006). 
Hence, biomonitorizing mine workers for low toxic levels of neurotoxic metal mixtures 
is surely indispensable (Dahtrak and Nandi, 2009).  In this perspective, occupational 
toxicology is focused on the application of toxicology principles and methodologies 
toward chemical hazards encountered at work, aiming to prevent and control 
occupational disease using BM as important tools (Casarett and Doull’s, 2007; Schulte 
and Hauser, 2012). However, nowadays additional challenges are recognized since the 
changing  pattern  of human  exposure  to  a  more  complex  low  level exposure  
requires  improvements  in  the  capacity  to identify  and  monitor  subgroups,  using  
model  predictions for  the  estimation  of  exposures and for diagnostic purposes 
(Kossowska et al, 2013). Additionally, as trace  elements  concentration  in  humans is  
affected  by  physiological  parameters and genetic traits,  it  may vary considerably 
among subgroups  and even among subjects. When workers are exposed to a mixture  
of trace elements, a single BM is rarely  sufficient  to  classify  the exposure  or   
quantitatively  predict  the  outcomes of  one  single person. Therefore, a new 
approach for dealing with combined exposures and the inherent possibility of  
interferences  among  various  elements,  is the acquisition of information from  
multivariate  analysis  of  different  parameters  measured  simultaneously  in  the  
same  sample (Christensen, 1995).  
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A reasonable number of works indicate that several mine surrounding areas in 
Portugal are contaminated with Pb, As and/or Mn (Carvalho et al, 2013; Grangeia et al, 
2011; Pratas et al, 2013). Despite the existence of little information about the levels of 
occupational exposure to these metals or its mixtures, it is the opinion of some authors 
that Portuguese mining activities may adversely affect the health of miners (Coelho et 
al, 2013). Being the use of animal models a relevant tool for the prediction of human 
safety (Chapman et al, 2013),  previously  an in vivo assay was performed using Wistar 
rats, which were exposed to Pb, As, Mn,  or the mixture of these metals (Fig.3.1, 
Chapter 3). The levels of the metals and several other BMs of exposure and/or 
predictive of neurotoxic effects were determined and later, selected BMs were 
combined to identify the type of exposure aiming a further application in a population 
of Portuguese workers exposed to the same mixture.  Preliminary data concerning to 
the levels of exposure to a mixture of Pb, As, Mn were collected in a Portuguese 
population occupationally exposed, miners from Alentejo. Two control populations, 
not occupationally exposed, were used: one belonging to the administrative service of 
the mining company and living in a rural area and the other living in an urban area of 
Portugal, Lisbon. 
 
 
  
   6.2. Methodology 
 
6.2.1. Chemicals 
 
Chemicals were obtained from the following source: sodium borohydride (NaBH4; 
>98%), ascorbic acid (C6H8O6; >99%), potassium iodide (KI; >99%) and sodium 
hydroxide reagent grade (NaOH; > 98%) from Sigma.  
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6.2.2. Experimental design 
 
Biological samples of workers from a mining company in Alentejo (Portugal) (group M) 
were obtained from the Occupational Health department under the supervision of the 
medical doctor of this company.  Two non-exposed groups were used in this study: one 
with people not occupationally exposed in mines and living in an urban area (Lisbon, 
Portugal), obtained from the laboratory of Clinical Analysis of the Faculdade de 
Farmácia, Universidade de Lisboa (group CU) and the other constituted by the 
administrative workers of the mining industry in the rural area of Alentejo (group CR). 
All the samples correspond to male adult persons. 
 
 
6.2.3. Sample collection  
 
All the biological samples, blood and urine, were collected on the last day of the shift 
and stored at –80°C until the analysis. The blood was stored in heparinized tubes, and 
the urine samples were collected in 25-mL aseptic containers. The collection of all the 
samples was performed under the supervision of a qualified nurse. Twenty samples 
were used for each group.  
 
 
6.2.4. Determination of biomarkers 
 
The levels of Pb and Mn in blood and urine, AChE activity in blood and urinary delta-
ALA, total porphyrins and the porphyrin profile were determined as previously 
described in Chapters 3 and 4. Concerning human blood and urine As analysis it was 
expected lower levels of As than in treated rats, thus, we used the hydride generation 
atomic absorption spectrometry (HGAAS), which would allow us to detect lower 
concentrations of As.  
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6.2.4.1. Arsenic analysis by hydride generation atomic absorption 
spectrometry 
 
 
The levels of As were determined by HGAAS. In this technique, a sample loop on a flow 
injection valve is filled with an acidified sample, blank, or standard. The sample is 
mixed with a pumped stream of sodium borohydride, to produce arsenic hydrides in 
vapor phase.  A flow of argon is added to this mixture allowing the gaseous phase 
containing the analyte to enter the quartz cell on the AAS, for analysis (Hineman, 
2012).  
 
Prior to analysis the samples were digested as described in Chapter 3 and then 
acidified through the following procedure: to 1 mL of each sample, 1 mL of HCl, 1 mL of 
ascorbic acid 31% (w/v) and 1 mL of potassium iodide 31% (w/v) was added and filled 
in a volumetric flask to 10 mL with deionized water. After 45 minutes at room 
temperature, total As determination was carried out using a PerkinElmer AAnalyst™ 
700 equipped with a hydride generation system, Perkin-Elmer Corp. Hydride 
generation was performed using 0.2% (w/v) NaBH4 in 0.05% NaOH and 10% HCl. The 
radiation source was a hollow cathode lamp of As (Perkin-Elmer) used at a wavelength 
of 193.7 nm and a spectral slit width of 0.7 nm. The QL of the method was 0.037µg/L. 
 
 
6.2.5. Statistical analysis 
 
All the groups were compared by Mann-Whitney tests and BMs were integrated using 
discriminant analysis and multi-regression statistical tools, as previously described in 
Chapters 3 and 5. 
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6.3. Results 
 
 
6.3.1. Biomarkers in blood 
 
Metal levels 
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Figs.6.1. (a), (b) and (c): Blood concentrations of Pb (a), As (b) and Mn (c) in rural (CR), urban (CU) 
and mining (M) populations. Data represent the mean ± SD and n=15 each group. All the groups 
were compared by Mann-Whitney U tests.  * and ^ are p < 0.05 versus CR and CU. 
 
 
 
 
 
Slight increases of Pb, As and Mn were attained in the blood of miners, with respect to 
the rural group, however none of these differences were statistically significant 
(Figs.6.1a, b and c).  Pb concentrations in the blood of the urban population were 
significantly (p<0.05) higher than in the rural group (Fig.6.1a).  
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AChE activity 
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Fig.6.2: Total blood AChE activity in rural (CR), urban (CU) and mining (M) populations. Data 
represent the mean ± SD and n=15 each group. All the groups were compared by Mann-Whitney U 
tests.  * and ^ are p < 0.05 versus CR and CU. 
 
 
 
 
AChE activity in the blood significantly (p<0.05) increased in both urban and mining 
populations comparing with the rural group (Fig. 6.2). The urban group exhibited the 
highest levels of the parameter, which was significantly (p<0.05) higher than the value 
observed in the miners (Fig. 6.2).    
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6.3.2. Biomarkers in urine 
 
 
Metal levels 
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Figs. 6.3 (a), (b) and (c): Urinary concentrations of Pb (a), As (b) and Mn (c) of rural (CR), urban (CU) 
and mining (M) populations. Data represent the mean ± SD and n=20 each group. All the groups 
were compared by Mann-Whitney U tests.  * and ^ are p < 0.05 versus CR and CU. 
 
 
 
 
 
The miners´ Pb, As and Mn urinary levels were higher than in rural and urban groups 
(Figs.6.3b and c), although Pb concentrations lacked statistical significance (p>0.05) 
(Fig.6.3). Mn urinary levels of the urban population were significantly (p<0.05) lower 
than the rural group (Fig.6.3c). 
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Delta-ALA levels 
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Fig.6.4: Urinary concentrations of delta-ALA in rural (CR), urban (CU) and mining (M) populations. 
Data represent the mean ± SD and n=20 each group. All the groups were compared by Mann-
Whitney U tests.  * and ^ are p < 0.05 versus CR and CU. 
 
      
No significant differences were attained among groups respecting to urinary delta-ALA 
concentrations.  
 
Total porphyrins 
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Fig.6.5: Urinary concentrations of total porphyrins of rural (CR), urban (CU) and mining (M) 
populations. Data represent the mean ± SD and n=20 in each group. All the groups were compared 
by Mann-Whitney U tests.  * and ^ are p < 0.05 versus CR and CU. 
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The concentrations of total porphyrins in the urine of miners and urban subjects were 
significantly (p<0.05) higher than the ones determined in the rural group.  
 
Porphyrin profile 
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Figs. 6.6 (a), (b), (c), (d), (e) and (f): Urinary levels of uroporphyrin (a), heptaporphyrin (b), 
hexaporphyrin (c), pentaporphyrin (d), coproporphyrin (e) and protoporphyrin (f) in rural (CR), 
urban (CU) and mining (M) populations. Data represent the mean ± SD and n=20 each group. All 
the groups were compared by Mann-Whitney U tests.  * and ^ are p < 0.05 versus CR and CU.  
 
 
The miners group revealed to have urinary levels of uro- and pentaporphyrins 
significantly (p<0.05) lower than the urban group (Fig.6.6a and d) and heptaporphyrin 
excretion significantly (p<0.05) lower than the rural subjects (Fig.6.6b). Urban subjects 
exhibited urinary hexa- and protoporphyrins concentrations significantly (p<0.05) 
increased as compared with the rural group (Fig.6.6c and f). 
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6.3.3. Integration of biomarkers 
 
   CF(CR)        CF (CU)               CF (M)
The subject is:
If the highest value is obtained with
Rural Urban
Miner
Assessment of the exposure in miners, urban and rural subjects                                                                                          
(Procedure I')
Classification
Functions:
CF (CR) = 0.08*As U + 0.23*Pb U + 26.64*Pb B + 4.57*Mn B + 1.67*ln ALA U - 13.1
CF (CU) = 0.14*As U + 0.38* Pb U + 39.99*Pb B + 6.78*Mn B + 0.78*ln ALA U - 27.46
CF (M) =  1.05*As U + 0.27*Pb U + 13.56*Pb B + 19.40*Mn B - 2.12*ln ALA U - 18.46
Determination of Pb U, Pb B,  As U, Mn B and ALA U 
 
Fig. 6.7: Procedure I’ proposed for individual assessment of the type of exposure in miners, urban 
and rural populations, through the determination of Pb and Mn in blood (B) and urinary (U) Pb, As 
and delta-ALA levels. Three classification functions (CF) were generated: for subjects non-
occupationally exposed and living in a rural environment [CF (CR)] or in an urban environment [CF 
(CU)] and for miners [CF (M)]. The CF with the highest value indicates the type of exposure 
predicted by the model.  
 
 
 
   CF(CR)        CF (CU)               CF (M)
The subject is:
If the highest value is obtained with
Rural Urban
Miner
Assessment of the exposure in miners, urban and rural subjects                                                        
(Procedure II')
Classification
Functions:
CF (CR) = 2004.41*Uro U + 2591.75*Hepta U - 5881.34*Hexa U + 3289.61*Penta U +874,20*Copro U + 889.16*Proto U - 2.81
CF (CU) = 2612.59*Uro U + 122.24*Hepta U - 4117.99*Hexa U + 6067.96*Penta U +193.11*Copro U + 131.08*Proto U - 2.88
CF (M) = 192.21*Uro U + 2894.82*Hepta U + 12062.09*Hexa U - 1669.91*Penta U +711.12*Copro U + 3808.12*Proto U - 2.45 
Determination of the urinary porphyrin profile 
 
Fig. 6.8: Procedure II’ proposed for individual assessment of the type of exposure in miners, urban 
and rural populations, through the determination of the urinary (U) porphyrins profile, the levels of 
Uro-, Hepta-, Hexa-, Penta-, Copro- and Protoporphyrins. Three classification functions (CF) were 
generated: for subjects non- occupationally exposed and living in a rural environment [CF (CR)] or 
in urban environment [CF (CU)] and for miners [CF (M)]. The CF with the highest value indicates the 
type of exposure predicted by the model. 
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6.3.3.1. Evaluation of the procedures 
 
Procedure I’ 
 
  
Table 6.1: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR), through the integration of their  Pb and Mn 
levels in blood and Pb, As and delta-ALA concentrations in urine by discriminant analysis. The table 
represents the type of exposure predicted by the model and the real exposure (Group). 
 
 
 
 
                                
Predicted type of exposure
CR CU M
CR 10 9 1 0
CU 12 0 12 0
M 13 0 0 13
97.1% of the cases correctly classified
Group N
 
 
 
 
 
Procedure I’ was applied to access if the type of exposure of each subject could be 
correctly identified through the combination of Pb and Mn levels in blood and the 
concentrations of Pb, As and delta-ALA in urine. With exception of one person living in 
the rural area, which was wrongly classified as belonging to the urban environment 
group, all subjects were properly classified by the model, corresponding to 97.1% of 
the cases correctly identified (Table 6.1).  
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Fig. 6.9: Graphical representation of each subject classification according to the type of exposure, 
through the integration of its Pb and Mn levels in blood and urinary Pb, As and delta-ALA 
concentrations by discriminant analysis. A centroid value was calculated for each group and the 
results are plotted by the canonical discriminant functions.   
 
 
 
 
 
The 3 groups, CR, CU and M, were clearly discriminated by Procedure I’ showing clearly 
separated areas. However, one subject from the rural area was classified erroneously 
in the urban environment group, revealing to be distant from the area corresponding 
to its original population (Fig.6.9).     
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Procedure II’ 
 
 
 
Table 6.2: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR), using  their  individual urinary (U) porphyrin 
profile, the levels of uro-, hepta-, penta-, copro- and protoporphyrins. Discriminant analysis was 
performed. The table represents the type of exposure predicted by the model and the real 
exposure (Group).  
 
 
 
                               
Predicted type of exposure
CR CU M
CR 20 10 6 4
CU 20 3 12 5
M 20 4 1 15
61.7% of the cases correctly classified
Group N
 
 
 
 
 
 
The assessment of the type of exposure in humans through the application of 
Procedure II’ showed that the individual urinary porphyrin profile allowed that only 
61.7% of the cases were correctly classified. Both rural and urban groups exhibited 
greater amount of errors as compared with the group of miners. In fact 75% of the 
miners were correctly identified while respectively 50% and 60%, of rural and urban 
subjects were classified appropriately by this procedure (Table 6.2).    
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Fig. 6.10: Graphical representation of each subject classification according to the type of exposure, 
through its urinary porphyrin profile by discriminant analysis. A centroid value was calculated for 
each group and the results are plotted by the canonical discriminant functions.   
 
 
Fig.6.10 shows that the areas of the 3 groups overlapped, revealing a poor 
discrimination capability of Procedure II’.  
 
 
Testing Procedure I’ through external data 
 
Procedure I’ was tested thereafter in 7 subjects who were randomly selected and were 
not included in the previous models. Using this procedure, six of the seven subjects 
were correctly classified according to the type of exposure (Table A5.1, appendix 5). 
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6.4. Discussion 
 
Pb, As and Mn are neurotoxic metals co-occurring in several environmental settings, 
such as mines  (Balbuena et al,  2011;  Dahtrak and Nandi, 2009; Martinez-Finley  et  
al.,  2012; Yokel et al, 2009;) and since neurological  disorders  can  clinically manifest  
only decades  after  the  initial  exposure  (Gil  and  Pla,  2001), early predictive  BMs 
have become increasingly  important  for  the detection  and diagnosis of the onset of 
these diseases (Kakkar  and Jaffery,  2005;  Scherer,  2005). Having some authors the 
opinion that exposed populations should be studied using a combination of exposure 
and/or effect BMs (Kakkar and Jaffery, 2005; Zhai et al, 2005), a multibiomarker 
approach was used to identify the exposure in a Portuguese population occupationally 
exposed to the mixture of Pb, As and Mn. Thus, in this work several BM of exposure 
and/or effect were applied to control the miners’ exposure to this mixture. 
 
 
6.4.1. Biomarkers of internal dose 
 
Metal levels in blood and urine 
 
Blood and urinary Pb concentrations of miners showed a trend to be higher than in 
non-occupationally exposed subjects. Higher standard deviations were also attained in 
this group, certainly explaining the lack of statistical differences (Figs 6.1a and 6.3a). 
Being this work a preliminary study to apply  the results from the in vivo study 
(Chapters 4 and 5), further work with more subjects and the knowledge of other 
variables, such as the time of employment and confounding factors (e.g. smoking 
habits) would provide a clearer picture. In addition, NIOSH and ACGIH’s BEIs are 
respectively 600 µg Pb/L and 300 µg Pb/L in blood [0.60 µg/g and 0.30 µg/g, 
considering a blood density of 1.0506 Kg/m3 (Trudnowski and Rico, 1974)]. The mean 
Pb levels in blood observed in miners was 0.55 µg/g, with an upper limit of 0.81µg/g 
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suggesting that some workers might be at risk of excessive exposure to Pb. Despite 
their average urinary levels (30 µg/g creat) were within a range of urinary Pb 
concentrations described for urban populations (4-270 µg/g creat) (ASTDR, 2014), 
blood Pb levels are a more accepted BM (Moreira and Neves, 2008). Pb excretion in 
rural and urban populations was similar (Fig.6.3a), but urban subjects, with blood Pb 
levels within the range described in urban populations (ASTDR, 2014), had this 
parameter significantly (p<0.05) higher than in the rural group. The North of Lisbon is a 
very industrialized area and is also very populous, contributing for the degradation of 
the air quality. However, airborne-Pb measured over an urban-industrial corridor 
within metropolitan Lisbon in 2003 was sharply reduced as compared with the early 
1990s. These findings were attributed to the widespread use of unleaded gasoline, 
introduced and fully enforced in 1990 and 1999 respectively (Freitas et al, 2003). The 
observed values are possibly attributed to the Pb disposition‘ characteristics, where 
the skeleton represents the largest and kinetically slow pool (having a half-life of more 
than 20 years), with Pb in bone may contributing as much as 50% to Pb in blood 
(Casarett and Doull’s, 2007).   
 
Figs. 6.1b and c and 6.3b and c shows that there was a trend for the miners to have 
increased levels of As and Mn in both peripheral samples, comparing to the other two 
groups. This difference was more marked in the urine, were a statistical significance 
(p<0.05) was observed. Concerning to As, the result is in agreement with the 
information that urinary As has been the most used BM to indicate As exposure 
(Marchiset-Ferlay et al, 2012). The mean values observed in the miners group seems to 
indicate an excessive exposure to As, when comparing their As levels in blood (0.003 
µg/g) with references of 0.5- 2 µg/L in non exposed subjects and 2-41 µg/L upon 
exposure to contaminated drinking water (ASTDR, 2007a, MAK, 2002). The comparison 
of their urinary As mean value (15.31 µg/g creat) with a study with copper smelters, 
which revealed average values of 16.9 µg/g (range 2.6 to 50.8 µg/g creat) (ASTDR, 
2007a) supports this awareness. Blood and urinary levels of As in urban subjects 
(respectively, 0.0020 µg/g and 0.78 µg/g creat), which actually were similar to the rural 
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population (0.0022 µg/g in blood and 1.39 µg/g creat in urine (Fig. 6.1b and 6.3b), 
were not suggestive of an excessive exposure. 
 
While no reliable BMs are established for Mn, in this work urinary determinations 
seemed to indicate better the exposure than blood values do, disagreeing with several 
other studies (ASTDR, 2007c) possibly duo to the small size of our sample. Even so, 
when comparing Mn proposed BEI values in blood of <15 μg/L (MAK Commission) and 
<10 µg/L (Lauwerys and Hoet, 2011) and the description of 4-15 µg/L in the blood of 
non exposed subjects (Santamaria, 2008), the miners (exhibiting 0.013 µg/g Mn blood 
values) are possibly excessively exposed to Mn. In the same way, the limit exposure 
levels proposed by Lauwerys and Hoet, 2011 in urine (<3µg/g creat) are lower than the 
values observed in this group of workers (10.86 µg/g creat). The urban subjects 
presented inconsistent results pertaining to the levels of Mn in peripheral samples. In 
fact while in blood there was only a slight and not statistical significant increase when 
compared with the rural group (Fig. 6.1c), the urinary excretion was significantly lower 
than in rural subjects (Fig.6.3c), reflecting again the need of suitable BMs to indicate 
Mn exposures. Even so, the obtained results did not indicate excessive exposure (Fig. 
6.1c and 6.3c).  
 
At a general rule, the results obtained with the human populations are in agreement 
with the experimental results, since increased levels of the three metals in mixture 
treated rats/exposed human group, as compared with controls, were observed in both 
cases (Fig. 3.2 and 3.6, Chapter 3; Fig.6.1a, b and c and Fig.6.3a, b and c).  However 
limitations exist, such as the impossibility of comparing single and co-exposed humans 
and ascertain if in the co-exposed population there was a higher deposition of Pb in 
the brain and/or increased neurotoxicity, then in the control groups. 
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6.4.2. Biochemical markers 
 
Neurochemical and heme synthesis endpoints  
 
AChE activity in the blood of miners was significantly (p<0.05) higher than in the rural 
population (Fig.6.2), in accordance with the trend observed in experimental data 
where mixture treated rat’s AChE activity was higher than controls, despite the 
alteration lacked statistical significance (Fig. 4.5, Chapter 4). This parameter can show 
a biphasic response (Chapter 4), corresponding the first phase to its increase due to 
the low levels of metals exposure, in the same way as is suggested in the miners 
(Fig.6.1a, b and c and 6.3a,b and c).  The reason why the urban population had the 
highest (p<0.05) AChE activity in blood demands further explanation (Fig.6.2).  
 
Differently from experimental observations (Fig. 4.7), delta-ALA levels in the urine of 
miners exhibited only a very slight and not significant increase, as compared with the 
other two groups of subjects (Fig. 6.4). High standard deviations were observed, 
possibly due to polymorphisms in genes for the enzyme ALAD (Bergdahl et al., 1997) 
and also due to the small number of subjects.  In addition, delta-ALA levels of 3 mg/g 
creat are proposed as a threshold to detect levels of Pb in blood equal to or higher 
than 20 µg/dL (Caldeira et al, 2000), for which adverse health effects including 
neurological alterations are described (ASTDRb, 2007), suggesting that the finding of 
4.36 mg/g creat as the highest delta-ALA levels in the miners justifies further studies. 
 
Total porphyrins in the urine of miners and urban subjects were significantly (p<0.05) 
higher than in the rural population (Fig.6.5) and similarly, Pb/As/Mn mixture –treated 
rats increased the excretion of these heme precursors as compared with the controls 
(Fig.4.8, Chapter 4).  Woods et al. (2009) described urinary total porphyrins of 35.2µg/g 
creat in normal subjects, while miners and urban subjects presented mean values of 
18.70 µg/g creat and 17.45 µg/g creat, respectively, which do not seem to indicate 
cause of concern respecting to porphyrins accumulation.   
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After analyzing the urinary porphyrin profile (Fig.6.6), the results obtained in humans 
seem to be even more inconsistent then the ones observed in the rats (Fig.4.9, Chapter 
4), at least when considering each porphyrin alone.  Currently, the human populations 
are exposed to mixtures of these 3 metals, certainly including more metals, which 
might also interfere with heme biosynthesis (Pingree et al, 2001). Since different 
metals can have different effects on porphyrins, the complexity of eventual additional 
interactions might explain some of the inconsistency of the results. When considering 
each porphyrin alone, the confrontation of the obtained values (Fig. 6.6) with the 
urinary porphyrin profile of normal subjects, with 20.7 nmol/g creat of uroporphyrins, 
4.1 nmol/g creat of heptaporphyrins, 0.89 nmol/g creat of hexaporphyrins, 4.45 
nmol/g creat of pentaporphyrins and 195 nmol/g creat of coproporphyrins (Kern et al, 
2011), does not suggest relevant alterations in any of the studied groups. 
 
Each BM alone was tested with respect to its capability to predict the type of exposure 
(Tables A4.1-11, appendix 4) and revealed a weaker prediction capability as compared 
with their combination, as will be testified.   
 
 
6.4.3. Combination of biomarkers 
 
The phase 1 of the procedures I and II (Figs.5.2 and 5.3, Chapter 5) was translated to 
humans as Procedures I’ and II’ (Fig.6.7 and 6.8). Our goal was to use the same 
combination of BMs that was used in the rats (Chapter 4), to identify whether each 
subject was living in a rural environment, was exposed to metals in an urban setting or 
was occupationally exposed in mines. Moreover, we intended to investigate if the 
procedures could be applied to distinguish persons living in an urban and rural 
environment, as urban environment may be polluted with traces of these 3 metals. 
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Procedure I’, allowed to correctly classify 97.1% of the cases, with only 1 of 35 subjects 
erroneously identified as living in a urban environment, when in fact it was a person 
from the rural group (Table 6.1). This person was actually quite distant from its original 
group (Fig.6.9). Due to the fact that this is a preliminarily study  no data is available 
concerning  the history of the subject and thus, it is not possible to conclude if a 
procedure failure occurred while classifying the subject. Differently all miners were 
correctly identified (Table 6.1), with a clear separation from the other two groups 
(Fig.6.9). 
 
Procedure II’ was also evaluated as a more practical and advantageous alternative, 
where using the urinary porphyrins profile could only imply one analytical 
determination. However, and differently from what was experimentally observed 
(Table 5.4, Chapter 5), only 61.7% of the subjects were correctly classified (Table 6.2) 
with Fig.6.10 showing that this procedure had a poor separation capability among 
groups. Despite the miners ‘group did not detached from the other two groups (Fig. 
6.10), 75% of miners were correctly identified (Table 6.2), which is a motive to confirm 
these studies using a higher number of samples. In fact and considering the instability 
of porphyrins in the samples that were transported from Alentejo to Lisbon, further 
studies are necessary to clarify if the transport procedure was inadequate. 
  
After constructing prediction models an immediate question may arise, “what will be 
its applicability to other exposed persons in similar contexts?” Hence, procedure I’ was 
later applied in 7 randomly selected individuals, which data were not used to construct 
the models. It must be highlighted that using 7 persons is largely far from being 
sufficient and that no valid conclusion can be extracted from such a small preliminary 
test. Even so, only one of the 7 cases was erroneously identified (Table A5.1, appendix 
5) leading the will of further robust confirmation.  
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6.5. Conclusions 
 
This work suggests that some workers from the studied population of miners might be 
exposed to excessive levels of Pb, As and Mn. When considering the co-occurrence of 
these metals in their workplace, we suggest that in particular the exposure to Pb 
should be controlled. The translation of the results obtained from experimental data 
revealed that the use of the selected BMs, Pb and Mn blood levels and urinary Pb, As 
and delta-ALA levels to identify exposed workers and identify urban environmental 
exposures was promising when the parameters were applied in combination. We 
believe that this approach may possibly contribute to prevent the risk of neurotoxicity 
of these exposed populations. 
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Chapter 7 
 
Final discussion and conclusions 
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7.1. Final discussion 
 
Pb, As and Mn are among the major toxic contaminants in mining environments 
(Dahtrak and Nandi, 2009). Considering that the three metals have neurotoxic effects 
(Finkelstein et al, 1998; Rodriguez et al, 2003; Wong, 2006) it was hypothesized that 
mine workers could be at risk of increased neurotoxicity. In Chapters 3 and 4 an in vivo 
assay was performed with rats treated with each single metal, Pb, As and Mn and co-
treated with the mixture. The aim was to investigate the mechanism of interaction 
among these 3 metals in order to select endpoints of toxicity to apply as BMs to 
control and prevent the risk of exposure to this mixture.  To achieve this objective we 
evaluated the changes in: 1) behavioral motor activities; 2) metals’ levels in target 
organs, blood and urine; 3) and biochemical markers in brain, blood and urine.  The 
results evidence that upon the co-exposure to Pb, As and Mn behavioral toxicity was 
higher than upon single exposures (Chapter 4).  
 
In Chapter 3, the interactions among the 3 metals were investigated, and it was 
observed a higher deposition of Pb in rat kidney and brain, as compared with metal 
deposition after treatments with each single metal. However, blood Pb levels did not 
reflect brain status, concerning to the increased Pb accumulation; it raises concern to 
an underestimation of the risk of neurotoxicity in humans, since the  exposure to this 
metal is frequently biomonitored through  blood Pb measurements (ASTDRc, 2007). 
 
Subsequently, in Chapter 4, brain Pb levels were correlated with behavioral changes 
suggesting a causal relation between Pb accumulation in brain and motor activity 
dysfunctions. Neurochemical endpoints were also determined and decreased activity 
of AChE in the brain and increased delta-ALA levels were found.  The increase of delta-
ALA in rats co-exposed to the mixture, may contribute to increase of motor 
dysfunction in the same group of rats as it is documented that in excess delta ALA can 
act as a neurotoxin (Ennis et al., 2003). 
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Considering that neurotoxicity induced by chronic metal exposure can be progressive 
and may clinically manifest only decades after the initial exposure (Gil and Pla, 2001) 
our goal was  to select early BMs to be applied in the control of chronic occupational 
exposure to the mixture of Pb, As and Mn. The results of the in vivo assay showed that 
when comparing controls and/or single exposed groups, in rats treated with the metal 
mixture, there was an increase of blood or urinary metal levels, augments in the 
concentrations of serum PRL, urinary delta-ALA, total porphryrins and changes in the 
urinary porphyrin profile. The correlations of these markers with brain and/or 
behavioral parameters (Chapters 4 and 5), suggested their suitability as peripheral BMs 
of exposure and/or neurotoxicity upon exposure to the mixture of Pb, As and Mn 
(Chapter 4). However when used alone, none of the BMs revealed to be accurate 
enough and could be applied only to one type of exposure (Chapter 4 and 5). This was 
in fact an expected outcome due to the complexity of the nervous system and to the 
multi-mechanisms of toxicity of the different metals (Quinones and Daouk, 2009; 
Rachakonda et al, 2004).  
 
In chapter 5 a multibiomarker procedure was proposed based on a novel approach of 
BMs´ integration methodologies, which was already employed to diagnose disorders 
with multifactorial etiologies, such as cancer and PD or AD (Ahmed et al, 2010; Da et 
al, 2014; Edgell et al, 2010). In that sense, the determined BMs were selected and 
combined aiming to provide a tool that could timely identify exposed rats and semi-
quantitatively predict the magnitude of neurotoxic effects induced by the co-exposure 
to the mixture of Pb, As and Mn, with the purpose of a further translation to humans’ 
studies. Owing to each personal time of exposure, life habits, and different individual 
susceptibility to metal exposures, there is a need to develop an adequate tool to be 
applied to each subject, rather than merely in a group basis. In this perspective two 
procedures were generated: one combining the levels of Pb, Mn and AChE activity in 
blood, serum PRL and urinary Pb, As, delta-ALA and total porphyrins, while the second 
procedure integrated the urinary porphyrin profile, as a more practical alternative. 
Both procedures revealed to be suitable to achieve the proposed objectives better 
  
201 
 
than the traditional approach, focused on the search of a strong BM to be used alone 
(Chapter 5).  
 
In chapter 6, the collection of preliminary data pertaining to levels of exposure to 
metals in Portuguese mines leaded to find that the studied population of workers 
might be exposed to excessive levels of Pb, As and Mn (Chapter 6), as compared with 
reference limit values as well as after comparing with results from other studies 
(ASTDRa, 2007; ASTDR, 2014; Lauwerys and Hoet, 2011; MAK, 2002; Santamaria, 
2008). Given the co-occurrence of these metals in their workplace, exposure levels to 
Pb should be investigated with more detail. The pertinence of exploring BMs’ 
integration methodologies to detect exposed workers while in a still potentially 
reversible stage was suggested from the experimental results; thus, these results were 
tested in a risky population of Portuguese miners co-exposed to Pb, As and Mn.  The 
combination of the several BMs in blood and urine of the exposed population seemed 
encouraging concerning the identification of the exposure, differently from the 
integration of the urinary porphyrin profile, justifying further studies with more 
samples.  
 
Some authors consider a naïve expectation that a single BM can capture the intricate 
process underlying a CNS illness (Quinones and Daouk, 2009), but it is also unreal to 
expect that the predictive procedure developed in this work can function as “a magical 
formula”. Rather, this work intended to test BMs’ integration methodologies in the 
context of occupational exposure to a mixture of these metals. It is plausible that the 
integration of different BMs, such as susceptibility BMs, could also be considered and 
might have an even better applicability. A relevant outcome is the suggestion that 
weak BMs can gain predictive strength when used together. In fact, while no better 
BMs are found concerning some type of exposures, the combination of the available 
weaker ones can be considered a good tool to use and explore.  
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However, and as in many science issues, the rapprochement to some answers 
upsurges an even greater number of questions. The tested procedures were generated 
from toxicity data with the same dose, being important to understand if the procedure 
would maintain its suitability with different doses. Moreover, while in human scenarios 
accidental single exposures generally occurs to high chemical’s levels and co-exposures 
frequently occur at chronic low levels, the applied procedures were generated from 
data obtained using low doses. Biphasic responses are also described for some of the 
combined BMs (de Lima, 2013; Herrera et al, 2013) and also for the effects (Chandra  
et  al.,  1981;  Reddy  et  al., 2003;  Rocha  et  al.,  2001;  Rodrigues  et  al.,  1996),  
being yet to be known how would the models respond to the use of threshold doses. 
In addition, miners are co-exposed to other metals beyond Pb, As and Mn, which may 
interfere with the integrated BMs being important to ascertain their potential 
influence in these models.  
 
Finally, in real life scenarios people are co-exposed to an almost infinite number of 
chemical mixtures and thus, it is barely impossible to determine all the components of 
a mixture present in an environmental setting (ASTRD, 2004). For all practical 
purposes, if mixtures´ components are not usually well known, criteria are needed to 
define the relevant components of a mixture. Such criteria cannot rely simply on the 
concentrations of the compounds in the mixture, but must also take note of the 
expected contribution to relevant endpoints of toxicity (Kortenkamp and Faust, 2009). 
Recently, it has been argued that grouping criteria should focus on common adverse 
outcomes (Kortenkamp and Faust, 2009), leading to wonder if integrating specific but 
also some unspecific BMs could lead to better results, covering common effects of 
more chemicals. It is a possibility that the integration of BMs relied on previous 
identification of key components of a mixture from specific environmental settings 
may be a valid approach to monitor persons exposed to complex mixtures of 
chemicals. 
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7.2. Final conclusions 
  
This work established that: 
 
1- In the experimental co-exposure of rats to Pb, As and Mn, it was observed:  
 
a) An increase in motor activity impairment compared to single exposures;  
 
b) An augment of Pb’s deposition in kidney and brain as compared with rats 
treated with Pb alone, while blood Pb levels fail to reflect these alterations; 
 
c) An induction of neurochemical modifications in the brain,  such as decreased 
AChE activity and accumulation of delta-ALA (which can act as a neurotoxin), 
more than upon single exposures; 
 
d) A change in peripheral parameters, such as blood and urinary metal levels, 
serum PRL, urinary delta-ALA, total porphryrins and the urinary porphyrin 
profile;  
 
2- The  multivariate methodology used to  integrate BMs is an useful tool for 
prediction of the type of exposure and the magnitude of the induced 
neurotoxic effects upon co-exposure to Pb, As and Mn  
3- The application of a biomarker approach in a population of miners to control 
their exposure to Pb, As and Mn suggested that the integration of Pb and Mn 
blood levels and urinary Pb, As and delta-ALA levels could be used to identify 
exposed workers, and may represent a tool to prevent the risk of neurotoxicity 
in these occupational cohorts. 
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7.3. Future perspectives 
 
Our future work will be focused in a new toxicological in vivo model and in the 
implementation of the risk assessment in miners exposed to the studied metals 
mixture.  
 
Thus, we intend: 
 
1- To perform an in vivo assay with rats exposed to the same mixture of Pb, As 
and Mn increasing Pb doses, for a longer exposure period and using other 
behavioral evaluations, determining the same studied BMs and exploring the 
applicability of integrating BMs of susceptibility. 
 
2- To continue and optimize the research in the same mining company after  
screening the metals content in mine airborne, increasing the number of 
persons under study and collecting personal details concerning these subjects. 
The workers will be grouped according to high, medium and low level 
exposures with the aim of improving the predictive procedures. 
 
Blood and urine samples will be collected for determination of Pb, As and Mn as 
well as other metals which could interact with them. All the other biochemical 
BMs will be determined in the same samples. 
 
Neurobehavioral and performance tests will be implemented in collaboration 
with a clinical psychologist (including the control population) to identify subtle 
changes in motor and memory dysfunction. The neuropsychological test battery 
includes tests of motor function, response speed, memory, attention and 
executive functions. 
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3- Finally, the multiparameter model with procedures I and II will be tested in this 
risky population in order to select the combination of BMs to apply in risk 
assessment to mixtures of these neurotoxic metals. 
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Appendix 1 
 
 
Table A1.1: Identification of controls (C) and Pb treated rats through its levels of Pb in urine, by 
discriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
            
C Pb
C 6 2 4
Pb 6 2 4
50.0% of the cases correctly classified
Group N
Predicted type 
of exposure
 
 
 
 
Table A1.2: Identification of controls (C) and Pb treated rats through its levels of Pb in blood, 
bydiscriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
                                          
C Pb
C 6 5 1
Pb 6 2 4
75.0% of the cases correctly classified
Group N
Predicted type 
of exposure
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Table A1.3: Identification of controls (C) and As exposed rats through its levels of As in urine, by 
discriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
                                         
C As
C 6 6 0
As 6 2 4
83.3% of the cases correctly classified
Group N
Predicted type 
of exposure
 
 
 
 
Table A1.4: Identification of controls (C) and As exposed rats through its levels of As in blood, by 
discriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
                                       
C As
C 6 4 2
As 6 4 2
50.0% of the cases correctly classified
Group N
Predicted type 
of exposure
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Table A1.5: Identification of controls (C) and Mn exposed rats through its levels of Mn in urine by 
discriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
                                           
C Mn
C 6 2 4
Mn 6 0 6
66.7% of the cases correctly classified
Group N
Predicted type 
of exposure
 
 
 
 
Table A1.6: Identification of controls (C) and Mn exposed rats through its levels of Mn in blood by 
discriminant analysis. The table represents the type of exposure predicted by the model versus 
their real exposure (Group). 
 
 
                                         
C Mn
C 6 6 0
Mn 6 0 6
100.0% of the cases correctly classified
Group N
Predicted type 
of exposure
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Table A1.7: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of delta-ALA in urine, by discriminant analysis. C represents control rats. The table 
shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
 
                          
C As Mn Pb Mixt
C 6 4 1 1 0 0
As 6 1 4 1 0 0
Mn 6 1 3 2 0 0
Pb 6 0 1 0 5 0
Mixt 6 0 0 0 2 4
63.3% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
 
Table A1.8: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of total porphyrins in urine, by discriminant analysis. C represents control rats. 
The table shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
 
                        
C As Mn Pb Mixt
C 6 6 0 0 0 0
As 6 0 3 1 2 0
Mn 6 2 0 4 0 0
Pb 6 0 2 0 4 0
Mixt 6 0 4 0 0 2
63.3% of the cases correctly classified
Group N
Predicted type of exposure
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Table A1.9: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of serum prolactin, by discriminant analysis. C represents control rats. The table 
shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
                    
C As Mn Pb Mixt
C 6 3 0 0 3 0
As 6 0 4 1 1 0
Mn 6 0 1 2 2 1
Pb 6 2 0 3 3 1
Mixt 6 1 3 0 0 1
43.3% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
 
Table A1.10: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) uroporphyrins, by discriminant analysis. C represents control rats. 
The shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
                   
C As Mn Pb Mixt
C 6 6 0 0 0 0
As 6 1 2 1 1 1
Mn 6 0 2 2 1 1
Pb 6 0 1 1 1 3
Mixt 6 0 0 1 1 4
50.0% of the cases correctly classified
Group N
Predicted type of exposure
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Table A1.11: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) heptaporphyrins, by discriminant analysis. C represents control 
rats. The table shows the type of exposure predicted by the model versus its real exposure (Group). 
 
 
                         
C As Mn Pb Mixt
C 6 5 0 1 0 0
As 6 1 1 2 2 0
Mn 6 2 1 2 0 1
Pb 6 1 3 0 1 1
Mixt 6 0 1 1 2 2
36.7% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
 
Table A1.12: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) hexaporphyrins, by discriminant analysis. C represents control rats. 
The table shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
 
                        
C As Mn Pb Mixt
C 6 3 0 2 1 0
As 6 0 1 1 3 1
Mn 6 2 0 3 1 0
Pb 6 0 2 2 2 0
Mixt 6 0 2 0 0 4
43.3% of the cases correctly classified
Group N
Predicted type of exposure
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Table A1.13: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) pentaporphyrins, by discriminant analysis. C represents control 
rats. The table shows the type of exposure predicted by the model versus their real exposure 
(Group). 
 
 
                       
C As Mn Pb Mixt
C 6 4 0 2 0 0
As 6 1 4 1 0 0
Mn 6 2 4 0 0 0
Pb 6 1 0 0 5 0
Mixt 6 0 0 0 0 6
63.3% of the cases correctly classified
Group N
Predicted type of exposure
 
 
 
 
Table A1.14: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) coproporphyrins, by discriminant analysis. C represents control 
rats. The table shows the type of exposure predicted by the model versus their real exposure 
(Group). 
 
 
                      
C As Mn Pb Mixt
C 6 3 1 2 0 0
As 6 2 3 0 1 0
Mn 6 1 0 5 0 0
Pb 6 1 2 0 2 1
Mixt 6 0 0 0 3 3
53.3% of the cases correctly classified
Group N
Predicted type of exposure
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Table A1.15: Identification of the exposure, to Pb, As, Mn or the mixture of Pb/As/Mn of each rat 
through its levels of urinary (U) protoporphyrins, by discriminant analysis. C represents control rats. 
The table shows the type of exposure predicted by the model versus their real exposure (Group). 
 
 
                       
C As Mn Pb Mixt
C 6 1 0 2 2 1
As 6 0 2 2 0 2
Mn 6 0 1 2 2 1
Pb 6 0 0 1 5 0
Mixt 6 0 0 1 2 3
43.3% of the cases correctly classified
Group N
Predicted type of exposure
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Appendix 2 
Table A2.1: Relationship of each BM, urinary (U) Pb, As, Mn , delta aminolivulinic acid (ALA) and 
total porphyrins (Port T), levels of Pb, As and Mn in blood (B) and urine (U) and serum (S) prolactin 
(PRL S), with  motor activity, ambulation and rearing counts, in rats exposed to Pb, As, Mn or to the 
mixture of Pb/As/Mn.  For significant (p<0.05) regressions the goodness-of-fit of linear regression is 
represented (R2). “NS” indicates not significant regressions.   
Pb As Mn Mixt
Ambulation NS - - -
Rearing NS - - -
Ambulation R2=0.389 - - -
Rearing NS - - -
Ambulation - R2=0.718 - -
Rearing - R2=0.628 - -
Ambulation - R2=0.610 - -
Rearing - R2=0.486 - -
Ambulation - - NS -
Rearing - - NS -
Ambulation - - R2=0.370 -
Rearing - - R2=0.500 -
Ambulation NS NS NS R2=0.877
Rearing NS NS NS R2=0.739
Ambulation NS R2=0.519 NS R2=0.865
Rearing NS R2=0.499 NS R2=0.860
Ambulation NS R2=0.641 R2=0.490 R2=0.679
Rearing NS R2=0.803 R2=0.686 R2=0.528
Ambulation R2=0.625 NS NS R2=0.812
Rearing NS NS NS R2=0.630
Ambulation NS NS NS R2=0.780
Rearing NS NS NS R2=0.697
Ambulation R2=0.591 NS NS R2=0.901
Rearing NS NS NS R2=0.818
Ambulation NS NS R2=0.373 R2=0.756
Rearing NS NS R2=0.520 R2=0.747
Ambulation NS NS NS NS
Rearing NS NS NS NS
Ambulation NS R2=0.564 NS R2=0.334
Rearing NS R2=0.419 NS NS
PRL S
Group
Pb U
Pb B
As U
As B
Mn U
Uro U
Hepta U
Hexa U
Penta U
Copro U
Proto U
Mn B
ALA U
Porf T U
 
The equations of significant regressions (p<0.05) which were exclusive of only one 
group were used to estimate the motor activity of each rat, as is described in the 
following tables.  
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Table A2.2: Estimation of ambulation counts of rats exposed to Pb through its levels of urinary (U) 
Pb, by linear regression. The values predicted by the model are compared with the values observed 
in each rat. 
 
(µg/L) Predicted Observed Error
25 -3,22 43 22 21
26 -2,12 37 18 19
27 -2,66 40 9 31
28 0,03 26 21 5
29 -1,97 36 29 7
30 -0,4 28 18 10
averge error: 15 ± 10
Motor activity
Ambulation counts = -5.21 ln Pb U + 25.92 
Ambulation counts
Individual                       
(code number)
ln Pb U
 
 
 
 
Table A2.3: Estimation of motor activity, ambulation and rearing counts, of rats exposed to As 
through its levels of urinary (U) As, by linear regression. The values predicted by the model are 
compared with the values observed in each rat. 
 
(µg/L) Predicted Observed Error Predicted Observed Error
13 -0,04 10 8 2 17 14 3
14 0,18 9 12 3 16 19 3
15 -1,24 16 20 4 21 28 7
16 -0,42 12 20 8 18 23 5
17 -0,53 12 2 10 19 14 5
18 -1,35 16 12 4 21 13 8
averge error: 5 ± 3 averge error: 5 ± 2
Ambulation counts = -4.94 ln As U + 9.65 
Individual                       
(code number)
ln As U
Ambulation counts Rearing counts
Motor activity
Rearing counts = -3.52 ln As U + 16.66  
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Table A2.4: Estimation of motor activity, ambulation and rearing counts, of rats exposed to As 
through its levels of As in blood (B), by linear regression. The values predicted by the model are 
compared with the values observed in each rat. 
 
(µg/L) Predicted Observed Error Predicted Observed Error
13 -0,04 10 8 2 17 14 3
14 -1,56 17 12 5 22 19 3
15 0,01 10 20 10 17 28 11
16 -0,65 13 20 7 19 23 4
17 -0,66 13 2 11 19 14 5
18 -1,42 16 12 4 22 13 9
averge error: 7 ± 3 averge error: 6 ± 3
Ambulation counts = -4.76 ln As B + 9.66 
Rearing counts = -3.24 ln As B + 16.99 
Individual                       
(code number)
ln As B
Motor activity
Ambulation counts Rearing counts
 
 
 
 
Table A2.5: Estimation of motor activity, ambulation and rearing counts, of rats exposed to Mn 
through its levels of Mn in blood (B), by linear regression. The values predicted by the model are 
compared with the values observed in each rat. 
 
(µg/L) Predicted Observed Error Predicted Observed Error
13 -1,02 17 22 5 16 14 7
14 -1,32 19 15 4 18 19 1
15 -0,87 16 30 14 15 28 12
16 -1,2 18 14 4 17 23 6
17 -1,21 18 8 10 17 14 3
18 -1,08 17 6 11 17 13 4
averge error: 8 ± 4 averge error: 5 ± 4
Ambulation counts = -7.03 ln Mn B + 9.76 
Rearing counts = -6.32 ln Mn B + 9.76 
Individual                       
(code number)
ln Mn B
Motor activity
Ambulation counts Rearing counts
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Table A2.6: Estimation of motor activity, ambulation and rearing counts, of rats exposed to the 
mixture of Pb/As/Mn through its levels of urinary (U) hexaporphyrins (Hexa), by linear regression. 
The values predicted by the model are compared with the values observed in each rat. 
 
nmol/g creat) Predicted Observed Error Predicted Observed Error
7 -5,55 0 1 1 3 0 3
8 -6,57 9 5 4 12 12 0
9 -6,32 6 2 4 10 5 5
10 -6,81 11 4 4 14 12 2
11 -6,81 11 4 7 14 5 9
12 -6,57 9 7 2 12 7 5
averge error: 4 ± 4 averge error: 4 ± 3
Ambulation counts = -9.9 ln Hexa U - 56.35 
Rearing counts = -9.2 ln Hexa U - 48.23 
Individual                       
(code number)
ln Hexa U
Motor activity
Ambulation counts Rearing counts
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Appendix 3 
Table A3.1: Prediction of motor activity, ambulation and rearing counts of rats  exposed to Pb, As, Mn or the mixture of the three elements through the integration 
of BMs, the levels of Pb, Mn and AChE activity in blood (B), PRL in serum (S) and urinary (U) levels of Pb, As, ALA and total porphyrins. Data were analyzed by 
multiple linear regression.  All the values estimated by the model are compared with the number of movements observed in each rat.                   
 
Rat Group ln As U ln Pb U ln Mn B ln Pb B ln AChE B ln PRL S ln ALA U ln Porf T U
(code number) (nmol/min/g blood) (ng/ mL serum) (mg/g creat) (µg/ g creat)
13 As -0,04 3,55 -6,44 12 8 4 18 14 4
14 As 0,18 3,79 -6,44 9 12 3 16 19 3
15 As -1,24 3,92 -6,81 15 20 5 20 28 8
16 As -0,42 3,41 -6,57 15 20 5 19 23 4
17 As -0,53 3,94 -7,42 8 2 6 17 14 3
18 As -1,35 3,98 -6,91 15 12 3 21 13 8
4 ± 1 5 ± 2
19 Mn 1,47 3,72 -7,42 22 17 14 3
20 Mn 1,29 3,92 -8,11 15 14 19 5
21 Mn 1,13 3,51 -7,42 30 19 28 9
22 Mn 1,15 3,43 -7,6 14 18 23 5
23 Mn 1,04 3,36 -8,11 8 16 14 2
24 Mn 1,16 3,53 -7,67 6 17 13 4
5 ± 3
25 Pb -3,22 1,49 -1,14 3,68 -4,25 -7,01 25 22 3 28 24 4
26 Pb -2,12 1,44 -1,08 3,36 -3,76 -6,32 18 18 0 21 23 2
27 Pb -2,66 1,25 -2,14 2,74 -4,64 -7,01 11 9 2 6 5 1
28 Pb 0,03 1,43 -0,29 3,30 -4,14 -6,5 22 21 1 31 31 0
29 Pb -1,97 1,72 -1,94 3,20 -4,17 -6,81 22 29 7 22 27 5
30 Pb -0,4 1,24 -1,91 3,30 -4,06 -6,81 21 18 3 25 21 4
3 ± 3 3 ± 2
7 Mixt -0,39 -0,77 1,27 -4,82 2 1 1 1 0 1
8 Mixt 0,18 -1,05 1,28 -5,99 3 5 2 8 12 4
9 Mixt 0,32 -1,16 1,42 -4,44 0 2 2 5 5 0
10 Mixt -1,97 -0,87 1,42 -6,38 13 4 9 14 12 2
11 Mixt -0,84 -0,92 1,18 -6,32 8 4 4 9 5 4
12 Mixt -1,66 -1,07 1,86 -6,65 12 7 5 20 7 13
4 ± 3 4 ± 4
Average error: Average error:
Average error: Average error:
(µg/ g creat) (µg/ g blood)
Average error: Average error:
Average error:
Predicted Observed Abs Error Predicted Observed Abs Error
BMs  Levels Motor activity
Ambulation counts Rearing counts
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Table A3.2: Prediction of motor activity, ambulation and rearing counts, of rats exposed to Pb, As, Mn or the mixture of the three elements through its urinary (U) 
porphyrins, uro-, hepta, hexa-, penta-, copro- and protoporphyrins. Data were analyzed by multiple linear regression. The values estimated by the model were 
compared with the number of movements observed in each rat. 
 
Rat Group ln Penta U ln Copro U ln Proto T U
(code number)
13 As -6,65 -6,5 -7,13 -3,13 9 8 1 18 14 4
14 As -6,57 -6,44 -7,13 -2,93 13 12 1 21 19 2
15 As -6,91 -6,73 -7,42 -2,75 14 20 6 20 28 8
16 As -5,52 -5,07 -7,26 -2,34 20 20 0 23 23 0
17 As -7,13 -6,65 -7,26 -3,09 6 2 4 15 14 1
18 As -7,82 -8,52 -9,21 -2,74 12 12 0 14 13 1
2 ± 3 3 ± 3
19 Mn -6,81 -9,21 -3,52 -7 22 4 14 10
20 Mn -6,57 -6,32 -3,77 -7,4 15 4 19 15
21 Mn -6,5 -6,07 -3,22 -7,1 30 7 28 21
22 Mn -7,42 -8,11 -5,91 -8,1 14 0 23 23
23 Mn -7,01 -7,01 -4,32 -7,8 8 0 14 14
24 Mn -6,78 -6,75 -3,77 -7,4 6 3 13 10
16 ± 5
25 Pb -8,11 -6,38 -9,2 19 22 3 24
26 Pb -7,01 -6,12 -7,8 19 18 1 23
27 Pb -6,73 -6,21 -9,2 15 9 6 5
28 Pb -7,42 -6,27 -9,2 17 21 4 31
29 Pb -7,26 -7,82 -8,1 30 29 1 27
30 Pb -6,44 -6,21 -7,4 20 18 2 21
3 ± 2
7 Mixt -6,81 -4,08 -0,91 -6,1 3 1 2 6 0 6
8 Mixt -7,42 -4,85 -1,89 -6,9 7 5 2 6 12 6
9 Mixt -7,42 -4,72 -1,77 -7 4 2 2 7 5 2
10 Mixt -8,11 -5,1 -2,34 -7,8 2 4 2 5 12 7
11 Mixt -7,13 -4,83 -2,38 -7,4 10 4 6 11 5 6
12 Mixt -8,11 -5,17 -2,18 -8,1 0 7 7 7 7 0
4 ± 2 5 ± 3Average error: Average error:
(nmol/ g creat)
Average error: Average error:
Average error:
Average error:
Ambulation counts Rearing counts
ln Uro U ln Hepta U
Predicted Observed Abs Error Predicted Observed Abs Error
BMs  Levels Motor activity
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Table A3.3: Prediction of motor activity, ambulation and rearing counts of rats exposed to the mixture of Pb/As/Mn through its brain porphyrin levels, uro-, penta-, 
copro- and protoporphyrins. Data were analyzed by multiple linear regression. The values estimated by the model were compared with the number of movements 
observed in each rat. 
 
Rat Group ln UroP ln PentaP ln CoproP ln ProtoP
(code number)
7 Mixt -4,68 -6,07 -5,65 -6,38 4 1 3 7 0 7
8 Mixt -4,88 -6,21 -5,71 -6,38 6 5 1 9 12 3
9 Mixt -5,71 -6,27 -6,21 -6,57 -2 2 4 4 5 1
10 Mixt -5,17 -6,27 -6,17 -6,57 9 4 5 13 12 1
11 Mixt -5,71 -6,21 -6,21 -7,01 4 4 0 3 5 2
12 Mixt -4,68 -6,07 -5,65 -6,5 6 7 1 7 7 0
2 2Average error: Average error:
Brain Porphyrin (P) Levels Motor activity
Ambulation counts Rearing counts
Predicted Observed Error Predicted Observed Error
(nmol/ g brain protein)
261 
 
Appendix 4 
 
Table A4.1: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of Pb in blood, 
by discriminant analysis. The table represents the type of exposure predicted by the model versus 
its real exposure (Group). 
 
                           
 
 
Table A4.2: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of Mn in blood, 
by discriminant analysis. The table represents the type of exposure predicted by the model versus 
its real exposure (group). 
 
                           
 
 
Predicted type of exposure
CR CU M
CR 10 5 3 2
CU 12 0 12 0
M 13 2 0 11
80.0% of the cases correctly classified
Group N
Predicted type of exposure
CR CU M
CR 10 7 3 0
CU 12 4 8 0
M 13 2 3 10
71.4% of the cases correctly classified
Group N
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Table A4.3: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of As in urine, 
by discriminant analysis. The table represents the type of exposure predicted by the model versus 
its real exposure (Group). 
 
                            
 
 
Table A4.4: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of Pb in urine, 
by discriminant analysis. The table represents the type of exposure predicted by the model versus 
its real exposure (Group). 
 
                              
 
 
 
 
 
Predicted type of exposure
CR CU M
CR 10 5 5 0
CU 12 7 5 0
M 13 0 4 9
54.3% of the cases correctly classified
Group N
Predicted type of exposure
CR CU M
CR 10 6 3 1
CU 12 4 8 0
M 13 7 3 3
48.6% of the cases correctly classified
Group N
263 
 
 
Table A4.5: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of delta-ALA in 
urine, by discriminant analysis. The table represents the type of exposure predicted by the model 
versus its real exposure (Group). 
 
                              
 
 
Table A4.6: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of 
uroporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
 
                             
 
 
 
Predicted type of exposure
CR CU M
CR 10 6 1 3
CU 12 7 1 4
M 13 5 1 7
40.0% of the cases correctly classified
Group N
Predicted type of exposure
CR CU M
CR 20 4 7 9
CU 20 6 8 6
M 20 2 0 18
50.0% of the cases correctly classified
Group N
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Table A4.7: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of 
heptaporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
                           
 
 
Table A4.8: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through its individual levels of 
hexaporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
                             
 
 
 
 
 
Predicted type of exposure
CR CU M
CR 20 3 10 7
CU 20 2 14 4
M 20 1 18 1
30.0% of the cases correctly classified
Group N
Predicted type of exposure
CR CU M
CR 20 16 0 4
CU 20 6 7 7
M 20 10 5 5
46.7% of the cases correctly classified
Group N
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Table A4.9: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of 
pentaporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
                            
 
 
Table A4.10: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of 
coproporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
                              
 
 
 
 
Predicted type of exposure
CR CU M
CR 20 4 8 8
CU 20 1 13 6
M 20 3 2 15
53.3% of the cases correctly classified
Group N
Predicted type of exposure
CR CU M
CR 20 15 0 5
CU 20 7 5 8
M 20 4 0 16
60.0% of the cases correctly classified
Group N
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Table A4.11: Identification of occupationally exposed subjects, miners (M), persons living in a urban 
environment (CU) and subjects from a rural area (CR) through their individual levels of 
protoporphyrins in urine, by discriminant analysis. The table represents the type of exposure 
predicted by the model versus its real exposure (Group). 
 
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
Predicted type of exposure
CR CU M
CR 20 19 1 0
CU 20 8 12 0
M 20 16 1 3
56.7% of the cases correctly classified
Group N
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Appendix 5 
 
Table A5.1: The procedure I’ was tested subsequently in 7 subjects randomly selected to do not be 
included in the models. The table shows the real type of exposure, miners (M), urban (CU) and rural 
(CR) populations,  the concentrations of urinary (U) As, Pb and ALA and the levels of Pb and Mn in 
blood (B) and the final result of the classification functions (CF) of each group [CF (CR)], [CF (CU)] 
and  [CF (M)] (see Fig. x). The CF with the highest value corresponds to the type of exposure 
predicted by the model.  
 
 
One of seven subjects external to the model was wrongly identified as belonging to the 
rural population (CR), being its original classification occupationally exposed (M). 
 
As U Pb U ln ALA U Pb B Mn B
(highest CF value)
I- H CR 0.00 2.30 1.18 1.05 0.21 CF (CR ) = 18.2
CF (CU ) = 17.6
CF (M ) = -2.02
II - H CR 1.39 20.20 1.68 0.80 0.10 CF (CR ) = 16.20 CR
CF (CU ) = 14.40
CF (M ) = -2.36
III - H CU 2.80 10.40 -0.80 1.19 0.15 CF (CR ) = 20.6 CU
CF (CU ) = 24.90
CF (M ) = 8.05
9.31 19.88 -1.03 0.28 0.34 CF (CR ) = -0.56 M
CF (CU ) = -6.01
CF (M ) = 9.19
V - H M 0.96 23.58 0.05 0.67 0.23 CF (CR ) = 11.3 CR
CF (CU ) = 9.93
CF (M ) = 2.25
VI - H M 17.99 18.60 -1,01 1.05 0.12 CF (CR ) = 19.3 M
CF (CU ) = 23.95
CF (M ) = 24.01
VII - H M 7.66 23.99 0,02 0.30 0.26 CF (CR ) = 2.26 M
CF (CU ) = -3.47
CF (M ) = 5.22
(µg/g creat) (mg/g creat)
CR
IV - H M
Subject 
(code)
Original 
group
CF values
Predicted type of 
exposure 
(µg/g blood) 
